Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ6	positive	NISCH	ENSG00000010322	COQ6	1	COQ6	1	0.00201556616456999	WBGene00008750	WBGene00008750(0)			GO:0005737;GO:0016020;GO:0005886;GO:0005515;GO:0006915;GO:0035091;GO:0042802;GO:0005768;GO:0005769;GO:0005178;GO:0019901;GO:0055037;GO:0005829;GO:0006006;GO:0008217;GO:0016601;GO:0030036;GO:0030336;GO:0032228;GO:0048243	protein binding;phosphatidylinositol binding;integrin binding;cytoplasm;membrane;endosome;plasma membrane;apoptotic process;identical protein binding;early endosome;protein kinase binding;recycling endosome;cytosol;glucose metabolic process;regulation of blood pressure;Rac protein signal transduction;actin cytoskeleton organization;negative regulation of cell migration;regulation of synaptic transmission, GABAergic;norepinephrine secretion	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell membrane;Coiled coil;Cytoplasm;Endosome;Leucine-rich repeat;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat		
COQ6	positive	COG4	ENSG00000103051	COQ6	1	COQ6	1	0.00201556616456999	WBGene00021784	WBGene00021784(1)		COG4-CDG;Microcephalic osteodysplastic dysplasia Saul-Wilson type;COG4-CDG;SAUL-WILSON SYNDROME;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIj;SAUL-WILSON SYNDROME	GO:0005737;GO:0016020;GO:0015031;GO:0005794;GO:0005829;GO:0005515;GO:0000139;GO:0017119;GO:0007030;GO:0006890;GO:0032588;GO:0006888;GO:0048213	cytoplasm;membrane;protein transport;Golgi apparatus;cytosol;protein binding;Golgi membrane;Golgi transport complex;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Golgi organization;trans-Golgi network membrane;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi vesicle prefusion complex stabilization	3D-structure;Acetylation;Alternative splicing;Congenital disorder of glycosylation;Cytoplasm;Disease mutation;Dwarfism;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-6811438;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network
COQ6	positive	PAN2	ENSG00000135473	COQ6	1	COQ6	1	0.00201556616456999	WBGene00017951	WBGene00017951(0)			GO:0003676;GO:0006397;GO:0005634;GO:0005737;GO:0046872;GO:0016787;GO:0090305;GO:0005515;GO:0004527;GO:0004518;GO:0000175;GO:0090503;GO:0000932;GO:0000288;GO:0000289;GO:0010606;GO:0031251;GO:0004535;GO:0005829	protein binding;nucleic acid binding;mRNA processing;poly(A)-specific ribonuclease activity;nuclear-transcribed mRNA poly(A) tail shortening;PAN complex;nucleus;cytoplasm;metal ion binding;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;exonuclease activity;nuclease activity;3'-5'-exoribonuclease activity;RNA phosphodiester bond hydrolysis, exonucleolytic;P-body;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;positive regulation of cytoplasmic mRNA processing body assembly;cytosol	Alternative splicing;Cytoplasm;Exonuclease;Hydrolase;Metal-binding;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat;mRNA processing	R-HSA-8953854;R-HSA-429914;R-HSA-429947	Metabolism of RNA;Deadenylation-dependent mRNA decay;Deadenylation of mRNA
COQ6	positive	VPS11	ENSG00000160695	COQ6	1	COQ6	1	0.00201556616456999	WBGene00011067	WBGene00011067(1)		VPS11-related autosomal recessive hypomyelinating leukodystrophy;Leukodystrophy hypomyelinating 12	GO:0016020;GO:0006886;GO:0015031;GO:0016192;GO:0005765;GO:0031410;GO:0006914;GO:0005764;GO:1901998;GO:0005768;GO:0005769;GO:0005776;GO:0005884;GO:0030123;GO:0030136;GO:0030897;GO:0031902;GO:0033263;GO:0048786;GO:0005515;GO:0005623;GO:0046872;GO:0000166;GO:0008333;GO:0005770;GO:0007032;GO:0007033;GO:0019905;GO:0019904;GO:1903955;GO:0030674;GO:0030139;GO:0031647;GO:0006904;GO:1902115;GO:1903364;GO:2000643;GO:0034058;GO:0035542	protein binding;intracellular protein transport;vesicle-mediated transport;membrane;protein transport;endosome;lysosomal membrane;cytoplasmic vesicle;autophagy;lysosome;toxin transport;early endosome;autophagosome;actin filament;AP-3 adaptor complex;clathrin-coated vesicle;HOPS complex;late endosome membrane;CORVET complex;presynaptic active zone;metal ion binding;nucleotide binding;endosome to lysosome transport;late endosome;endosome organization;vacuole organization;syntaxin binding;protein domain specific binding;positive regulation of protein targeting to mitochondrion;protein binding, bridging;endocytic vesicle;regulation of protein stability;vesicle docking involved in exocytosis;regulation of organelle assembly;positive regulation of cellular protein catabolic process;positive regulation of early endosome to late endosome transport;endosomal vesicle fusion;regulation of SNARE complex assembly	Acetylation;Autophagy;Coiled coil;Cytoplasmic vesicle;Disease mutation;Endosome;Leukodystrophy;Lysosome;Membrane;Metal-binding;Methylation;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Transport;Zinc;Zinc-finger		
COQ6	positive	NOXA1	ENSG00000188747	COQ6	1	COQ6	1	0.00201556616456999					GO:0005737;GO:0016020;GO:0005886;GO:0043085;GO:0005515;GO:0005829;GO:0043020;GO:0006801;GO:0016176;GO:0017124;GO:0019899;GO:0048365;GO:0042554;GO:0010310;GO:0060263	protein binding;NADPH oxidase complex;superoxide metabolic process;cytoplasm;membrane;plasma membrane;positive regulation of catalytic activity;cytosol;superoxide-generating NADPH oxidase activator activity;SH3 domain binding;enzyme binding;Rac GTPase binding;superoxide anion generation;regulation of hydrogen peroxide metabolic process;regulation of respiratory burst	Alternative splicing;Cell membrane;Cytoplasm;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;TPR repeat	R-HSA-162582;R-HSA-194315;R-HSA-195258;R-HSA-5668599	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate NADPH Oxidases
COQ6	positive	ANTKMT	ENSG00000103254	COQ6	1	COQ6	1	0.00364217228998909	WBGene00012658	WBGene00012658(0)			GO:0016020;GO:0016021;GO:0016740;GO:0008168;GO:0032259;GO:0005739;GO:0016279;GO:0031966;GO:0018023;GO:0018022	protein-lysine N-methyltransferase activity;membrane;integral component of membrane;transferase activity;methyltransferase activity;methylation;mitochondrion;mitochondrial membrane;peptidyl-lysine trimethylation;peptidyl-lysine methylation	Membrane;Methyltransferase;Mitochondrion;Reference proteome;S-adenosyl-L-methionine;Transferase;Transmembrane;Transmembrane helix		
COQ6	positive	METRN	ENSG00000103260	COQ6	1	COQ6	1	0.00364217228998909					GO:0007165;GO:0005576;GO:0007275;GO:0030154;GO:0005615;GO:0007399;GO:0005179;GO:0010001;GO:0050772	glial cell differentiation;positive regulation of axonogenesis;signal transduction;extracellular region;multicellular organism development;cell differentiation;extracellular space;nervous system development;hormone activity	Developmental protein;Differentiation;Disulfide bond;Neurogenesis;Reference proteome;Secreted;Signal		
COQ6	positive	ACAD10	ENSG00000111271	COQ6	1	COQ6	1	0.00364217228998909	WBGene00019599	WBGene00016943(0);WBGene00015894(0);WBGene00020366(0);WBGene00019406(0);WBGene00008566(0);WBGene00008567(0);WBGene00008565(0);WBGene00008564(0)			GO:0050660;GO:0055114;GO:0016627;GO:0016787;GO:0016491;GO:0005739;GO:0005759;GO:0006635;GO:0003995	hydrolase activity;flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity, acting on the CH-CH group of donors;oxidoreductase activity;mitochondrion;mitochondrial matrix;fatty acid beta-oxidation;acyl-CoA dehydrogenase activity	Acetylation;Alternative splicing;FAD;Flavoprotein;Oxidoreductase;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation
COQ6	positive	IL11RA	ENSG00000137070	COQ6	1	COQ6	1	0.00364217228998909				Craniosynostosis-dental anomalies;Autosomal Recessive Craniosynostosis;Crouzon-like craniosynostosis;Craniosynostosis and dental anomalies	GO:0016020;GO:0016021;GO:0004896;GO:0019221;GO:0009897;GO:0005886;GO:0043235;GO:0005887;GO:0004888;GO:0008284;GO:0019955;GO:0038154;GO:0060322;GO:0004921;GO:0019970;GO:0032502;GO:0005515	protein binding;membrane;cytokine receptor activity;integral component of membrane;external side of plasma membrane;plasma membrane;cytokine-mediated signaling pathway;receptor complex;integral component of plasma membrane;transmembrane signaling receptor activity;positive regulation of cell population proliferation;cytokine binding;interleukin-11-mediated signaling pathway;head development;interleukin-11 receptor activity;interleukin-11 binding;developmental process	Alternative splicing;Craniosynostosis;Disease mutation;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-6783589;R-HSA-6788467	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
COQ6	positive	SGSM2	ENSG00000141258	COQ6	1	COQ6	1	0.00364217228998909	WBGene00008018				GO:0005737;GO:0005096;GO:0042470;GO:0017137;GO:0006886;GO:0090630;GO:0043547;GO:0034499	GTPase activator activity;cytoplasm;melanosome;Rab GTPase binding;intracellular protein transport;activation of GTPase activity;positive regulation of GTPase activity;late endosome to Golgi transport	Alternative splicing;Cytoplasm;GTPase activation;Phosphoprotein;Polymorphism;Reference proteome		
COQ6	positive	CFAP410	ENSG00000160226	COQ6	1	COQ6	1	0.00364217228998909	WBGene00017320	WBGene00017320(0)		Amyotrophic lateral sclerosis;Cone rod dystrophy;Axial Spondylometaphyseal Dysplasia;RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA;Spondylometaphyseal dysplasia axial	GO:0005737;GO:0005739;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0006974;GO:0036064;GO:0003674;GO:0007010;GO:0030030;GO:0060271;GO:0001750;GO:0008360;GO:0032391;GO:0042769	protein binding;cytoplasm;intracellular membrane-bounded organelle;cytosol;mitochondrion;cytoskeleton;plasma membrane;cell projection;cellular response to DNA damage stimulus;ciliary basal body;molecular_function;cytoskeleton organization;cell projection organization;cilium assembly;photoreceptor outer segment;regulation of cell shape;photoreceptor connecting cilium;DNA damage response, detection of DNA damage;cilium organization	Alternative splicing;Cell projection;Ciliopathy;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;DNA damage;Disease mutation;Dwarfism;Leucine-rich repeat;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ6	positive	KIFC2	ENSG00000167702	COQ6	1	COQ6	1	0.00364217228998909	WBGene00002216	WBGene00002216(0)			GO:0000166;GO:0005524;GO:0003774;GO:0003777;GO:0008017;GO:0005874;GO:0007018;GO:0005737;GO:0005856;GO:0005871;GO:0008574	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;nucleotide binding;motor activity;microtubule;cytoplasm;cytoskeleton;kinesin complex;ATP-dependent microtubule motor activity, plus-end-directed	ATP-binding;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Motor protein;Nucleotide-binding;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-983189;R-HSA-983231	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ6	positive	SIK2	ENSG00000170145	COQ6	1	COQ6	1	0.00364217228998909	WBGene00002210	WBGene00002210(0)			GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0000287;GO:0035556;GO:0005515;GO:0005634;GO:0046777;GO:0046626	ATP binding;magnesium ion binding;protein phosphorylation;intracellular signal transduction;protein serine/threonine kinase activity;protein kinase activity;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;protein binding;nucleus;protein autophosphorylation;regulation of insulin receptor signaling pathway	ATP-binding;Acetylation;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ6	positive	UCKL1	ENSG00000198276	COQ6	1	COQ6	1	0.00364217228998909	WBGene00008948;WBGene00008131	WBGene00008948(1)			GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0009116;GO:0005515;GO:0004849;GO:0044206;GO:0044211;GO:0005829;GO:0016032;GO:0043097;GO:0006222	ATP binding;nucleoside metabolic process;kinase activity;uridine kinase activity;nucleus;cytoplasm;nucleotide binding;transferase activity;phosphorylation;protein binding;UMP salvage;cytosol;viral process;pyrimidine nucleoside salvage;CTP salvage;UMP biosynthetic process	ATP-binding;Alternative splicing;Cytoplasm;Host-virus interaction;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation	R-HSA-1430728;R-HSA-15869;R-HSA-73614;R-HSA-8956321	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
COQ6	positive	TCTN1	ENSG00000204852	COQ6	1	COQ6	1	0.00364217228998909	WBGene00017120	WBGene00017120(0)		Joubert Syndrome;Joubert Syndrome and Related Disorders;JOUBERT SYNDROME 13	GO:0005737;GO:0005856;GO:0042995;GO:0005576;GO:0007275;GO:0060271;GO:0005829;GO:0030030;GO:0097711;GO:0036038;GO:1904491;GO:0001701;GO:0001841;GO:0008589;GO:0021523;GO:0021537;GO:0021904;GO:0021956;GO:0005615;GO:0016020;GO:0035869	cytoplasm;cytoskeleton;cell projection;extracellular region;multicellular organism development;cilium assembly;cytosol;cell projection organization;ciliary basal body-plasma membrane docking;MKS complex;protein localization to ciliary transition zone;in utero embryonic development;neural tube formation;regulation of smoothened signaling pathway;somatic motor neuron differentiation;telencephalon development;dorsal/ventral neural tube patterning;central nervous system interneuron axonogenesis;extracellular space;membrane;ciliary transition zone	Alternative splicing;Cell projection;Ciliopathy;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Developmental protein;Glycoprotein;Joubert syndrome;Reference proteome;Secreted;Signal	R-HSA-1852241;R-HSA-5617833;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
COQ6	positive	KLHL20	ENSG00000076321	COQ6	1	COQ6	1	0.00636204249060557	WBGene00020030	WBGene00020030(0)			GO:0005634;GO:0005737;GO:0015031;GO:0005794;GO:0043066;GO:0005829;GO:0016567;GO:0003779;GO:0042995;GO:0005515;GO:0004842;GO:0048471;GO:0030425;GO:0030424;GO:0005802;GO:0043161;GO:0043687;GO:0016605;GO:0006895;GO:0015629;GO:0031463;GO:0007010;GO:0035455;GO:0019964;GO:1990390	protein binding;nucleus;cytoplasm;protein transport;Golgi apparatus;negative regulation of apoptotic process;cytosol;protein ubiquitination;actin binding;cell projection;ubiquitin-protein transferase activity;perinuclear region of cytoplasm;dendrite;axon;PML body;trans-Golgi network;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;Golgi to endosome transport;actin cytoskeleton;Cul3-RING ubiquitin ligase complex;cytoskeleton organization;response to interferon-alpha;interferon-gamma binding;protein K33-linked ubiquitination	3D-structure;Actin-binding;Alternative splicing;Cell projection;Cytoplasm;Golgi apparatus;Kelch repeat;Nucleus;Protein transport;Reference proteome;Repeat;Transport;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-983168;R-HSA-983169;R-HSA-8951664	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
COQ6	positive	MOK	ENSG00000080823	COQ6	1	COQ6	1	0.00636204249060557		WBGene00009921(0)			GO:0004672;GO:0005524;GO:0006468;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0042995;GO:0051726;GO:0035556;GO:0005929;GO:0097546;GO:0010468;GO:0007165;GO:0004693	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;cell projection;regulation of cell cycle;intracellular signal transduction;cilium;ciliary base;regulation of gene expression;signal transduction;cyclin-dependent protein serine/threonine kinase activity	ATP-binding;Alternative splicing;Cell projection;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ6	positive	MLYCD	ENSG00000103150	COQ6	1	COQ6	1	0.00636204249060557	WBGene00009439	WBGene00009439(1)		Malonic aciduria;MALONYL-CoA DECARBOXYLASE DEFICIENCY;MALONYL-CoA DECARBOXYLASE DEFICIENCY	GO:0005737;GO:0016829;GO:0005739;GO:0005759;GO:0006629;GO:0006631;GO:0006633;GO:0016831;GO:0005777;GO:0042802;GO:0050080;GO:0006085;GO:0046321;GO:2001294;GO:0005782;GO:0005829;GO:0006625;GO:0006637;GO:0002931;GO:0010906;GO:0019395;GO:0031998;GO:0046320	fatty acid biosynthetic process;malonyl-CoA decarboxylase activity;cytoplasm;lyase activity;mitochondrion;mitochondrial matrix;lipid metabolic process;fatty acid metabolic process;carboxy-lyase activity;peroxisome;identical protein binding;acetyl-CoA biosynthetic process;positive regulation of fatty acid oxidation;malonyl-CoA catabolic process;peroxisomal matrix;cytosol;protein targeting to peroxisome;acyl-CoA metabolic process;response to ischemia;regulation of glucose metabolic process;fatty acid oxidation;regulation of fatty acid beta-oxidation;regulation of fatty acid oxidation	3D-structure;Acetylation;Alternative initiation;Cytoplasm;Decarboxylase;Disulfide bond;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Lyase;Mitochondrion;Peroxisome;Reference proteome;Transit peptide		
COQ6	positive	TGFB3	ENSG00000119699	COQ6	1	COQ6	1	0.00636204249060557	WBGene00021594			Familial isolated arrhythmogenic ventricular dysplasia biventricular form;Familial isolated arrhythmogenic ventricular dysplasia left dominant form;Familial isolated arrhythmogenic ventricular dysplasia right dominant form;Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA FAMILIAL 1;LOEYS-DIETZ SYNDROME 5	GO:0050714;GO:0008284;GO:1904706;GO:0007179;GO:0008285;GO:0043065;GO:0010718;GO:0045944;GO:0045893;GO:0005615;GO:0043231;GO:0008083;GO:0007165;GO:0005515;GO:0005576;GO:0005160;GO:0042802;GO:0005114;GO:0034714;GO:0046982;GO:0000187;GO:0001666;GO:0007565;GO:0007568;GO:0030512;GO:0034616;GO:0042060;GO:0043627;GO:0048565;GO:0048702;GO:0048839;GO:0051781;GO:0060364;GO:0005634;GO:0005737;GO:0009986;GO:0030141;GO:0030315;GO:0043025;GO:0042981;GO:0062023;GO:0060395;GO:0002576;GO:0005886;GO:0030501;GO:0030509;GO:0005125;GO:0010862;GO:0043408;GO:0048468;GO:0031093;GO:0051491;GO:0062009;GO:0051496;GO:0034713;GO:0043524;GO:0032967;GO:0042127;GO:0050431;GO:0032570;GO:0001701;GO:0007435;GO:0010936;GO:0030879;GO:0042476;GO:0042704;GO:0043932;GO:0045216;GO:0048286;GO:0060325;GO:0060391;GO:0070483;GO:1905075;GO:0016049	growth factor activity;extracellular space;transforming growth factor beta receptor binding;positive regulation of protein secretion;positive regulation of cell population proliferation;negative regulation of vascular smooth muscle cell proliferation;transforming growth factor beta receptor signaling pathway;negative regulation of cell population proliferation;positive regulation of apoptotic process;positive regulation of epithelial to mesenchymal transition;positive regulation of transcription by RNA polymerase II;positive regulation of transcription, DNA-templated;intracellular membrane-bounded organelle;signal transduction;protein binding;extracellular region;identical protein binding;positive regulation of cell division;type II transforming growth factor beta receptor binding;type III transforming growth factor beta receptor binding;protein-containing complex binding;activation of MAPK activity;response to hypoxia;female pregnancy;aging;negative regulation of transforming growth factor beta receptor signaling pathway;response to laminar fluid shear stress;wound healing;response to estrogen;digestive tract development;embryonic neurocranium morphogenesis;inner ear development;frontal suture morphogenesis;nucleus;cytoplasm;cell surface;secretory granule;T-tubule;neuronal cell body;collagen-containing extracellular matrix;SMAD protein signal transduction;regulation of cell population proliferation;platelet degranulation;plasma membrane;positive regulation of bone mineralization;BMP signaling pathway;cytokine activity;positive regulation of pathway-restricted SMAD protein phosphorylation;platelet alpha granule lumen;positive regulation of filopodium assembly;secondary palate development;positive regulation of stress fiber assembly;type I transforming growth factor beta receptor binding;negative regulation of neuron apoptotic process;positive regulation of collagen biosynthetic process;transforming growth factor beta binding;response to progesterone;in utero embryonic development;salivary gland morphogenesis;negative regulation of macrophage cytokine production;mammary gland development;odontogenesis;uterine wall breakdown;ossification involved in bone remodeling;cell-cell junction organization;lung alveolus development;face morphogenesis;positive regulation of SMAD protein signal transduction;detection of hypoxia;positive regulation of tight junction disassembly	3D-structure;Alternative splicing;Cardiomyopathy;Cleavage on pair of basic residues;Disease mutation;Disulfide bond;Extracellular matrix;Glycoprotein;Growth factor;Methylation;Mitogen;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-109582;R-HSA-1474244;R-HSA-3000178;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-1566948;R-HSA-2129379	Hemostasis;Extracellular matrix organization;ECM proteoglycans;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Elastic fibre formation;Molecules associated with elastic fibres
COQ6	positive	ZFP30	ENSG00000120784	COQ6	1	COQ6	1	0.00636204249060557	WBGene00044651;WBGene00001223;WBGene00021931				GO:0003676;GO:0006355;GO:0005622;GO:0005634;GO:0046872;GO:0003677	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding	DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ6	positive	PEX6	ENSG00000124587	COQ6	1	COQ6	1	0.00636204249060557	WBGene00004195	WBGene00004195(0)		Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome;Deafness-enamel hypoplasia-nail defects syndrome;Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 4;Zellweger Syndrome;HEIMLER SYNDROME 2;PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 4B	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0042995;GO:0005515;GO:0007031;GO:0005778;GO:0097733;GO:0005777;GO:0016887;GO:0050821;GO:0001750;GO:0006625;GO:0008022;GO:0016558;GO:0044877;GO:0042623;GO:0016561	ATP binding;cytoplasm;membrane;nucleotide binding;cytosol;cell projection;protein binding;ATPase activity;peroxisome organization;peroxisomal membrane;photoreceptor cell cilium;peroxisome;protein stabilization;photoreceptor outer segment;protein targeting to peroxisome;protein C-terminus binding;protein import into peroxisome matrix;protein-containing complex binding;ATPase activity, coupled;protein import into peroxisome matrix, translocation	ATP-binding;Alternative splicing;Amelogenesis imperfecta;Cell projection;Cytoplasm;Deafness;Disease mutation;Membrane;Methylation;Nucleotide-binding;Peroxisome;Peroxisome biogenesis;Peroxisome biogenesis disorder;Polymorphism;Reference proteome;Repeat;Zellweger syndrome	R-HSA-9033241;R-HSA-9609507	Peroxisomal protein import;Protein localization
COQ6	positive	IFT172	ENSG00000138002	COQ6	1	COQ6	1	0.00636204249060557	WBGene00003883	WBGene00003883(1)		Bardet-Biedl syndrome;Jeune syndrome;Retinitis pigmentosa;Saldino-Mainzer syndrome;Jeune syndrome;Mainzer-Saldino Syndrome;RETINITIS PIGMENTOSA 71;SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY	GO:0042995;GO:0007275;GO:0005929;GO:0035735;GO:0060271;GO:0030992;GO:0036064;GO:0097542;GO:1903561;GO:0005930;GO:0042073;GO:0001841;GO:0001843;GO:0001947;GO:0007219;GO:0007224;GO:0007368;GO:0007420;GO:0007507;GO:0008544;GO:0008589;GO:0009953;GO:0016485;GO:0021522;GO:0021915;GO:0031122;GO:0045880;GO:0050680;GO:0060021;GO:0060173;GO:0060348;GO:0061525;GO:0070986;GO:1905515;GO:0097225;GO:0097228;GO:0097598;GO:0005515	protein binding;cell projection;multicellular organism development;cilium;intraciliary transport involved in cilium assembly;cilium assembly;intraciliary transport particle B;ciliary basal body;ciliary tip;extracellular vesicle;axoneme;intraciliary transport;neural tube formation;neural tube closure;heart looping;Notch signaling pathway;smoothened signaling pathway;determination of left/right symmetry;brain development;heart development;epidermis development;regulation of smoothened signaling pathway;dorsal/ventral pattern formation;protein processing;spinal cord motor neuron differentiation;neural tube development;cytoplasmic microtubule organization;negative regulation of smoothened signaling pathway;positive regulation of smoothened signaling pathway;embryonic camera-type eye morphogenesis;negative regulation of epithelial cell proliferation;roof of mouth development;limb development;bone development;hindgut development;left/right axis specification;non-motile cilium assembly;sperm midpiece;sperm principal piece;sperm cytoplasmic droplet	Acetylation;Alternative splicing;Cell projection;Ciliopathy;Cilium;Developmental protein;Disease mutation;Isopeptide bond;Methylation;Polymorphism;Reference proteome;Repeat;Retinitis pigmentosa;TPR repeat;Ubl conjugation;WD repeat	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-162582;R-HSA-5358351;R-HSA-5610787	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
COQ6	positive	LOXL4	ENSG00000138131	COQ6	1	COQ6	1	0.00636204249060557					GO:0016020;GO:0046872;GO:0016491;GO:0055114;GO:0005615;GO:0005515;GO:0005576;GO:0005044;GO:0006897;GO:0005507;GO:0070062;GO:0016641;GO:0030199;GO:0043235;GO:0004720;GO:0018057	membrane;oxidation-reduction process;copper ion binding;scavenger receptor activity;oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor;metal ion binding;oxidoreductase activity;extracellular space;protein binding;extracellular region;endocytosis;extracellular exosome;receptor complex;collagen fibril organization;protein-lysine 6-oxidase activity;peptidyl-lysine oxidation	Copper;Disulfide bond;Glycoprotein;LTQ;Metal-binding;Oxidoreductase;Polymorphism;Reference proteome;Repeat;Secreted;Signal;TPQ	R-HSA-1474244;R-HSA-1474290;R-HSA-2022090;R-HSA-2243919;R-HSA-1566948	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils;Elastic fibre formation
COQ6	positive	SLC26A1	ENSG00000145217	COQ6	1	COQ6	1	0.00636204249060557	WBGene00010788;WBGene00010789;WBGene00012259;WBGene00013963;WBGene00018283;WBGene00020914;WBGene00017464	WBGene00018283(0);WBGene00020914(0);WBGene00012259(1);WBGene00013963(1);WBGene00010788(1);WBGene00010789(1);WBGene00017464(1)		NEPHROLITHIASIS CALCIUM OXALATE	GO:0016020;GO:0016021;GO:0055085;GO:0005887;GO:0006811;GO:0005886;GO:0015297;GO:0006821;GO:0015701;GO:1902476;GO:0008271;GO:0015116;GO:0008272;GO:0098656;GO:1902358;GO:0016323;GO:0050428;GO:0015106;GO:0015108;GO:0015301;GO:0019531;GO:0019532	integral component of membrane;membrane;transmembrane transport;integral component of plasma membrane;chloride transport;secondary active sulfate transmembrane transporter activity;sulfate transport;sulfate transmembrane transporter activity;chloride transmembrane transporter activity;oxalate transmembrane transporter activity;oxalate transport;ion transport;plasma membrane;antiporter activity;bicarbonate transport;chloride transmembrane transport;anion transmembrane transport;sulfate transmembrane transport;basolateral plasma membrane;3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;bicarbonate transmembrane transporter activity;anion:anion antiporter activity	Alternative splicing;Anion exchange;Antiport;Cell membrane;Disease mutation;Glycoprotein;Ion channel;Ion transport;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-382551;R-HSA-425407;R-HSA-71387;R-HSA-156580;R-HSA-211859;R-HSA-1630316;R-HSA-156584;R-HSA-425393;R-HSA-174362;R-HSA-427601	Metabolism;Transport of small molecules;SLC-mediated transmembrane transport;Metabolism of carbohydrates;Phase II - Conjugation of compounds;Biological oxidations;Glycosaminoglycan metabolism;Cytosolic sulfonation of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;Transport and synthesis of PAPS;Multifunctional anion exchangers
COQ6	positive	DCHS1	ENSG00000166341	COQ6	1	COQ6	1	0.00636204249060557	WBGene00019994;WBGene00000396;WBGene00001980			Cerebro-facio-articular syndrome;Familial mitral valve prolapse;periventricular neuronal heterotopia;MITRAL VALVE PROLAPSE 2;VAN MALDERGEM SYNDROME 1	GO:0016020;GO:0016021;GO:0005509;GO:0007155;GO:0007156;GO:0005886;GO:0035329;GO:0022008;GO:0007157;GO:0016339;GO:0001658;GO:0001822;GO:0003007;GO:0003183;GO:0003192;GO:0003273;GO:0007389;GO:0009653;GO:0016477;GO:0021915;GO:0036342;GO:0043931;GO:0048565;GO:0072006;GO:0072137;GO:0072659;GO:0090102;GO:0098609;GO:0045177	plasma membrane;membrane;calcium ion binding;homophilic cell adhesion via plasma membrane adhesion molecules;cell adhesion;integral component of membrane;hippo signaling;neurogenesis;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;branching involved in ureteric bud morphogenesis;kidney development;heart morphogenesis;mitral valve morphogenesis;mitral valve formation;cell migration involved in endocardial cushion formation;pattern specification process;anatomical structure morphogenesis;cell migration;neural tube development;post-anal tail morphogenesis;ossification involved in bone maturation;digestive tract development;nephron development;condensed mesenchymal cell proliferation;protein localization to plasma membrane;cochlea development;cell-cell adhesion;apical part of cell	Calcium;Cell adhesion;Cell membrane;Deafness;Disease mutation;Glycoprotein;Membrane;Mental retardation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
COQ6	positive	COQ4	ENSG00000167113	COQ6	1	COQ6	1	0.00636204249060557	WBGene00000764	WBGene00000764(0)		Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome;COENZYME Q10 DEFICIENCY PRIMARY 7;COENZYME Q10 DEFICIENCY PRIMARY 7	GO:0016020;GO:0005739;GO:0005743;GO:0006744;GO:0005515;GO:0032991;GO:0031314	mitochondrial inner membrane;ubiquinone biosynthetic process;membrane;mitochondrion;protein binding;protein-containing complex;extrinsic component of mitochondrial inner membrane	Alternative splicing;Disease mutation;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Transit peptide;Ubiquinone biosynthesis		
COQ6	positive	TMEM134	ENSG00000172663	COQ6	1	COQ6	1	0.00636204249060557	WBGene00017676	WBGene00017676(0)			GO:0005737;GO:0016020;GO:0016021;GO:0048471;GO:0005515	cytoplasm;membrane;integral component of membrane;perinuclear region of cytoplasm;protein binding;viral process	Alternative splicing;Cytoplasm;Host-virus interaction;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ6	positive	ADCK5	ENSG00000173137	COQ6	1	COQ6	1	0.00636204249060557	WBGene00008410				GO:0016020;GO:0016021;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0006468;GO:0005515	membrane;integral component of membrane;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein phosphorylation;protein binding	Kinase;Membrane;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Transmembrane;Transmembrane helix		
COQ6	positive	CTSF	ENSG00000174080	COQ6	1	COQ6	1	0.00636204249060557	WBGene00007055;WBGene00000776;WBGene00019986	WBGene00000784(0);WBGene00000785(0);WBGene00013076(0);WBGene00013072(0);WBGene00013764(0);WBGene00009158(0);WBGene00019314(0);WBGene00016306(0);WBGene00016300(0);WBGene00044760(0);WBGene00022189(0);WBGene00019986(0);WBGene00007055(0);WBGene00000782(0);WBGene00000781(0)		CLN13 disease;CEROID LIPOFUSCINOSIS NEURONAL 13	GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005764;GO:0005615;GO:0070062;GO:0004197;GO:0062023;GO:0019886;GO:0043202;GO:1903561;GO:0051603	proteolysis;cysteine-type peptidase activity;hydrolase activity;peptidase activity;lysosome;extracellular space;extracellular exosome;cysteine-type endopeptidase activity;collagen-containing extracellular matrix;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal lumen;extracellular vesicle;proteolysis involved in cellular protein catabolic process	3D-structure;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Neurodegeneration;Neuronal ceroid lipofuscinosis;Polymorphism;Protease;Reference proteome;Signal;Thiol protease;Zymogen	R-HSA-1280218;R-HSA-168256;R-HSA-2132295	Adaptive Immune System;Immune System;MHC class II antigen presentation
COQ6	positive	PHYKPL	ENSG00000175309	COQ6	1	COQ6	1	0.00636204249060557	WBGene00020139			Phosphohydroxylysinuria	GO:0003824;GO:0016829;GO:0005739;GO:0005515;GO:0030170;GO:0042802;GO:0008483;GO:0006554;GO:0005759;GO:0030574	catalytic activity;pyridoxal phosphate binding;transaminase activity;lyase activity;mitochondrion;protein binding;identical protein binding;lysine catabolic process;mitochondrial matrix;collagen catabolic process	Alternative splicing;Disease mutation;Lyase;Mitochondrion;Polymorphism;Pyridoxal phosphate;Reference proteome	R-HSA-1430728;R-HSA-71064;R-HSA-71291;R-HSA-1474228;R-HSA-1474244;R-HSA-1442490	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen degradation
COQ6	positive	SEPTIN1	ENSG00000180096	COQ6	1	COQ6	1	0.00636204249060557	WBGene00006793	WBGene00006795(0)			GO:0005737;GO:0000166;GO:0005525;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005815;GO:0030496;GO:0042802;GO:0003924;GO:0015630;GO:0061640;GO:0005940;GO:0031105;GO:0008021;GO:0017157;GO:0007056;GO:0051311;GO:0072687	GTP binding;cytoplasm;nucleotide binding;cytoskeleton;cell division;protein binding;cell cycle;microtubule organizing center;midbody;identical protein binding;GTPase activity;molecular adaptor activity;cellular protein localization;cytoskeleton-dependent cytokinesis;septin ring;microtubule cytoskeleton;septin complex;cell division site;synaptic vesicle;regulation of exocytosis;cell;spindle assembly involved in female meiosis;meiotic metaphase plate congression;meiotic spindle	Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome		
COQ6	positive	SLC25A42	ENSG00000181035	COQ6	1	COQ6	1	0.00636204249060557	WBGene00009666	WBGene00009666(1)		METABOLIC CRISES RECURRENT WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION	GO:0005634;GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005739;GO:0005743;GO:0015217;GO:0015228;GO:0080122;GO:0015866;GO:0005347;GO:0015867;GO:0043262;GO:0035349;GO:0080121	transmembrane transporter activity;transmembrane transport;mitochondrial inner membrane;nucleus;membrane;integral component of membrane;mitochondrion;ADP transmembrane transporter activity;coenzyme A transmembrane transporter activity;AMP transmembrane transporter activity;ADP transport;ATP transmembrane transporter activity;ATP transport;adenosine-diphosphatase activity;coenzyme A transmembrane transport;AMP transport	Disease mutation;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport		
COQ6	positive	AP2A2	ENSG00000183020	COQ6	1	COQ6	1	0.00636204249060557	WBGene00000161	WBGene00000161(0)			GO:0016020;GO:0006886;GO:0015031;GO:0016192;GO:0030117;GO:0030131;GO:0005886;GO:0005515;GO:0005905;GO:0008289;GO:0072583;GO:0035615;GO:0030122;GO:0005829;GO:0006897;GO:0003674;GO:0060071;GO:0043312;GO:0019886;GO:0030667;GO:0061024;GO:0048013;GO:0030666;GO:0031410;GO:0034383;GO:0101003;GO:0036020;GO:0050690;GO:0019901;GO:0032802;GO:0030669;GO:0045334;GO:0019904;GO:0097718	intracellular protein transport;vesicle-mediated transport;membrane coat;membrane;protein transport;clathrin adaptor complex;clathrin adaptor activity;clathrin-dependent endocytosis;AP-2 adaptor complex;plasma membrane;protein binding;lipid binding;clathrin-coated pit;endocytosis;cytosol;molecular_function;Wnt signaling pathway, planar cell polarity pathway;neutrophil degranulation;antigen processing and presentation of exogenous peptide antigen via MHC class II;secretory granule membrane;membrane organization;ephrin receptor signaling pathway;endocytic vesicle membrane;cytoplasmic vesicle;low-density lipoprotein particle clearance;ficolin-1-rich granule membrane;endolysosome membrane;regulation of defense response to virus by virus;protein kinase binding;low-density lipoprotein particle receptor catabolic process;clathrin-coated endocytic vesicle membrane;clathrin-coated endocytic vesicle;protein domain specific binding;disordered domain specific binding	Alternative splicing;Cell membrane;Coated pit;Endocytosis;Lipid-binding;Membrane;Protein transport;Reference proteome;Transport	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-382551;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-195721;R-HSA-3858494;R-HSA-4086400;R-HSA-2132295;R-HSA-9006934;R-HSA-6798695;R-HSA-8856828;R-HSA-2682334;R-HSA-166520;R-HSA-187037;R-HSA-8856825;R-HSA-5099900;R-HSA-3928665;R-HSA-174824;R-HSA-8964038;R-HSA-8964043;R-HSA-164938;R-HSA-164952;R-HSA-167590;R-HSA-177504;R-HSA-182218;R-HSA-5140745;R-HSA-8866427	Adaptive Immune System;Innate Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Transport of small molecules;Signal Transduction;Membrane Trafficking;Disease;HIV Infection;Infectious disease;Host Interactions of HIV factors;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;MHC class II antigen presentation;Signaling by Receptor Tyrosine Kinases;Neutrophil degranulation;Clathrin-mediated endocytosis;EPH-Ephrin signaling;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Cargo recognition for clathrin-mediated endocytosis;WNT5A-dependent internalization of FZD4;EPH-ephrin mediated repulsion of cells;Plasma lipoprotein assembly, remodeling, and clearance;LDL clearance;Plasma lipoprotein clearance;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;VLDLR internalisation and degradation
COQ6	positive	ZNF846	ENSG00000196605	COQ6	1	COQ6	1	0.00636204249060557	WBGene00021931				GO:0003676;GO:0006355;GO:0005634;GO:0046872;GO:0003677;GO:0005515;GO:0003700;GO:0043565;GO:0005622	nucleic acid binding;regulation of transcription, DNA-templated;nucleus;metal ion binding;DNA binding;protein binding;DNA-binding transcription factor activity;sequence-specific DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ6	positive	ABCB8	ENSG00000197150	COQ6	1	COQ6	1	0.00636204249060557	WBGene00001816;WBGene00001811;WBGene00001813;WBGene00001817;WBGene00001818	WBGene00004003(0);WBGene00003995(0);WBGene00004000(0);WBGene00004001(0);WBGene00004002(0);WBGene00001817(0);WBGene00001818(0);WBGene00004008(0);WBGene00004006(0)			GO:0016020;GO:0016021;GO:0055085;GO:0005634;GO:0000166;GO:0005524;GO:0005730;GO:0005739;GO:0005743;GO:0016887;GO:0042626;GO:0031966;GO:0043190	integral component of membrane;ATP binding;transmembrane transport;ATPase-coupled transmembrane transporter activity;ATPase activity;membrane;nucleotide binding;nucleoplasm;nucleolus;mitochondrion;mitochondrial inner membrane;ion transport;potassium ion transport;potassium ion transmembrane transport;protein binding;mitochondrial membrane;mitochondrial ATP-gated potassium channel complex;ATP-binding cassette (ABC) transporter complex	3D-structure;ATP-binding;Alternative splicing;Ion transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Polymorphism;Potassium;Potassium transport;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-382556;R-HSA-1369007	Transport of small molecules;ABC-family proteins mediated transport;Mitochondrial ABC transporters
COQ6	positive	SPG7	ENSG00000197912	COQ6	1	COQ6	1	0.00636204249060557	WBGene00021425;WBGene00021615;WBGene00022429;WBGene00004978;WBGene00010842	WBGene00021615(1);WBGene00022429(0);WBGene00021425(1)		Primary lateral sclerosis;Spastic paraplegia type 7;SPASTIC PARAPLEGIA 7 AUTOSOMAL RECESSIVE	GO:0016020;GO:0016021;GO:0008270;GO:0005524;GO:0006508;GO:0004222;GO:0046872;GO:0000166;GO:0016787;GO:0005743;GO:0005739;GO:1904115;GO:0005515;GO:0008233;GO:0008237;GO:0007399;GO:0051082;GO:0006851;GO:0046902;GO:0007005;GO:0005757;GO:1902686;GO:0008089;GO:0005745	zinc ion binding;integral component of membrane;ATP binding;membrane;proteolysis;metalloendopeptidase activity;metal ion binding;nucleotide binding;hydrolase activity;mitochondrial inner membrane;mitochondrion;axon cytoplasm;protein binding;peptidase activity;metallopeptidase activity;nervous system development;unfolded protein binding;mitochondrial calcium ion transmembrane transport;mitochondrion organization;mitochondrial permeability transition pore complex;regulation of mitochondrial membrane permeability;mitochondrial outer membrane permeabilization involved in programmed cell death;anterograde axonal transport;m-AAA complex	3D-structure;ATP-binding;Alternative splicing;Disease mutation;Hereditary spastic paraplegia;Hydrolase;Membrane;Metal-binding;Metalloprotease;Mitochondrion;Mitochondrion inner membrane;Neurodegeneration;Nitration;Nucleotide-binding;Osteogenesis imperfecta;Polymorphism;Protease;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Zinc	R-HSA-382551;R-HSA-8949215;R-HSA-8949664	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
COQ6	positive	ZNF783	ENSG00000204946	COQ6	1	COQ6	1	0.00636204249060557					GO:0003676;GO:0005634;GO:0006355;GO:0003677;GO:0005515;GO:0042802;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;DNA binding;protein binding	Acetylation;Alternative splicing;Coiled coil;DNA-binding;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation		
COQ6	positive	VPS16	ENSG00000215305	COQ6	1	COQ6	1	0.00636204249060557	WBGene00006516	WBGene00006516(0)			GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0005765;GO:0005515;GO:0031410;GO:0006914;GO:0005764;GO:0005768;GO:0005769;GO:0005776;GO:0030136;GO:0030897;GO:0031902;GO:0008333;GO:0005770;GO:0055037;GO:0016197;GO:0003779;GO:0097352;GO:0035542;GO:0007033;GO:0051015;GO:0032889;GO:0030424;GO:0043025	cytoplasm;intracellular protein transport;vacuole organization;membrane;protein transport;endosome;lysosomal membrane;protein binding;cytoplasmic vesicle;autophagy;lysosome;early endosome;autophagosome;clathrin-coated vesicle;HOPS complex;late endosome membrane;endosome to lysosome transport;late endosome;recycling endosome;endosomal transport;actin binding;autophagosome maturation;regulation of SNARE complex assembly;actin filament binding;regulation of vacuole fusion, non-autophagic;axon;neuronal cell body	3D-structure;Alternative splicing;Autophagy;Cytoplasmic vesicle;Disease mutation;Endosome;Lysosome;Membrane;Nitration;Polymorphism;Protein transport;Reference proteome;Transport		
COQ6	negative	HPSE	ENSG00000173083	COQ6	1	COQ6	1	2.86699723540673e-05					GO:0005634;GO:0016020;GO:0043231;GO:0005654;GO:0016787;GO:0007155;GO:0005765;GO:0005576;GO:0005764;GO:0016798;GO:0005515;GO:0031012;GO:0043312;GO:0007160;GO:0035580;GO:0043202;GO:0006027;GO:0045545;GO:0051897;GO:0046983;GO:0006029;GO:0033690;GO:0004566;GO:0030200;GO:0010575;GO:0060055;GO:0030194;GO:0030305;GO:0051797;GO:0042060;GO:0051798;GO:0061042;GO:0045121	membrane;hydrolase activity, acting on glycosyl bonds;nucleus;intracellular membrane-bounded organelle;nucleoplasm;hydrolase activity;cell adhesion;lysosomal membrane;extracellular region;lysosome;protein binding;extracellular matrix;neutrophil degranulation;cell-matrix adhesion;specific granule lumen;lysosomal lumen;glycosaminoglycan catabolic process;syndecan binding;positive regulation of protein kinase B signaling;proteoglycan metabolic process;positive regulation of osteoblast proliferation;beta-glucuronidase activity;heparan sulfate proteoglycan catabolic process;positive regulation of vascular endothelial growth factor production;angiogenesis involved in wound healing;positive regulation of blood coagulation;heparanase activity;regulation of hair follicle development;wound healing;positive regulation of hair follicle development;vascular wound healing;membrane raft	3D-structure;Alternative splicing;Calcium;Cell adhesion;Direct protein sequencing;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Magnesium;Membrane;Nucleus;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-71387;R-HSA-6798695;R-HSA-1630316;R-HSA-1638091;R-HSA-2024096	Innate Immune System;Immune System;Metabolism;Metabolism of carbohydrates;Neutrophil degranulation;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG degradation
COQ6	negative	JARID2	ENSG00000008083	COQ6	1	COQ6	1	7.01410263680424e-05	WBGene00004319				GO:0005634;GO:0005739;GO:0003677;GO:0006325;GO:0007275;GO:0030154;GO:0006338;GO:0032452;GO:0016577;GO:0035097;GO:0005654;GO:0003682;GO:0035098;GO:0048863;GO:0007417;GO:0045892;GO:0045814;GO:0051574;GO:0034721;GO:0000977;GO:0001227;GO:0008134;GO:0000122;GO:0001889;GO:0008285;GO:0010614;GO:0031061;GO:0042127;GO:0048536;GO:0048538;GO:0060044;GO:1990830	DNA binding;nucleus;nucleoplasm;mitochondrion;chromatin organization;multicellular organism development;cell differentiation;chromatin remodeling;histone demethylase activity;histone demethylation;histone methyltransferase complex;chromatin binding;ESC/E(Z) complex;stem cell differentiation;central nervous system development;negative regulation of transcription, DNA-templated;negative regulation of gene expression, epigenetic;positive regulation of histone H3-K9 methylation;histone H3-K4 demethylation, trimethyl-H3-K4-specific;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription factor binding;negative regulation of transcription by RNA polymerase II;liver development;negative regulation of cell population proliferation;negative regulation of cardiac muscle hypertrophy;negative regulation of histone methylation;regulation of cell population proliferation;spleen development;thymus development;negative regulation of cardiac muscle cell proliferation;cellular response to leukemia inhibitory factor	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Developmental protein;Differentiation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-74160;R-HSA-212165;R-HSA-212300	Gene expression (Transcription);Epigenetic regulation of gene expression;PRC2 methylates histones and DNA
COQ6	negative	RAB31	ENSG00000168461	COQ6	1	COQ6	1	7.01410263680424e-05					GO:0016020;GO:0000166;GO:0003924;GO:0005525;GO:0005794;GO:0031410;GO:0005886;GO:0006886;GO:0005768;GO:0005769;GO:0005515;GO:0005829;GO:0001891;GO:0030670;GO:0032482;GO:0043312;GO:0043001;GO:0019003;GO:0030667;GO:0032869;GO:0032588;GO:0045055;GO:0045335;GO:0031623;GO:0031901;GO:0090382;GO:0060100;GO:0036186	GTP binding;GTPase activity;membrane;nucleotide binding;endosome;Golgi apparatus;cytoplasmic vesicle;plasma membrane;protein binding;intracellular protein transport;early endosome;cytosol;phagocytic cup;phagocytic vesicle membrane;Rab protein signal transduction;endomembrane system;neutrophil degranulation;Golgi to plasma membrane protein transport;GDP binding;secretory granule membrane;cellular response to insulin stimulus;trans-Golgi network membrane;regulated exocytosis;phagocytic vesicle;receptor internalization;early endosome membrane;phagosome maturation;positive regulation of phagocytosis, engulfment;early phagosome membrane	3D-structure;Cytoplasmic vesicle;Endosome;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Nucleotide-binding;Phosphoprotein;Prenylation;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719;R-HSA-6798695	Innate Immune System;Immune System;Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation;Neutrophil degranulation
COQ6	negative	UBE2D3	ENSG00000109332	COQ6	1	COQ6	1	0.00016417423304671	WBGene00002344				GO:0016020;GO:0000166;GO:0005524;GO:0016740;GO:0016567;GO:0005886;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0006915;GO:0005768;GO:0031625;GO:0061631;GO:0006511;GO:0000151;GO:0070936;GO:0005654;GO:0005829;GO:0070062;GO:0010008;GO:0006625;GO:0002756;GO:0035666;GO:0030509;GO:0006464;GO:0043161;GO:0070979;GO:1903955;GO:0000209;GO:0006513;GO:0051865;GO:0000122	membrane;nucleotide binding;ATP binding;transferase activity;protein ubiquitination;endosome;plasma membrane;protein binding;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;apoptotic process;ubiquitin protein ligase binding;ubiquitin conjugating enzyme activity;ubiquitin-dependent protein catabolic process;ubiquitin ligase complex;protein K48-linked ubiquitination;nucleoplasm;cytosol;extracellular exosome;endosome membrane;protein targeting to peroxisome;MyD88-independent toll-like receptor signaling pathway;TRIF-dependent toll-like receptor signaling pathway;BMP signaling pathway;cellular protein modification process;proteasome-mediated ubiquitin-dependent protein catabolic process;protein K11-linked ubiquitination;positive regulation of protein targeting to mitochondrion;protein polyubiquitination;protein monoubiquitination;protein autoubiquitination;negative regulation of transcription by RNA polymerase II;cellular response to cadmium ion;cellular response to mercury ion	3D-structure;ATP-binding;Alternative splicing;Apoptosis;Cell membrane;DNA damage;DNA repair;Disulfide bond;Endosome;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-162582;R-HSA-1234174;R-HSA-1234176;R-HSA-2262752;R-HSA-8951664;R-HSA-8953897;R-HSA-9033241;R-HSA-9609507;R-HSA-166016;R-HSA-166166;R-HSA-168898;R-HSA-937041;R-HSA-937061;R-HSA-201451;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-168164;R-HSA-168927;R-HSA-168928;R-HSA-936440;R-HSA-2173795	Adaptive Immune System;Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signal Transduction;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cellular responses to stress;Neddylation;Cellular responses to external stimuli;Peroxisomal protein import;Protein localization;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll-like Receptor Cascades;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Signaling by BMP;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Toll Like Receptor 3 (TLR3) Cascade;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling;Downregulation of SMAD2/3:SMAD4 transcriptional activity
COQ6	negative	USP9X	ENSG00000124486	COQ6	1	COQ6	1	0.00016417423304671	WBGene00011980			X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability;X-linked non-syndromic intellectual disability;Mental retardation X-linked 99;Mental retardation X-linked 99;MENTAL RETARDATION X-LINKED 99 SYNDROMIC FEMALE-RESTRICTED	GO:0005737;GO:0016020;GO:0016579;GO:0016787;GO:0051301;GO:0005829;GO:0042995;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0007049;GO:0048511;GO:0006511;GO:0036459;GO:0007059;GO:0016567;GO:0030426;GO:0050821;GO:0044267;GO:0004197;GO:0004843;GO:0030509;GO:1990380;GO:0006625;GO:0071108;GO:0007179;GO:0070410;GO:0042752;GO:0001764;GO:0007292;GO:0000122;GO:0048675;GO:1901537;GO:0071947;GO:0101005	ubiquitin-dependent protein catabolic process;thiol-dependent ubiquitinyl hydrolase activity;protein deubiquitination;cytoplasm;membrane;hydrolase activity;cell division;cytosol;cell projection;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;cell cycle;rhythmic process;chromosome segregation;protein ubiquitination;growth cone;protein stabilization;cellular protein metabolic process;cell migration;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;BMP signaling pathway;Lys48-specific deubiquitinase activity;protein targeting to peroxisome;protein K48-linked deubiquitination;transforming growth factor beta receptor signaling pathway;co-SMAD binding;regulation of circadian rhythm;neuron migration;female gamete generation;negative regulation of transcription by RNA polymerase II;positive regulation of DNA demethylation;axon extension;protein deubiquitination involved in ubiquitin-dependent protein catabolic process;ubiquitinyl hydrolase activity	3D-structure;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Cell projection;Chromosome partition;Cytoplasm;Disease mutation;Hydrolase;Mental retardation;Mitosis;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8866652;R-HSA-162582;R-HSA-977225;R-HSA-5688426;R-HSA-5689880;R-HSA-9033241;R-HSA-9609507;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173795	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Signal Transduction;Amyloid fiber formation;Deubiquitination;Ub-specific processing proteases;Peroxisomal protein import;Protein localization;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity
COQ6	negative	HMGA1	ENSG00000137309	COQ6	1	COQ6	1	0.00016417423304671			CD44;CDC25A;INSR;KL;POU1F1;PTGS2;SLC2A3;TWIST1	DIABETES MELLITUS NONINSULIN-DEPENDENT	GO:0045944;GO:0005634;GO:0006355;GO:0003677;GO:0005694;GO:0000785;GO:0005515;GO:0030374;GO:0045893;GO:0005925;GO:0000981;GO:0005654;GO:0005829;GO:0008285;GO:0042974;GO:0009615;GO:0006284;GO:0019899;GO:0008134;GO:0045892;GO:0003682;GO:0090575;GO:0065003;GO:0005667;GO:0042975;GO:0046965;GO:0051169;GO:0075713;GO:0003713;GO:0006337;GO:0001158;GO:0003680;GO:0003906;GO:0030527;GO:0006268;GO:0031936;GO:0035986;GO:0090402;GO:2000774;GO:0035985	DNA binding;regulation of transcription, DNA-templated;nucleus;chromatin;positive regulation of transcription by RNA polymerase II;focal adhesion;chromosome;protein binding;nuclear receptor transcription coactivator activity;positive regulation of transcription, DNA-templated;nucleoplasm;cytosol;negative regulation of cell population proliferation;retinoic acid receptor binding;response to virus;base-excision repair;enzyme binding;transcription factor binding;negative regulation of transcription, DNA-templated;protein-containing complex assembly;chromatin binding;RNA polymerase II transcription factor complex;transcription factor complex;peroxisome proliferator activated receptor binding;retinoid X receptor binding;nuclear transport;establishment of integrated proviral latency;transcription coactivator activity;nucleosome disassembly;cis-regulatory region sequence-specific DNA binding;AT DNA binding;DNA-(apurinic or apyrimidinic site) endonuclease activity;structural constituent of chromatin;DNA unwinding involved in DNA replication;negative regulation of chromatin silencing;senescence-associated heterochromatin focus assembly;oncogene-induced cell senescence;positive regulation of cellular senescence;senescence-associated heterochromatin focus	3D-structure;ADP-ribosylation;Acetylation;Alternative splicing;Chromosomal rearrangement;Chromosome;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1643685;R-HSA-162587;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-2262752;R-HSA-8953897;R-HSA-176033;R-HSA-180910;R-HSA-2559583;R-HSA-2559586;R-HSA-162592;R-HSA-162594;R-HSA-164843;R-HSA-175567;R-HSA-177539;R-HSA-180689;R-HSA-2559584	Disease;HIV Life Cycle;HIV Infection;Infectious disease;Host Interactions of HIV factors;Cellular responses to stress;Cellular responses to external stimuli;Interactions of Vpr with host cellular proteins;Vpr-mediated nuclear import of PICs;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Integration of provirus;Early Phase of HIV Life Cycle;2-LTR circle formation;Integration of viral DNA into host genomic DNA;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
COQ6	negative	IGF2BP2	ENSG00000073792	COQ6	1	COQ6	1	0.000367720524158011	WBGene00010908	WBGene00010908(0);WBGene00013347(0);WBGene00019692(0);WBGene00016489(0);WBGene00003978(0)		DIABETES MELLITUS NONINSULIN-DEPENDENT	GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0003729;GO:0051028;GO:0005829;GO:0005515;GO:0043488;GO:0006417;GO:0017148;GO:0003730;GO:0045182;GO:0048027;GO:0009653;GO:0042035;GO:0005856	RNA binding;nucleic acid binding;mRNA binding;cytoplasm;nucleus;mRNA transport;cytosol;protein binding;regulation of mRNA stability;regulation of translation;negative regulation of translation;mRNA 3'-UTR binding;translation regulator activity;mRNA 5'-UTR binding;anatomical structure morphogenesis;regulation of cytokine biosynthetic process;cytoskeleton	3D-structure;Acetylation;Alternative initiation;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Translation regulation;Transport;mRNA transport	R-HSA-8953854;R-HSA-428359	Metabolism of RNA;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
COQ6	negative	CD82	ENSG00000085117	COQ6	1	COQ6	1	0.000367720524158011	WBGene00006634;WBGene00006637				GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0005887;GO:0070062	integral component of membrane;membrane;plasma membrane;protein binding;integral component of plasma membrane;extracellular exosome	Alternative splicing;Cell membrane;Glycoprotein;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ6	negative	QKI	ENSG00000112531	COQ6	1	COQ6	1	0.000367720524158011	WBGene00006423;WBGene00001595			Angiocentric glioma;Intellectual disability	GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0005515;GO:0007275;GO:0030154;GO:0003729;GO:0006417;GO:0017124;GO:0001570;GO:0007286;GO:0008366;GO:0010628;GO:0042552;GO:0042692;GO:0042759;GO:0045202	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;mRNA transport;nucleus;cytoplasm;protein binding;multicellular organism development;cell differentiation;mRNA binding;regulation of translation;SH3 domain binding;vasculogenesis;spermatid development;axon ensheathment;positive regulation of gene expression;myelination;muscle cell differentiation;long-chain fatty acid biosynthetic process;synapse	3D-structure;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Methylation;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;SH3-binding;Translation regulation;Transport;mRNA processing;mRNA splicing;mRNA transport	R-HSA-1643685;R-HSA-5663202;R-HSA-6802952;R-HSA-6802957	Disease;Diseases of signal transduction;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
COQ6	negative	GTDC1	ENSG00000121964	COQ6	1	COQ6	1	0.000367720524158011							Alternative splicing;Polymorphism;Reference proteome		
COQ6	negative	STK26	ENSG00000134602	COQ6	1	COQ6	1	0.000367720524158011	WBGene00001526				GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005794;GO:0005829;GO:0042803;GO:0005515;GO:0006915;GO:0000287;GO:0048471;GO:0042802;GO:0070062;GO:0071944;GO:0009267;GO:0016324;GO:0042981;GO:0046777;GO:0023014;GO:0032147;GO:0042542;GO:0005798;GO:0030033;GO:0030336;GO:0012506;GO:1903205;GO:0000139	ATP binding;protein phosphorylation;protein kinase activity;cytoplasm;membrane;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;Golgi apparatus;cytosol;protein homodimerization activity;protein binding;apoptotic process;perinuclear region of cytoplasm;magnesium ion binding;identical protein binding;extracellular exosome;cell periphery;cellular response to starvation;apical plasma membrane;regulation of apoptotic process;protein autophosphorylation;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;response to hydrogen peroxide;Golgi-associated vesicle;microvillus assembly;negative regulation of cell migration;vesicle membrane;regulation of hydrogen peroxide-induced cell death;Golgi membrane	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Golgi apparatus;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-109581;R-HSA-5357801;R-HSA-75153;R-HSA-111465	Apoptosis;Programmed Cell Death;Apoptotic execution phase;Apoptotic cleavage of cellular proteins
COQ6	negative	STX6	ENSG00000135823	COQ6	1	COQ6	1	0.000367720524158011	WBGene00015789	WBGene00015789(0)			GO:0016020;GO:0016021;GO:0006886;GO:0015031;GO:0016192;GO:0005794;GO:0005829;GO:0005654;GO:0005886;GO:0005515;GO:0000139;GO:0048471;GO:0048193;GO:0005769;GO:0030136;GO:0005484;GO:0005802;GO:0042147;GO:0000149;GO:0031201;GO:0006906;GO:0048278;GO:0012505;GO:0008021;GO:0019905;GO:0032588;GO:0090161;GO:0032880;GO:0007032;GO:0016189;GO:0032456;GO:1903827;GO:0030285;GO:0045335	membrane;intracellular protein transport;vesicle-mediated transport;SNAP receptor activity;Golgi vesicle transport;integral component of membrane;protein transport;Golgi apparatus;nucleoplasm;cytosol;plasma membrane;protein binding;perinuclear region of cytoplasm;Golgi membrane;early endosome;clathrin-coated vesicle;trans-Golgi network;endomembrane system;retrograde transport, endosome to Golgi;SNARE binding;SNARE complex;vesicle fusion;vesicle docking;synaptic vesicle;syntaxin binding;trans-Golgi network membrane;Golgi ribbon formation;regulation of protein localization;endosome organization;synaptic vesicle to endosome fusion;endocytic recycling;regulation of cellular protein localization;integral component of synaptic vesicle membrane;phagocytic vesicle	3D-structure;Acetylation;Alternative splicing;Coiled coil;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-6811438;R-HSA-6811440	Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network
COQ6	negative	TMX1	ENSG00000139921	COQ6	1	COQ6	1	0.000367720524158011	WBGene00001073	WBGene00003963(0);WBGene00014807(0);WBGene00003962(0)			GO:0016020;GO:0016021;GO:0055114;GO:0005783;GO:0005789;GO:0045454;GO:0034976;GO:0015036;GO:0005623	cell redox homeostasis;cell;membrane;integral component of membrane;oxidation-reduction process;endoplasmic reticulum;endoplasmic reticulum membrane;response to endoplasmic reticulum stress;disulfide oxidoreductase activity	3D-structure;Disulfide bond;Electron transport;Endoplasmic reticulum;Membrane;Phosphoprotein;Redox-active center;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport		
COQ6	negative	MPZL3	ENSG00000160588	COQ6	1	COQ6	1	0.000367720524158011					GO:0016020;GO:0016021;GO:0007155;GO:0005515;GO:0030198;GO:0042633	membrane;integral component of membrane;cell adhesion;protein binding;extracellular matrix organization;hair cycle	Alternative splicing;Cell adhesion;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ6	negative	LYN	ENSG00000254087	COQ6	1	COQ6	1	0.000367720524158011	WBGene00005077				GO:0001934;GO:0005634;GO:0005737;GO:0016020;GO:0005794;GO:0043231;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0005886;GO:0005515;GO:0006974;GO:0004715;GO:0030218;GO:0048471;GO:0006954;GO:0045121;GO:0002376;GO:0045087;GO:0002250;GO:0038095;GO:0038096;GO:0050900;GO:0042629;GO:0030154;GO:0007169;GO:0005829;GO:0031234;GO:0070062;GO:0008285;GO:0002223;GO:0034136;GO:0034144;GO:0016032;GO:0008284;GO:0031175;GO:0044325;GO:0007165;GO:2000670;GO:0030168;GO:0001933;GO:0014068;GO:0048013;GO:0046777;GO:0005102;GO:0070667;GO:0033628;GO:0070373;GO:0030889;GO:0001932;GO:0033003;GO:0007596;GO:0031295;GO:0043407;GO:0070304;GO:0051272;GO:0042531;GO:0046579;GO:0060397;GO:1902961;GO:0097028;GO:0070372;GO:0031663;GO:0046875;GO:0018108;GO:0050777;GO:0001817;GO:0009725;GO:0042127;GO:0038083;GO:0043304;GO:0005161;GO:0005178;GO:0017124;GO:0019899;GO:0031625;GO:0043015;GO:0043208;GO:0044877;GO:0051219;GO:0140031;GO:0001782;GO:0002431;GO:0002513;GO:0002553;GO:0002576;GO:0002762;GO:0002768;GO:0002774;GO:0002902;GO:0006991;GO:0009636;GO:0009743;GO:0010976;GO:0014003;GO:0014070;GO:0030097;GO:0030335;GO:0031668;GO:0032868;GO:0034142;GO:0034605;GO:0035556;GO:0042327;GO:0042493;GO:0043200;GO:0043434;GO:0043552;GO:0045646;GO:0048678;GO:0050663;GO:0050707;GO:0050727;GO:0050853;GO:0050855;GO:0051279;GO:0060252;GO:0060369;GO:0070447;GO:0070668;GO:0071300;GO:0090025;GO:0090330;GO:1902532;GO:0005758;GO:0005913;GO:0014069;GO:0030061;GO:0031966;GO:0032991;GO:0034666;GO:0098978;GO:0099091	ATP binding;protein binding;protein phosphorylation;protein kinase activity;protein tyrosine kinase activity;positive regulation of protein phosphorylation;nucleus;cytoplasm;membrane;Golgi apparatus;intracellular membrane-bounded organelle;nucleotide binding;kinase activity;transferase activity;phosphorylation;plasma membrane;cellular response to DNA damage stimulus;non-membrane spanning protein tyrosine kinase activity;perinuclear region of cytoplasm;inflammatory response;membrane raft;immune system process;innate immune response;adaptive immune response;Fc-epsilon receptor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;leukocyte migration;mast cell granule;cell differentiation;transmembrane receptor protein tyrosine kinase signaling pathway;erythrocyte differentiation;cytosol;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome;negative regulation of cell population proliferation;stimulatory C-type lectin receptor signaling pathway;negative regulation of toll-like receptor 2 signaling pathway;negative regulation of toll-like receptor 4 signaling pathway;viral process;positive regulation of cell population proliferation;neuron projection development;regulation of cell population proliferation;ion channel binding;signal transduction;positive regulation of dendritic cell apoptotic process;platelet activation;negative regulation of protein phosphorylation;positive regulation of phosphatidylinositol 3-kinase signaling;ephrin receptor signaling pathway;protein autophosphorylation;signaling receptor binding;negative regulation of mast cell proliferation;regulation of cell adhesion mediated by integrin;negative regulation of ERK1 and ERK2 cascade;negative regulation of B cell proliferation;regulation of protein phosphorylation;regulation of mast cell activation;blood coagulation;T cell costimulation;negative regulation of MAP kinase activity;positive regulation of stress-activated protein kinase signaling cascade;positive regulation of cellular component movement;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of Ras protein signal transduction;growth hormone receptor signaling pathway via JAK-STAT;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;dendritic cell differentiation;regulation of ERK1 and ERK2 cascade;lipopolysaccharide-mediated signaling pathway;ephrin receptor binding;peptidyl-tyrosine phosphorylation;negative regulation of immune response;regulation of cytokine production;response to hormone;peptidyl-tyrosine autophosphorylation;regulation of mast cell degranulation;platelet-derived growth factor receptor binding;integrin binding;SH3 domain binding;enzyme binding;ubiquitin protein ligase binding;gamma-tubulin binding;glycosphingolipid binding;protein-containing complex binding;phosphoprotein binding;phosphorylation-dependent protein binding;B cell homeostasis;Fc receptor mediated stimulatory signaling pathway;tolerance induction to self antigen;histamine secretion by mast cell;platelet degranulation;negative regulation of myeloid leukocyte differentiation;immune response-regulating cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;regulation of B cell apoptotic process;response to sterol depletion;response to toxic substance;response to carbohydrate;positive regulation of neuron projection development;oligodendrocyte development;response to organic cyclic compound;hemopoiesis;positive regulation of cell migration;cellular response to extracellular stimulus;response to insulin;toll-like receptor 4 signaling pathway;cellular response to heat;intracellular signal transduction;positive regulation of phosphorylation;response to drug;response to amino acid;response to peptide hormone;positive regulation of phosphatidylinositol 3-kinase activity;regulation of erythrocyte differentiation;response to axon injury;cytokine secretion;regulation of cytokine secretion;regulation of inflammatory response;B cell receptor signaling pathway;regulation of B cell receptor signaling pathway;regulation of release of sequestered calcium ion into cytosol;positive regulation of glial cell proliferation;positive regulation of Fc receptor mediated stimulatory signaling pathway;positive regulation of oligodendrocyte progenitor proliferation;positive regulation of mast cell proliferation;cellular response to retinoic acid;regulation of monocyte chemotaxis;regulation of platelet aggregation;negative regulation of intracellular signal transduction;mitochondrial intermembrane space;postsynaptic density;mitochondrial crista;mitochondrial membrane;protein-containing complex;integrin alpha2-beta1 complex;glutamatergic synapse;postsynaptic specialization, intracellular component	3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Cell membrane;Cytoplasm;Golgi apparatus;Host-virus interaction;Immunity;Inflammatory response;Innate immunity;Kinase;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;SH2 domain;SH3 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-2029480;R-HSA-2029481;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-983695;R-HSA-983705;R-HSA-388841;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-1640170;R-HSA-1280215;R-HSA-449147;R-HSA-5621481;R-HSA-69278;R-HSA-9006934;R-HSA-76002;R-HSA-453279;R-HSA-512988;R-HSA-9006335;R-HSA-9027276;R-HSA-912631;R-HSA-2682334;R-HSA-3928662;R-HSA-114604;R-HSA-1433557;R-HSA-389356;R-HSA-69231;R-HSA-69236;R-HSA-1433559;R-HSA-982772;R-HSA-3928665;R-HSA-3928663;R-HSA-9027277;R-HSA-9027283;R-HSA-9027284;R-HSA-75892;R-HSA-5621575;R-HSA-210990;R-HSA-389513;R-HSA-5621480	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Costimulation by the CD28 family;Developmental Biology;Axon guidance;Signal Transduction;Cell Cycle;Cytokine Signaling in Immune system;Signaling by Interleukins;C-type lectin receptors (CLRs);Cell Cycle, Mitotic;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;Mitotic G1 phase and G1/S transition;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by Erythropoietin;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Regulation of signaling by CBL;EPH-Ephrin signaling;EPHB-mediated forward signaling;GPVI-mediated activation cascade;Signaling by SCF-KIT;CD28 co-stimulation;Cyclin D associated events in G1;G1 Phase;Regulation of KIT signaling;Growth hormone receptor signaling;EPH-ephrin mediated repulsion of cells;EPHA-mediated growth cone collapse;Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS;Platelet Adhesion to exposed collagen;CD209 (DC-SIGN) signaling;PECAM1 interactions;CTLA4 inhibitory signaling;Dectin-2 family
COQ6	negative	SENP1	ENSG00000079387	COQ6	1	COQ6	1	0.000788341748587884	WBGene00006736				GO:0005634;GO:0005737;GO:0016787;GO:0031965;GO:0005925;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0016926;GO:0005654;GO:0016925;GO:0097190;GO:0045944;GO:0006919;GO:0004175;GO:0070140;GO:0010724;GO:0032435	proteolysis;cysteine-type peptidase activity;nucleus;cytoplasm;nucleoplasm;hydrolase activity;nuclear membrane;focal adhesion;protein binding;peptidase activity;protein desumoylation;protein sumoylation;apoptotic signaling pathway;positive regulation of transcription by RNA polymerase II;activation of cysteine-type endopeptidase activity involved in apoptotic process;endopeptidase activity;SUMO-specific isopeptidase activity;regulation of definitive erythrocyte differentiation;negative regulation of proteasomal ubiquitin-dependent protein catabolic process	3D-structure;Alternative splicing;Cytoplasm;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-2990846;R-HSA-3065679;R-HSA-3215018	Metabolism of proteins;Post-translational protein modification;SUMOylation;SUMO is proteolytically processed;Processing and activation of SUMO
COQ6	negative	DIMT1	ENSG00000086189	COQ6	1	COQ6	1	0.000788341748587884	WBGene00008455;WBGene00020189	WBGene00008455(0)			GO:0003723;GO:0016740;GO:0008168;GO:0032259;GO:0006364;GO:0000179;GO:0008649;GO:0000154;GO:0031167;GO:0005634;GO:0005730;GO:0005829;GO:0005654;GO:0005759;GO:2000234;GO:0052909	RNA binding;transferase activity;methyltransferase activity;methylation;rRNA processing;rRNA (adenine-N6,N6-)-dimethyltransferase activity;rRNA methyltransferase activity;rRNA modification;rRNA methylation;nucleus;nucleoplasm;nucleolus;cytosol;mitochondrial matrix;positive regulation of rRNA processing;18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity	3D-structure;Methyltransferase;Nucleus;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase;rRNA processing	R-HSA-8953854;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ6	negative	CD40	ENSG00000101017	COQ6	1	COQ6	1	0.000788341748587884				Hyper-IgM syndrome type 3;IMMUNODEFICIENCY WITH HYPER-IgM TYPE 3	GO:0043536;GO:2000353;GO:0045766;GO:0042531;GO:0045944;GO:0001934;GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0005576;GO:0009986;GO:0002376;GO:0009897;GO:0050776;GO:0038023;GO:0042113;GO:0002768;GO:0006874;GO:0030890;GO:0032735;GO:0042832;GO:0043491;GO:0048304;GO:0051023;GO:0051607;GO:0035631;GO:0043231;GO:0070062;GO:0033209;GO:0031625;GO:0043123;GO:0071260;GO:0005887;GO:0006954;GO:0043547;GO:0019899;GO:0065003;GO:0051092;GO:0043406;GO:0030168;GO:0042100;GO:0090037	protein binding;signaling receptor activity;B cell activation;regulation of immune response;external side of plasma membrane;positive regulation of blood vessel endothelial cell migration;positive regulation of endothelial cell apoptotic process;positive regulation of angiogenesis;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of transcription by RNA polymerase II;positive regulation of protein phosphorylation;cell;membrane;integral component of membrane;plasma membrane;extracellular region;cell surface;immune system process;antigen binding;protein domain specific binding;immune response-regulating cell surface receptor signaling pathway;cellular calcium ion homeostasis;inflammatory response;response to bacterium;positive regulation of B cell proliferation;response to nutrient levels;positive regulation of interleukin-12 production;response to cobalamin;response to interferon-gamma;cellular response to erythropoietin;defense response to protozoan;protein kinase B signaling;positive regulation of isotype switching to IgG isotypes;regulation of immunoglobulin secretion;defense response to virus;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to tumor necrosis factor;response to peptide;extracellular space;cytoplasm;CD40 receptor complex;neuronal cell body;varicosity;intracellular membrane-bounded organelle;extracellular exosome;tumor necrosis factor-mediated signaling pathway;ubiquitin protein ligase binding;positive regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to mechanical stimulus;integral component of plasma membrane;positive regulation of GTPase activity;enzyme binding;protein-containing complex assembly;positive regulation of NF-kappaB transcription factor activity;positive regulation of MAP kinase activity;platelet activation;B cell proliferation;CD40 signaling pathway;positive regulation of protein kinase C signaling	3D-structure;Alternative splicing;Cell membrane;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Immunity;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix		
COQ6	negative	PCYT1B	ENSG00000102230	COQ6	1	COQ6	1	0.000788341748587884	WBGene00017241;WBGene00021215;WBGene00017878	WBGene00021215(0);WBGene00017241(0)			GO:0016740;GO:0005783;GO:0003824;GO:0006629;GO:0009058;GO:0008654;GO:0016779;GO:0006657;GO:0005789;GO:0031210;GO:0006656;GO:0005737;GO:0004105;GO:0001541;GO:0007283	catalytic activity;biosynthetic process;transferase activity;endoplasmic reticulum;lipid metabolic process;phospholipid biosynthetic process;nucleotidyltransferase activity;endoplasmic reticulum membrane;phosphatidylcholine binding;phosphatidylcholine biosynthetic process;cytoplasm;CDP-choline pathway;choline-phosphate cytidylyltransferase activity;ovarian follicle development;spermatogenesis	Alternative splicing;Endoplasmic reticulum;Lipid biosynthesis;Lipid metabolism;Nucleotidyltransferase;Phospholipid biosynthesis;Phospholipid metabolism;Phosphoprotein;Reference proteome;Transferase	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483191	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PC
COQ6	negative	RAB38	ENSG00000123892	COQ6	1	COQ6	1	0.000788341748587884	WBGene00011083				GO:0016020;GO:0015031;GO:0016192;GO:0000166;GO:0003924;GO:0005525;GO:0005886;GO:0006996;GO:0060155;GO:2001247;GO:0005737;GO:0005783;GO:0005794;GO:0005802;GO:0005829;GO:0031982;GO:0042470;GO:0031410;GO:0006886;GO:0030670;GO:0032482;GO:0043687;GO:0030742;GO:0005515;GO:0007005;GO:0005739;GO:0035646;GO:0072657;GO:0005769;GO:0045335;GO:0007264;GO:0005764;GO:0033162;GO:0090383;GO:0035650;GO:0035651;GO:0036461;GO:1903232;GO:0044233	GTP binding;Golgi apparatus;GTPase activity;vesicle-mediated transport;trans-Golgi network;vesicle;cell;membrane;protein transport;nucleotide binding;plasma membrane;organelle organization;platelet dense granule organization;positive regulation of phosphatidylcholine biosynthetic process;cytoplasm;endoplasmic reticulum;cytosol;melanosome;cytoplasmic vesicle;intracellular protein transport;phagocytic vesicle membrane;Rab protein signal transduction;endomembrane system;post-translational protein modification;GTP-dependent protein binding;protein binding;mitochondrion organization;mitochondrion;endosome to melanosome transport;protein localization to membrane;melanosome organization;early endosome;phagocytic vesicle;small GTPase mediated signal transduction;lysosome;melanosome membrane;phagosome acidification;AP-1 adaptor complex binding;AP-3 adaptor complex binding;BLOC-2 complex binding;melanosome assembly;mitochondria-associated endoplasmic reticulum membrane	3D-structure;Cell membrane;Cytoplasmic vesicle;GTP-binding;Lipoprotein;Membrane;Nucleotide-binding;Palmitate;Polymorphism;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation
COQ6	negative	VOPP1	ENSG00000154978	COQ6	1	COQ6	1	0.000788341748587884					GO:0016020;GO:0016021;GO:0031410;GO:0030659;GO:0031301;GO:0005768	cytoplasmic vesicle membrane;membrane;integral component of membrane;cytoplasmic vesicle;integral component of organelle membrane;endosome	Alternative splicing;Cytoplasmic vesicle;Membrane;Reference proteome;Signal;Transcription;Transcription regulation;Transmembrane;Transmembrane helix		
COQ6	negative	SH2B2	ENSG00000160999	COQ6	1	COQ6	1	0.000788341748587884					GO:0042802;GO:0035556;GO:0001725;GO:0005070;GO:0019221;GO:0030036;GO:0001726;GO:0001922;GO:0008286;GO:0019222;GO:0050776;GO:0050851;GO:0050873;GO:0005068;GO:0007399;GO:0046578;GO:0005884;GO:0007165;GO:0035591;GO:0005829;GO:0009967	signal transduction;signaling adaptor activity;identical protein binding;intracellular signal transduction;stress fiber;SH3/SH2 adaptor activity;cytokine-mediated signaling pathway;actin cytoskeleton organization;ruffle;B-1 B cell homeostasis;insulin receptor signaling pathway;regulation of metabolic process;regulation of immune response;antigen receptor-mediated signaling pathway;brown fat cell differentiation;transmembrane receptor protein tyrosine kinase adaptor activity;nervous system development;regulation of Ras protein signal transduction;actin filament;cytosol;positive regulation of signal transduction			
COQ6	negative	MORF4L1	ENSG00000185787	COQ6	1	COQ6	1	0.000788341748587884	WBGene00003406				GO:0005634;GO:0016607;GO:0006355;GO:0035267;GO:0006325;GO:0016580;GO:0005515;GO:0006281;GO:0006310;GO:0006974;GO:0005654;GO:0040008;GO:0047485;GO:0043967;GO:0000724;GO:0016575;GO:0006342;GO:0000123;GO:0043968;GO:0016573;GO:0003682;GO:0008283	regulation of transcription, DNA-templated;nucleus;chromatin organization;NuA4 histone acetyltransferase complex;Sin3 complex;nuclear speck;protein binding;DNA repair;DNA recombination;cellular response to DNA damage stimulus;chromatin silencing;nucleoplasm;regulation of growth;protein N-terminus binding;histone H4 acetylation;double-strand break repair via homologous recombination;histone deacetylation;histone acetyltransferase complex;histone H2A acetylation;histone acetylation;chromatin binding;cell population proliferation	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;DNA damage;DNA recombination;DNA repair;Direct protein sequencing;Growth regulation;Nucleus;Reference proteome;Transcription;Transcription regulation	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ6	negative	ZNF267	ENSG00000185947	COQ6	1	COQ6	1	0.000788341748587884	WBGene00021931;WBGene00001223				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0006357;GO:0000981;GO:0007275;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding;DNA-binding transcription factor activity;multicellular organism development	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ6	negative	R3HDM4	ENSG00000198858	COQ6	1	COQ6	1	0.000788341748587884	WBGene00012908	WBGene00012908(0)			GO:0003676;GO:0005634	nucleic acid binding;nucleus	Nucleus;Reference proteome		
COQ6	negative	PTBP1	ENSG00000011304	COQ6	1	COQ6	1	0.00161812654014637	WBGene00004207	WBGene00004207(1)			GO:0005634;GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0016020;GO:0005515;GO:0005654;GO:0070062;GO:0000381;GO:0075522;GO:0048025;GO:0005730;GO:0000398;GO:0008543;GO:0016070;GO:0036002;GO:0033119;GO:0035307;GO:0070886;GO:0008187;GO:0051148	nucleus;RNA binding;nucleic acid binding;mRNA processing;RNA splicing;membrane;protein binding;mRNA binding;nucleoplasm;extracellular exosome;regulation of alternative mRNA splicing, via spliceosome;regulation of RNA splicing;regulation of cell differentiation;IRES-dependent viral translational initiation;negative regulation of mRNA splicing, via spliceosome;nucleolus;mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway;RNA metabolic process;pre-mRNA binding;regulation of translation;negative regulation of RNA splicing;positive regulation of protein dephosphorylation;positive regulation of calcineurin-NFAT signaling cascade;poly-pyrimidine tract binding;negative regulation of muscle cell differentiation	3D-structure;Acetylation;Activator;Alternative splicing;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-162582;R-HSA-8953854;R-HSA-9006934;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-190236;R-HSA-5654738;R-HSA-6803529	Signal Transduction;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing
COQ6	negative	UHRF1BP1	ENSG00000065060	COQ6	1	COQ6	1	0.00161812654014637	WBGene00008094	WBGene00008094(0)			GO:0005515;GO:0042826;GO:0042802	protein binding;histone deacetylase binding;identical protein binding	Coiled coil;Phosphoprotein;Polymorphism;Reference proteome		
COQ6	negative	MTHFD2	ENSG00000065911	COQ6	1	COQ6	1	0.00161812654014637	WBGene00000929;WBGene00019492	WBGene00000929(0);WBGene00019492(0)			GO:0016491;GO:0055114;GO:0016787;GO:0003824;GO:0005739;GO:0005615;GO:0006730;GO:0008152;GO:0000287;GO:0004488;GO:0035999;GO:0005759;GO:0042301;GO:0046655;GO:0046653;GO:0004477;GO:0004487	oxidation-reduction process;catalytic activity;methylenetetrahydrofolate dehydrogenase (NADP+) activity;oxidoreductase activity;hydrolase activity;mitochondrion;extracellular space;one-carbon metabolic process;metabolic process;magnesium ion binding;tetrahydrofolate interconversion;mitochondrial matrix;phosphate ion binding;folic acid metabolic process;tetrahydrofolate metabolic process;methenyltetrahydrofolate cyclohydrolase activity;methylenetetrahydrofolate dehydrogenase (NAD+) activity	3D-structure;Acetylation;Alternative splicing;Hydrolase;Isopeptide bond;Magnesium;Mitochondrion;Multifunctional enzyme;NAD;NADP;One-carbon metabolism;Oxidoreductase;Reference proteome;Transit peptide;Ubl conjugation	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196757	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Metabolism of folate and pterines
COQ6	negative	GRK3	ENSG00000100077	COQ6	1	COQ6	1	0.00161812654014637	WBGene00001709				GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0007165;GO:0005515;GO:0004703;GO:0005886;GO:0005829;GO:0007186;GO:0031623;GO:0047696	ATP binding;signal transduction;G protein-coupled receptor kinase activity;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;nucleotide binding;kinase activity;transferase activity;phosphorylation;protein binding;plasma membrane;cytosol;G protein-coupled receptor signaling pathway;receptor internalization;beta-adrenergic receptor kinase activity	ATP-binding;Kinase;Nucleotide-binding;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-5653656;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-199991;R-HSA-418555;R-HSA-8856828;R-HSA-8856825	Vesicle-mediated transport;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Membrane Trafficking;G alpha (s) signalling events;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis
COQ6	negative	STK4	ENSG00000101109	COQ6	1	COQ6	1	0.00161812654014637	WBGene00017472;WBGene00016038			Combined immunodeficiency due to STK4 deficiency;T-cell immunodeficiency recurrent infections and autoimmunity with or without cardiac malformations	GO:0090090;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005654;GO:0007165;GO:0005515;GO:0016604;GO:0006915;GO:0000287;GO:0071902;GO:0042802;GO:0035329;GO:0043065;GO:0032991;GO:0048812;GO:0008134;GO:0023014;GO:0032147;GO:0035556;GO:0042803;GO:0018105;GO:0046983;GO:0043539;GO:0033138;GO:0001934;GO:0032092;GO:0046777;GO:0000902;GO:0001569;GO:0001841;GO:0003157;GO:0007417;GO:0008285;GO:0030216;GO:0045600;GO:0046621;GO:0050821;GO:0060215;GO:0060706;GO:0060800;GO:0097284;GO:1902043;GO:1905461	ATP binding;signal transduction;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;negative regulation of canonical Wnt signaling pathway;nucleus;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;protein binding;nuclear body;apoptotic process;magnesium ion binding;positive regulation of protein serine/threonine kinase activity;identical protein binding;hippo signaling;positive regulation of apoptotic process;protein-containing complex;neuron projection morphogenesis;transcription factor binding;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;intracellular signal transduction;protein homodimerization activity;peptidyl-serine phosphorylation;protein serine/threonine kinase activator activity;positive regulation of peptidyl-serine phosphorylation;positive regulation of protein phosphorylation;positive regulation of protein binding;protein autophosphorylation;cell morphogenesis;branching involved in blood vessel morphogenesis;neural tube formation;endocardium development;central nervous system development;negative regulation of cell population proliferation;keratinocyte differentiation;positive regulation of fat cell differentiation;negative regulation of organ growth;protein stabilization;primitive hemopoiesis;cell differentiation involved in embryonic placenta development;regulation of cell differentiation involved in embryonic placenta development;hepatocyte apoptotic process;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of substrate-dependent cell migration, cell attachment to substrate;positive regulation of vascular associated smooth muscle cell apoptotic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Coiled coil;Cytoplasm;Direct protein sequencing;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-162582;R-HSA-2028269	Signal Transduction;Signaling by Hippo
COQ6	negative	EIF3J	ENSG00000104131	COQ6	1	COQ6	1	0.00161812654014637	WBGene00012738	WBGene00012738(0)			GO:0005737;GO:0003743;GO:0001732;GO:0002183;GO:0006412;GO:0006413;GO:0005852;GO:0016282;GO:0033290;GO:0005829;GO:0005515	cytoplasm;translation initiation factor activity;eukaryotic translation initiation factor 3 complex;formation of cytoplasmic translation initiation complex;cytoplasmic translational initiation;translation;translational initiation;eukaryotic 43S preinitiation complex;eukaryotic 48S preinitiation complex;cytosol;protein binding	3D-structure;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Direct protein sequencing;Initiation factor;Isopeptide bond;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72689;R-HSA-72695;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766	Metabolism of proteins;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
COQ6	negative	JAK3	ENSG00000105639	COQ6	1	COQ6	1	0.00161812654014637				T-B+ severe combined immunodeficiency due to JAK3 deficiency;Severe Combined Immune Deficiency Autosomal Recessive T Cell-Negative B Cell -Positive NK Cell-Negative JAK3-Related;Severe combined immunodeficiency autosomal recessive T cell-negative B cell-positive NK cell-negative	GO:0005737;GO:0016020;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0035556;GO:0004713;GO:0018108;GO:0005856;GO:0005515;GO:0004715;GO:0002376;GO:0045087;GO:0002250;GO:0005886;GO:0042102;GO:0005829;GO:0000165;GO:0012505;GO:0019221;GO:0019903;GO:0038111;GO:0032695;GO:0043029;GO:0007167;GO:0007260;GO:0030218;GO:0060397;GO:0046425;GO:0030183;GO:0038110;GO:0005768;GO:0070244;GO:0035723;GO:0038113;GO:0070232;GO:0038114;GO:0045626;GO:0032693;GO:0002731;GO:0035771;GO:0045221;GO:0050868;GO:0070669;GO:0070670;GO:0070672;GO:0071104	ATP binding;membrane;protein phosphorylation;cytoskeleton;intracellular signal transduction;protein kinase activity;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;peptidyl-tyrosine phosphorylation;protein binding;immune system process;innate immune response;adaptive immune response;plasma membrane;positive regulation of T cell proliferation;cytosol;MAPK cascade;endomembrane system;regulation of apoptotic process;cytokine-mediated signaling pathway;protein phosphatase binding;interleukin-7-mediated signaling pathway;negative regulation of interleukin-12 production;T cell homeostasis;enzyme linked receptor protein signaling pathway;tyrosine phosphorylation of STAT protein;erythrocyte differentiation;growth hormone receptor signaling pathway via JAK-STAT;regulation of receptor signaling pathway via JAK-STAT;B cell differentiation;interleukin-2-mediated signaling pathway;endosome;negative regulation of thymocyte apoptotic process;interleukin-15-mediated signaling pathway;interleukin-9-mediated signaling pathway;regulation of T cell apoptotic process;interleukin-21-mediated signaling pathway;negative regulation of T-helper 1 cell differentiation;negative regulation of interleukin-10 production;negative regulation of dendritic cell cytokine production;interleukin-4-mediated signaling pathway;negative regulation of FasL biosynthetic process;negative regulation of T cell activation;response to interleukin-2;response to interleukin-4;response to interleukin-15;response to interleukin-9	3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Cytoplasm;Disease mutation;Immunity;Innate immunity;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SCID;SH2 domain;Transferase;Tyrosine-protein kinase	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-451927;R-HSA-512988;R-HSA-912526;R-HSA-1266695;R-HSA-6785807;R-HSA-8854691;R-HSA-9020558;R-HSA-8983432;R-HSA-8985947;R-HSA-9020958	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Interleukin receptor SHC signaling;Interleukin-7 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-20 family signaling;Interleukin-2 signaling;Interleukin-15 signaling;Interleukin-9 signaling;Interleukin-21 signaling
COQ6	negative	DNAJB6	ENSG00000105993	COQ6	1	COQ6	1	0.00161812654014637	WBGene00001042	WBGene00001019(0);WBGene00001044(0)		Autosomal dominant limb-girdle muscular dystrophy type 1D;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL DOMINANT 1	GO:0005634;GO:0005737;GO:0016020;GO:0005654;GO:0005829;GO:0005515;GO:0048471;GO:0032781;GO:1900034;GO:0006457;GO:0030018;GO:0043154;GO:0051082;GO:0051087;GO:0001671;GO:0031072;GO:0032880;GO:0045109;GO:0090084;GO:0003677;GO:0030036;GO:0030198;GO:0034504;GO:0045892;GO:0060710;GO:0060715;GO:0060717	nucleus;cytoplasm;membrane;nucleoplasm;cytosol;protein binding;perinuclear region of cytoplasm;positive regulation of ATPase activity;regulation of cellular response to heat;protein folding;Z disc;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;unfolded protein binding;chaperone binding;ATPase activator activity;heat shock protein binding;regulation of protein localization;intermediate filament organization;negative regulation of inclusion body assembly;DNA binding;actin cytoskeleton organization;extracellular matrix organization;protein localization to nucleus;negative regulation of transcription, DNA-templated;chorio-allantoic fusion;syncytiotrophoblast cell differentiation involved in labyrinthine layer development;chorion development	3D-structure;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Disease mutation;Limb-girdle muscular dystrophy;Methylation;Nucleus;Phosphoprotein;Reference proteome	R-HSA-2262752;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556	Cellular responses to stress;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress
COQ6	negative	HTATIP2	ENSG00000109854	COQ6	1	COQ6	1	0.00161812654014637	WBGene00050941	WBGene00050941(1)			GO:0005634;GO:0005737;GO:0016020;GO:0043066;GO:0005829;GO:0016491;GO:0055114;GO:1903508;GO:0005515;GO:0006915;GO:0007275;GO:0030154;GO:0016032;GO:0001525;GO:0003713;GO:0006357;GO:0005635;GO:0045765;GO:0051170	nucleus;cytoplasm;membrane;negative regulation of apoptotic process;cytosol;oxidoreductase activity;oxidation-reduction process;protein binding;apoptotic process;multicellular organism development;cell differentiation;viral process;angiogenesis;transcription coactivator activity;positive regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;nuclear envelope;protein serine/threonine kinase activity;regulation of angiogenesis;protein autophosphorylation;positive regulation of programmed cell death;import into nucleus	3D-structure;Acetylation;Alternative splicing;Angiogenesis;Apoptosis;Cytoplasm;Developmental protein;Differentiation;Host-virus interaction;NADP;Nucleus;Oxidoreductase;Polymorphism;Reference proteome;Tumor suppressor		
COQ6	negative	TDP2	ENSG00000111802	COQ6	1	COQ6	1	0.00161812654014637	WBGene00013405	WBGene00013405(1)		Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 23	GO:0005634;GO:0005737;GO:0046872;GO:0005654;GO:0016787;GO:0090305;GO:0016235;GO:0006281;GO:0006974;GO:0016604;GO:0000287;GO:1903507;GO:0004518;GO:0030145;GO:0006302;GO:0005730;GO:0005515;GO:0048666;GO:0003697;GO:0016605;GO:0007166;GO:0003714;GO:0036317;GO:0070260	protein binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;aggresome;DNA repair;cellular response to DNA damage stimulus;nuclear body;negative regulation of nucleic acid-templated transcription;nuclease activity;manganese ion binding;double-strand break repair;magnesium ion binding;nucleolus;neuron development;PML body;viral process;single-stranded DNA binding;cell surface receptor signaling pathway;transcription corepressor activity;tyrosyl-RNA phosphodiesterase activity;5'-tyrosyl-DNA phosphodiesterase activity	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Host-virus interaction;Hydrolase;Isopeptide bond;Magnesium;Mental retardation;Metal-binding;Neurodegeneration;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Spinocerebellar ataxia;Ubl conjugation	R-HSA-5693532;R-HSA-73894;R-HSA-5693571	DNA Double-Strand Break Repair;DNA Repair;Nonhomologous End-Joining (NHEJ)
COQ6	negative	ACTR3	ENSG00000115091	COQ6	1	COQ6	1	0.00161812654014637	WBGene00000199	WBGene00000199(1)			GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0007015;GO:0003779;GO:0005856;GO:0042995;GO:0005515;GO:0034314;GO:0005885;GO:0005925;GO:0007163;GO:0008356;GO:0016344;GO:0033206;GO:0051321;GO:0051653;GO:0071346;GO:0005903;GO:0005911;GO:0030027;GO:0038096;GO:0051015;GO:0060271;GO:0045944;GO:0005829;GO:0070062;GO:0030030;GO:0030479;GO:0035861;GO:0061024;GO:0048013;GO:0015629;GO:0005200;GO:0070358	ATP binding;actin filament organization;Arp2/3 complex-mediated actin nucleation;Arp2/3 protein complex;cell;nucleus;cytoplasm;membrane;nucleotide binding;actin binding;cytoskeleton;focal adhesion;cell projection;protein binding;establishment or maintenance of cell polarity;asymmetric cell division;meiotic chromosome movement towards spindle pole;meiotic cytokinesis;meiotic cell cycle;spindle localization;cellular response to interferon-gamma;brush border;cell-cell junction;lamellipodium;Fc-gamma receptor signaling pathway involved in phagocytosis;actin filament binding;cilium assembly;positive regulation of transcription by RNA polymerase II;cytosol;extracellular exosome;cell projection organization;site of double-strand break;membrane organization;ephrin receptor signaling pathway;positive regulation of lamellipodium assembly;actin cytoskeleton;structural constituent of cytoskeleton;actin polymerization-dependent cell motility	ATP-binding;Acetylation;Actin-binding;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Nucleus;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-5653656;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-194315;R-HSA-199991;R-HSA-195258;R-HSA-5663213;R-HSA-8856828;R-HSA-2682334;R-HSA-3928662	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Vesicle-mediated transport;Developmental Biology;Axon guidance;Signal Transduction;Signaling by Rho GTPases;Membrane Trafficking;RHO GTPase Effectors;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;EPH-Ephrin signaling;EPHB-mediated forward signaling
COQ6	negative	STAT1	ENSG00000115415	COQ6	1	COQ6	1	0.00161812654014637	WBGene00013111	WBGene00010251(0);WBGene00013111(0)	CCL3;CCR1;CD22;CD40;CD40LG;CDKN1A;CEBPE;CFTR;CIITA;EDN1;FGF2;GAST;HMOX1;ICAM1;IFNG;IL1B;IRF1;IRF7;IRF8;JAK2;KRT17;LY96;MUC1;MUC4;MVP;NOS2;NOX5;OPRM1;PML;PPARA;PTGS2;S100A10;STAT2;TLR3;TP53;UPP1	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency;Susceptibility to viral and mycobacterial infections;IMMUNODEFICIENCY 31A;IMMUNODEFICIENCY 31B;IMMUNODEFICIENCY 31C	GO:0005634;GO:0006355;GO:0007165;GO:0003700;GO:0045944;GO:0005737;GO:0005730;GO:0005829;GO:0005654;GO:0005164;GO:0003677;GO:0042803;GO:0005515;GO:0048471;GO:0045893;GO:0030425;GO:0042802;GO:0051607;GO:0001228;GO:0000122;GO:0000978;GO:0000981;GO:0000790;GO:0030424;GO:0045296;GO:0006952;GO:0032991;GO:0071346;GO:0016032;GO:0003690;GO:0019221;GO:0042981;GO:0019899;GO:0042393;GO:0070491;GO:0001937;GO:0016525;GO:0060333;GO:0044389;GO:0060334;GO:0070102;GO:0043124;GO:0002230;GO:0033209;GO:0060337;GO:0048661;GO:0035456;GO:0051591;GO:0035257;GO:0002053;GO:1990841;GO:0072162;GO:0070106;GO:0070757;GO:0000979;GO:0034097;GO:0035035;GO:0032727;GO:0035458;GO:0042127;GO:0043434;GO:0045648;GO:0038113;GO:0038114;GO:0010742;GO:0007221;GO:0007259;GO:0031730;GO:0043565;GO:0051721;GO:0003340;GO:0007584;GO:0008015;GO:0008284;GO:0009612;GO:0014070;GO:0032869;GO:0042493;GO:0042542;GO:0046725;GO:0051770;GO:0061326;GO:0071345;GO:0071407;GO:0072136;GO:0072308	DNA binding;regulation of transcription, DNA-templated;nucleus;signal transduction;DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;cytoplasm;nucleoplasm;nucleolus;cytosol;tumor necrosis factor receptor binding;protein homodimerization activity;protein binding;perinuclear region of cytoplasm;positive regulation of transcription, DNA-templated;dendrite;identical protein binding;defense response to virus;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;axon;cadherin binding;defense response;DNA-binding transcription activator activity, RNA polymerase II-specific;protein-containing complex;cellular response to interferon-gamma;viral process;double-stranded DNA binding;cytokine-mediated signaling pathway;regulation of cell population proliferation;regulation of apoptotic process;enzyme binding;histone binding;repressing transcription factor binding;negative regulation of endothelial cell proliferation;negative regulation of angiogenesis;positive regulation of interferon-alpha production;interferon-gamma-mediated signaling pathway;ubiquitin-like protein ligase binding;regulation of interferon-gamma-mediated signaling pathway;interleukin-6-mediated signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of defense response to virus by host;tumor necrosis factor-mediated signaling pathway;type I interferon signaling pathway;positive regulation of smooth muscle cell proliferation;response to interferon-beta;response to cAMP;nuclear hormone receptor binding;positive regulation of mesenchymal cell proliferation;promoter-specific chromatin binding;metanephric mesenchymal cell differentiation;interleukin-27-mediated signaling pathway;interleukin-35-mediated signaling pathway;RNA polymerase II core promoter sequence-specific DNA binding;response to cytokine;histone acetyltransferase binding;positive regulation of erythrocyte differentiation;cellular response to interferon-beta;response to peptide hormone;interleukin-9-mediated signaling pathway;interleukin-21-mediated signaling pathway;macrophage derived foam cell differentiation;positive regulation of transcription of Notch receptor target;receptor signaling pathway via JAK-STAT;CCR5 chemokine receptor binding;sequence-specific DNA binding;protein phosphatase 2A binding;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;response to nutrient;blood circulation;positive regulation of cell population proliferation;response to mechanical stimulus;response to organic cyclic compound;cellular response to insulin stimulus;response to drug;response to hydrogen peroxide;negative regulation by virus of viral protein levels in host cell;positive regulation of nitric-oxide synthase biosynthetic process;renal tubule development;cellular response to cytokine stimulus;cellular response to organic cyclic compound;metanephric mesenchymal cell proliferation involved in metanephros development;negative regulation of metanephric nephron tubule epithelial cell differentiation	3D-structure;ADP-ribosylation;Acetylation;Activator;Alternative splicing;Antiviral defense;Coiled coil;Cytoplasm;DNA-binding;Direct protein sequencing;Disease mutation;Host-virus interaction;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168256;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-5663202;R-HSA-8878166;R-HSA-8939902;R-HSA-186797;R-HSA-9006934;R-HSA-1169408;R-HSA-1169410;R-HSA-913531;R-HSA-157118;R-HSA-9012852;R-HSA-447115;R-HSA-451927;R-HSA-1433557;R-HSA-186763;R-HSA-6785807;R-HSA-982772;R-HSA-1059683;R-HSA-6783589;R-HSA-1226099;R-HSA-1839117;R-HSA-1839124;R-HSA-5655302;R-HSA-9013508;R-HSA-8854691;R-HSA-8984722;R-HSA-9020956;R-HSA-8985947;R-HSA-9020958	Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Diseases of signal transduction;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;Signaling by NOTCH;Signaling by NOTCH3;Interleukin-12 family signaling;Interleukin-2 family signaling;Signaling by SCF-KIT;Downstream signal transduction;Interleukin-4 and Interleukin-13 signaling;Growth hormone receptor signaling;Interleukin-6 signaling;Interleukin-6 family signaling;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;NOTCH3 Intracellular Domain Regulates Transcription;Interleukin-20 family signaling;Interleukin-35 Signalling;Interleukin-27 signaling;Interleukin-9 signaling;Interleukin-21 signaling
COQ6	negative	LYPLA1	ENSG00000120992	COQ6	1	COQ6	1	0.00161812654014637	WBGene00010564	WBGene00010564(0)			GO:0005737;GO:0016787;GO:0006629;GO:0006631;GO:0005515;GO:0005829;GO:0070062;GO:0050999;GO:0052689;GO:0004622;GO:0008474;GO:0016298;GO:0002084;GO:0042997;GO:0016020;GO:0016021	hydrolase activity;cytoplasm;endoplasmic reticulum;lipid metabolic process;fatty acid metabolic process;plasma membrane;protein binding;cytosol;extracellular exosome;nuclear membrane;regulation of nitric-oxide synthase activity;carboxylic ester hydrolase activity;phospholipase activity;lysophospholipase activity;palmitoyl-(protein) hydrolase activity;lipase activity;protein depalmitoylation;negative regulation of Golgi to plasma membrane protein transport;membrane;integral component of membrane	3D-structure;Acetylation;Alternative splicing;Cell membrane;Cytoplasm;Endoplasmic reticulum;Fatty acid metabolism;Hydrolase;Lipid metabolism;Membrane;Nucleus;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-202131;R-HSA-203615	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation
COQ6	negative	MRS2	ENSG00000124532	COQ6	1	COQ6	1	0.00161812654014637					GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0006811;GO:0055085;GO:0015693;GO:0015095;GO:0045016;GO:0006089	membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;ion transport;transmembrane transport;magnesium ion transport;magnesium ion transmembrane transporter activity;mitochondrial magnesium ion transmembrane transport;lactate metabolic process	Alternative splicing;Ion transport;Magnesium;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-5223345	Transport of small molecules;Miscellaneous transport and binding events
COQ6	negative	DTD1	ENSG00000125821	COQ6	1	COQ6	1	0.00161812654014637	WBGene00004151	WBGene00004151(1)			GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0005730;GO:0005829;GO:0016787;GO:0003677;GO:0006260;GO:0000049;GO:0002161;GO:0106074;GO:0051499;GO:0051500;GO:0006399	cytoplasm;aminoacyl-tRNA editing activity;D-aminoacyl-tRNA deacylase activity;RNA binding;nucleus;metal ion binding;hydrolase activity;DNA binding;DNA replication;tRNA binding;aminoacyl-tRNA metabolism involved in translational fidelity;D-tyrosyl-tRNA(Tyr) deacylase activity;tRNA metabolic process	3D-structure;Cytoplasm;DNA replication;DNA-binding;Hydrolase;Magnesium;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;tRNA-binding		
COQ6	negative	FRMD8	ENSG00000126391	COQ6	1	COQ6	1	0.00161812654014637	WBGene00001496	WBGene00001496(0)			GO:0005737;GO:0016020;GO:0005829;GO:0005886;GO:0005856;GO:0005515;GO:1904469	cytoskeleton;cytoplasm;membrane;cytosol;plasma membrane;protein binding;positive regulation of tumor necrosis factor secretion	Acetylation;Alternative splicing;Cell membrane;Cytoplasm;Membrane;Phosphoprotein;Reference proteome		
COQ6	negative	TRAF7	ENSG00000131653	COQ6	1	COQ6	1	0.00161812654014637				Developmental Delay Congenital Anomalies and Dysmorphic Features;Developmental delay congenital malformations and dysmorphism;CARDIAC FACIAL AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY	GO:0043231;GO:0008270;GO:0046872;GO:0016740;GO:0016567;GO:0005886;GO:0005515;GO:0004842;GO:0006915;GO:0031410;GO:0000151;GO:0000185;GO:0070372;GO:2001235;GO:0043410	zinc ion binding;protein binding;intracellular membrane-bounded organelle;metal ion binding;transferase activity;plasma membrane;protein ubiquitination;ubiquitin-protein transferase activity;apoptotic process;cytoplasmic vesicle;ubiquitin ligase complex;activation of MAPKKK activity;regulation of ERK1 and ERK2 cascade;positive regulation of apoptotic signaling pathway;positive regulation of MAPK cascade	Alternative splicing;Apoptosis;Cytoplasmic vesicle;Disease mutation;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;WD repeat;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ6	negative	IRAK2	ENSG00000134070	COQ6	1	COQ6	1	0.00161812654014637	WBGene00004029	WBGene00004029(0);WBGene00007258(0);WBGene00021214(0);WBGene00012159(0)			GO:0032088;GO:0000166;GO:0004672;GO:0005524;GO:0006468;GO:0007165;GO:0005515;GO:0007249;GO:0006954;GO:0002755;GO:0005886;GO:0005634;GO:0005737;GO:0004674;GO:0035556;GO:0005829;GO:0010008;GO:0070498;GO:0019221;GO:0051092;GO:0042803;GO:0046982;GO:0002224;GO:0007254;GO:0000187;GO:0001959;GO:0031663;GO:0034162;GO:0043433;GO:0070423;GO:0070555	ATP binding;protein binding;signal transduction;inflammatory response;protein phosphorylation;protein kinase activity;MyD88-dependent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;regulation of cytokine-mediated signaling pathway;interleukin-1-mediated signaling pathway;negative regulation of NF-kappaB transcription factor activity;nucleotide binding;plasma membrane;nucleus;cytoplasm;protein serine/threonine kinase activity;intracellular signal transduction;cytosol;endosome membrane;cytokine-mediated signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein homodimerization activity;protein heterodimerization activity;toll-like receptor signaling pathway;JNK cascade;activation of MAPK activity;lipopolysaccharide-mediated signaling pathway;toll-like receptor 9 signaling pathway;negative regulation of DNA-binding transcription factor activity;nucleotide-binding oligomerization domain containing signaling pathway;response to interleukin-1	3D-structure;ATP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-937072;R-HSA-975138;R-HSA-975155;R-HSA-975163;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-450321;R-HSA-975871;R-HSA-168643;R-HSA-168638;R-HSA-445989;R-HSA-450302;R-HSA-937042	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;MyD88 cascade initiated on plasma membrane;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;activated TAK1 mediates p38 MAPK activation;IRAK2 mediated activation of TAK1 complex
COQ6	negative	BARD1	ENSG00000138376	COQ6	1	COQ6	1	0.00161812654014637	WBGene00000265;WBGene00010498	WBGene00011802(0)	ESR1	Hereditary breast and ovarian cancer syndrome;Breast Cancer	GO:0005634;GO:0005737;GO:0016607;GO:0046872;GO:0016740;GO:0043066;GO:0016567;GO:0042803;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0085020;GO:0031436;GO:0036464;GO:0005654;GO:0016579;GO:0007050;GO:0043065;GO:0046982;GO:1901796;GO:0006260;GO:0000151;GO:0019900;GO:0001894;GO:0042325;GO:0000729;GO:0006303;GO:0045732;GO:0003723;GO:0046826;GO:0070531;GO:0031441	protein binding;nucleus;cytoplasm;nuclear speck;metal ion binding;transferase activity;negative regulation of apoptotic process;protein ubiquitination;protein homodimerization activity;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;protein K6-linked ubiquitination;BRCA1-BARD1 complex;cytoplasmic ribonucleoprotein granule;nucleoplasm;protein deubiquitination;cell cycle arrest;positive regulation of apoptotic process;protein heterodimerization activity;regulation of signal transduction by p53 class mediator;DNA replication;ubiquitin ligase complex;kinase binding;tissue homeostasis;regulation of phosphorylation;DNA double-strand break processing;double-strand break repair via nonhomologous end joining;positive regulation of protein catabolic process;RNA binding;negative regulation of protein export from nucleus;BRCA1-A complex;negative regulation of mRNA 3'-end processing	3D-structure;ANK repeat;Alternative splicing;DNA damage;DNA repair;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-5688426;R-HSA-5689603;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-5693565;R-HSA-5693606;R-HSA-6804756;R-HSA-5689901;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-5685938;R-HSA-5693571	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Deubiquitination;UCH proteinases;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Regulation of TP53 Activity through Phosphorylation;Metalloprotease DUBs;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ)
COQ6	negative	ABI2	ENSG00000138443	COQ6	1	COQ6	1	0.00161812654014637	WBGene00015146				GO:0008154;GO:0005515;GO:0005634;GO:0005737;GO:0005856;GO:0042995;GO:0030054;GO:0007399;GO:0030027;GO:0030175;GO:0016477;GO:0007010;GO:0005912;GO:0043197;GO:0016032;GO:0017124;GO:0003677;GO:0005829;GO:0070064;GO:0008093;GO:0031625;GO:0019900;GO:0061001;GO:0048365;GO:2000601;GO:0032433;GO:0018108;GO:0070309;GO:0016601;GO:0031209	protein binding;actin polymerization or depolymerization;nucleus;cytoplasm;cytoskeleton;cell projection;cell junction;identical protein binding;nervous system development;lamellipodium;filopodium;cell migration;cytoskeleton organization;adherens junction;dendritic spine;viral process;SH3 domain binding;DNA binding;cytosol;proline-rich region binding;cytoskeletal adaptor activity;ubiquitin protein ligase binding;kinase binding;regulation of dendritic spine morphogenesis;Rac GTPase binding;positive regulation of Arp2/3 complex-mediated actin nucleation;filopodium tip;peptidyl-tyrosine phosphorylation;lens fiber cell morphogenesis;Rac protein signal transduction;SCAR complex	3D-structure;Alternative splicing;Cell junction;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Host-virus interaction;Mental retardation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;SH3 domain	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-162582;R-HSA-194315;R-HSA-195258;R-HSA-5663213;R-HSA-9006934;R-HSA-194138;R-HSA-4420097	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Signaling by VEGF;VEGFA-VEGFR2 Pathway
COQ6	negative	PTPRF	ENSG00000142949	COQ6	1	COQ6	1	0.00161812654014637	WBGene00004215			Isolated congenital breast hypoplasia/aplasia;ATHELIA;BREASTS AND/OR NIPPLES APLASIA OR HYPOPLASIA OF 2	GO:0016020;GO:0016021;GO:0016787;GO:0007155;GO:0004721;GO:0006470;GO:0004725;GO:0016311;GO:0016791;GO:0005886;GO:0008201;GO:0070062;GO:0016477;GO:0035335;GO:0005887;GO:0099560;GO:0007185;GO:0005001;GO:0035373;GO:0044877;GO:0050839;GO:0010975;GO:0031102;GO:0048679;GO:1900121;GO:0043005;GO:0043025;GO:0005515	protein binding;phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;dephosphorylation;membrane;integral component of membrane;hydrolase activity;cell adhesion;phosphoprotein phosphatase activity;plasma membrane;heparin binding;extracellular exosome;cell migration;peptidyl-tyrosine dephosphorylation;integral component of plasma membrane;synaptic membrane adhesion;transmembrane receptor protein tyrosine phosphatase signaling pathway;transmembrane receptor protein tyrosine phosphatase activity;chondroitin sulfate proteoglycan binding;protein-containing complex binding;cell adhesion molecule binding;regulation of neuron projection development;neuron projection regeneration;regulation of axon regeneration;negative regulation of receptor binding;neuron projection;neuronal cell body	3D-structure;Alternative splicing;Cell adhesion;Disulfide bond;Glycoprotein;Heparin-binding;Hydrolase;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Protein phosphatase;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-112316;R-HSA-6794362;R-HSA-8849932;R-HSA-388844	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;Receptor-type tyrosine-protein phosphatases
COQ6	negative	EIF4E	ENSG00000151247	COQ6	1	COQ6	1	0.00161812654014637	WBGene00002061;WBGene00002059;WBGene00002060;WBGene00002063	WBGene00002063(0);WBGene00002059(0);WBGene00002062(0)		AUTISM SUSCEPTIBILITY TO 19	GO:0003723;GO:0005737;GO:0003743;GO:0006412;GO:0006413;GO:0005829;GO:0005515;GO:0036464;GO:0048471;GO:0000932;GO:0070062;GO:0006417;GO:0000340;GO:0005845;GO:0016281;GO:0016032;GO:0006406;GO:0010494;GO:0019899;GO:0031370;GO:0070491;GO:0006405;GO:0000339;GO:0045931;GO:0000082;GO:0016442;GO:0045182;GO:0001662;GO:0017148;GO:0019827;GO:0030324;GO:0045665;GO:0071549;GO:0099578;GO:0032991;GO:0033391;GO:0098794;GO:0098978;GO:0099524	RNA binding;cytoplasm;translation initiation factor activity;translational initiation;translation;cytosol;protein binding;cytoplasmic ribonucleoprotein granule;perinuclear region of cytoplasm;P-body;extracellular exosome;regulation of translation;RNA 7-methylguanosine cap binding;mRNA cap binding complex;eukaryotic translation initiation factor 4F complex;viral process;mRNA export from nucleus;cytoplasmic stress granule;enzyme binding;eukaryotic initiation factor 4G binding;repressing transcription factor binding;RNA export from nucleus;G1/S transition of mitotic cell cycle;RNA cap binding;positive regulation of mitotic cell cycle;RISC complex;translation regulator activity;behavioral fear response;negative regulation of translation;stem cell population maintenance;lung development;negative regulation of neuron differentiation;cellular response to dexamethasone stimulus;regulation of translation at postsynapse, modulating synaptic transmission;protein-containing complex;chromatoid body;postsynapse;glutamatergic synapse;postsynaptic cytosol	3D-structure;Acetylation;Alternative splicing;Autism;Autism spectrum disorder;Chromosomal rearrangement;Cytoplasm;Direct protein sequencing;Host-virus interaction;Initiation factor;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Translation regulation	R-HSA-168256;R-HSA-392499;R-HSA-162582;R-HSA-8953854;R-HSA-1280215;R-HSA-429914;R-HSA-429947;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-72202;R-HSA-72203;R-HSA-913531;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766;R-HSA-165159;R-HSA-166208	Immune System;Metabolism of proteins;Signal Transduction;Metabolism of RNA;Cytokine Signaling in Immune system;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;mTOR signalling;mTORC1-mediated signalling
COQ6	negative	CDC42SE2	ENSG00000158985	COQ6	1	COQ6	1	0.00161812654014637					GO:0035023;GO:0017048;GO:0005737;GO:0016020;GO:0009967;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0001891;GO:0008360;GO:0006909;GO:0009966;GO:0035591	Rho GTPase binding;regulation of Rho protein signal transduction;cytoplasm;membrane;positive regulation of signal transduction;cytoskeleton;plasma membrane;cell projection;protein binding;phagocytic cup;regulation of cell shape;phagocytosis;regulation of signal transduction;signaling adaptor activity	Cell membrane;Cell projection;Cell shape;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Palmitate;Phagocytosis;Phosphoprotein;Reference proteome		
COQ6	negative	M1AP	ENSG00000159374	COQ6	1	COQ6	1	0.00161812654014637					GO:0005737;GO:0016021;GO:0005515;GO:0030154;GO:0007283;GO:0042802;GO:0003674;GO:0007127;GO:0006396;GO:0031497;GO:0007292;GO:0051308	spermatogenesis;meiosis I;cytoplasm;integral component of membrane;protein binding;cell differentiation;identical protein binding;molecular_function;RNA processing;chromatin assembly;female gamete generation;male meiosis chromosome separation	Alternative splicing;Cytoplasm;Differentiation;Polymorphism;Reference proteome;Spermatogenesis		
COQ6	negative	IRF2	ENSG00000168310	COQ6	1	COQ6	1	0.00161812654014637			CIITA;IFNB1;TAP1		GO:0005634;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005925;GO:0005515;GO:0044212;GO:0051607;GO:0000981;GO:0008283;GO:0000790;GO:0001228;GO:0045944;GO:0060333;GO:0000977;GO:0000122;GO:0060337;GO:0002376;GO:0007596	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;cell population proliferation;transcription regulatory region DNA binding;nucleus;nucleoplasm;cytosol;DNA binding;focal adhesion;protein binding;defense response to virus;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;interferon-gamma-mediated signaling pathway;RNA polymerase II regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;type I interferon signaling pathway;immune system process;blood coagulation	Acetylation;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-109582;R-HSA-168256;R-HSA-1280215;R-HSA-983231;R-HSA-913531;R-HSA-877300;R-HSA-909733	Hemostasis;Immune System;Cytokine Signaling in Immune system;Factors involved in megakaryocyte development and platelet production;Interferon Signaling;Interferon gamma signaling;Interferon alpha/beta signaling
COQ6	negative	P2RY1	ENSG00000169860	COQ6	1	COQ6	1	0.00161812654014637					GO:0070374;GO:0001934;GO:0007204;GO:0016020;GO:0016021;GO:0000166;GO:0005524;GO:0004930;GO:0007186;GO:0005886;GO:0005515;GO:0007165;GO:0045028;GO:0009986;GO:0030168;GO:0005887;GO:0007596;GO:0007599;GO:0005929;GO:0008360;GO:0038023;GO:0007166;GO:0097110;GO:0030425;GO:0071415;GO:0023019;GO:0045211;GO:0007200;GO:0072659;GO:0044297;GO:0071318;GO:0031686;GO:0043531;GO:0045031;GO:0045032;GO:0046982;GO:0001973;GO:0007193;GO:0007568;GO:0008347;GO:0009612;GO:0010469;GO:0010700;GO:0019233;GO:0032962;GO:0035589;GO:0042060;GO:0042755;GO:0043270;GO:0045944;GO:0046887;GO:0051100;GO:0060406;GO:0070848;GO:0071407;GO:0090075;GO:0097746;GO:0099509;GO:2000300;GO:0005739;GO:0014069;GO:0016323;GO:0016324;GO:0098978;GO:0099059	G protein-coupled purinergic nucleotide receptor activity;G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;phospholipase C-activating G protein-coupled receptor signaling pathway;platelet activation;relaxation of muscle;positive regulation of ERK1 and ERK2 cascade;positive regulation of protein phosphorylation;cell;positive regulation of cytosolic calcium ion concentration;membrane;nucleotide binding;ATP binding;plasma membrane;protein binding;signal transduction;cell surface;integral component of plasma membrane;blood coagulation;hemostasis;cilium;regulation of cell shape;signaling receptor activity;cell surface receptor signaling pathway;scaffold protein binding;dendrite;cellular response to purine-containing compound;signal transduction involved in regulation of gene expression;postsynaptic membrane;protein localization to plasma membrane;cell body;cellular response to ATP;ADP receptor activity;A1 adenosine receptor binding;ADP binding;ATP-activated adenosine receptor activity;protein heterodimerization activity;adenosine receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;aging;glial cell migration;response to mechanical stimulus;regulation of signaling receptor activity;negative regulation of norepinephrine secretion;sensory perception of pain;positive regulation of inositol trisphosphate biosynthetic process;G protein-coupled purinergic nucleotide receptor signaling pathway;wound healing;eating behavior;positive regulation of ion transport;positive regulation of transcription by RNA polymerase II;positive regulation of hormone secretion;negative regulation of binding;positive regulation of penile erection;response to growth factor;cellular response to organic cyclic compound;regulation of blood vessel diameter;regulation of presynaptic cytosolic calcium ion concentration;regulation of synaptic vesicle exocytosis;mitochondrion;postsynaptic density;basolateral plasma membrane;apical plasma membrane;glutamatergic synapse;integral component of presynaptic active zone membrane	3D-structure;ATP-binding;Blood coagulation;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Hemostasis;Membrane;Nucleotide-binding;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-392518;R-HSA-76002;R-HSA-500792;R-HSA-373076;R-HSA-417957;R-HSA-418038;R-HSA-418592	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Signal amplification;Platelet activation, signaling and aggregation;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);P2Y receptors;Nucleotide-like (purinergic) receptors;ADP signalling through P2Y purinoceptor 1
COQ6	negative	UBE2C	ENSG00000175063	COQ6	1	COQ6	1	0.00161812654014637					GO:0000166;GO:0005524;GO:0016740;GO:0005829;GO:0016567;GO:0005886;GO:0051301;GO:0005515;GO:0004842;GO:0007049;GO:0006511;GO:0005634;GO:0061631;GO:0070936;GO:0005654;GO:0031145;GO:1901990;GO:0044389;GO:0010458;GO:0010994;GO:0031536;GO:0070979;GO:1904668;GO:0000151;GO:0005680	cell;nucleotide binding;ATP binding;transferase activity;cytosol;plasma membrane;protein ubiquitination;cell division;protein binding;ubiquitin-protein transferase activity;cell cycle;ubiquitin-dependent protein catabolic process;nucleus;ubiquitin conjugating enzyme activity;protein K48-linked ubiquitination;nucleoplasm;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;protein polyubiquitination;ubiquitin-like protein ligase binding;exit from mitosis;free ubiquitin chain polymerization;regulation of mitotic metaphase/anaphase transition;positive regulation of exit from mitosis;protein K11-linked ubiquitination;positive regulation of ubiquitin protein ligase activity;ubiquitin ligase complex;anaphase-promoting complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Mitosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866652;R-HSA-983168;R-HSA-983169;R-HSA-1640170;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69620;R-HSA-8953897;R-HSA-69618;R-HSA-174084;R-HSA-2559583;R-HSA-141405;R-HSA-141430;R-HSA-174048;R-HSA-176407;R-HSA-176412;R-HSA-179409;R-HSA-2559582	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cell Cycle Checkpoints;Cellular responses to external stimuli;Mitotic Spindle Checkpoint;Autodegradation of Cdh1 by Cdh1:APC/C;Cellular Senescence;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC/C:Cdc20 mediated degradation of Cyclin B;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Phosphorylation of the APC/C;APC-Cdc20 mediated degradation of Nek2A;Senescence-Associated Secretory Phenotype (SASP)
COQ6	negative	PCED1B	ENSG00000179715	COQ6	1	COQ6	1	0.00161812654014637	WBGene00008418	WBGene00008418(0)			GO:0005515	protein binding	Alternative splicing;Polymorphism;Reference proteome		
COQ6	negative	AC015871.1	ENSG00000180953	COQ6	1	COQ6	1	0.00161812654014637					GO:0030308;GO:0097190;GO:0008656;GO:0006919;GO:0071494;GO:1902512	negative regulation of cell growth;apoptotic signaling pathway;cysteine-type endopeptidase activator activity involved in apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to UV-C;positive regulation of apoptotic DNA fragmentation	Polymorphism;Reference proteome;Tumor suppressor		
COQ6	negative	PLSCR1	ENSG00000188313	COQ6	1	COQ6	1	0.00161812654014637	WBGene00011935;WBGene00014200;WBGene00015437;WBGene00008681;WBGene00009753;WBGene00013052;WBGene00019530;WBGene00019531;WBGene00235369;WBGene00016348;WBGene00022511	WBGene00019531(0);WBGene00019530(0);WBGene00009753(0);WBGene00013052(0)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0005794;GO:0003677;GO:0005886;GO:0005829;GO:0005515;GO:0006915;GO:0048471;GO:0045121;GO:0005509;GO:0005730;GO:0051607;GO:0005887;GO:0006953;GO:0045944;GO:0017128;GO:0017121;GO:0070062;GO:0010628;GO:0062023;GO:0045071;GO:0017124;GO:0019899;GO:0045089;GO:0005154;GO:0001228;GO:0042609;GO:0006659;GO:0030168;GO:0033003;GO:0035456;GO:0060368;GO:2000373	phospholipid scramblase activity;plasma membrane phospholipid scrambling;nucleus;cytoplasm;membrane;integral component of membrane;Golgi apparatus;nucleoplasm;plasma membrane;DNA binding;cytosol;protein binding;apoptotic process;perinuclear region of cytoplasm;membrane raft;calcium ion binding;nucleolus;defense response to virus;integral component of plasma membrane;acute-phase response;positive regulation of transcription by RNA polymerase II;extracellular exosome;positive regulation of gene expression;collagen-containing extracellular matrix;negative regulation of viral genome replication;SH3 domain binding;enzyme binding;positive regulation of innate immune response;epidermal growth factor receptor binding;DNA-binding transcription activator activity, RNA polymerase II-specific;CD4 receptor binding;phosphatidylserine biosynthetic process;platelet activation;regulation of mast cell activation;response to interferon-beta;regulation of Fc receptor mediated stimulatory signaling pathway;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity	3D-structure;Alternative splicing;Antiviral defense;Calcium;Cell membrane;Cytoplasm;DNA-binding;Direct protein sequencing;Lipoprotein;Membrane;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3-binding;Transmembrane;Transmembrane helix		
COQ6	negative	TOR4A	ENSG00000198113	COQ6	1	COQ6	1	0.00161812654014637	WBGene00003870;WBGene00006597;WBGene00006598	WBGene00006598(0);WBGene00003870(0);WBGene00006597(0)			GO:0016020;GO:0016021;GO:0000166;GO:0005524;GO:0005576;GO:0016887;GO:0005635;GO:0002576;GO:0031093;GO:0005788	ATP binding;membrane;integral component of membrane;nucleotide binding;extracellular region;ATPase activity;nuclear envelope;platelet degranulation;platelet alpha granule lumen;endoplasmic reticulum lumen	ATP-binding;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
COQ6	negative	MZT1	ENSG00000204899	COQ6	1	COQ6	1	0.00161812654014637					GO:0005737;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0005819;GO:0005829;GO:0090307;GO:0008274;GO:0033566;GO:0051415;GO:0031021	gamma-tubulin complex localization;gamma-tubulin ring complex;cytoplasm;cytoskeleton;protein binding;centrosome;microtubule organizing center;spindle;cytosol;mitotic spindle assembly;microtubule nucleation by interphase microtubule organizing center;interphase microtubule organizing center	Acetylation;Cytoplasm;Cytoskeleton;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-380270;R-HSA-380287	Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation
COQ6	negative	C8orf88	ENSG00000253250	COQ6	1	COQ6	1	0.00161812654014637					GO:0005737;GO:0008190;GO:0045947	cytoplasm;eukaryotic initiation factor 4E binding;negative regulation of translational initiation	Reference proteome		
COQ6	negative	C1orf112	ENSG00000000460	COQ6	1	COQ6	1	0.00318086498077241							Acetylation;Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ6	negative	ATP2C1	ENSG00000017260	COQ6	1	COQ6	1	0.00318086498077241	WBGene00004063;WBGene00004736	WBGene00015338(0);WBGene00015660(0);WBGene00003153(0);WBGene00019875(0);WBGene00004063(0)		Familial benign chronic pemphigus;BENIGN CHRONIC PEMPHIGUS	GO:0016020;GO:0016021;GO:0005794;GO:0046872;GO:0000166;GO:0005524;GO:0006811;GO:1902600;GO:0000139;GO:0005388;GO:0006816;GO:0070588;GO:0071421;GO:0034220;GO:0005802;GO:0043123;GO:0008553;GO:0008544;GO:0006874;GO:0031532;GO:0015410;GO:0016339;GO:0032468;GO:0032472	integral component of membrane;ATP binding;calcium ion transport;calcium ion transmembrane transport;nucleotide binding;calcium transmembrane transporter activity, phosphorylative mechanism;membrane;Golgi apparatus;ion transport;cell;metal ion binding;proton transmembrane transport;Golgi membrane;ion transmembrane transport;trans-Golgi network;positive regulation of I-kappaB kinase/NF-kappaB signaling;manganese ion transmembrane transport;proton-exporting ATPase activity, phosphorylative mechanism;epidermis development;cellular calcium ion homeostasis;actin cytoskeleton reorganization;manganese transmembrane transporter activity, phosphorylative mechanism;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;Golgi calcium ion homeostasis;Golgi calcium ion transport	ATP-binding;Alternative splicing;Calcium;Calcium transport;Disease mutation;Golgi apparatus;Ion transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Polymorphism;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-983712;R-HSA-936837	Transport of small molecules;Ion channel transport;Ion transport by P-type ATPases
COQ6	negative	TAB2	ENSG00000055208	COQ6	1	COQ6	1	0.00318086498077241				Polyvalvular heart disease syndrome;CONGENITAL HEART DISEASE NONSYNDROMIC 2;CONGENITAL HEART DEFECTS MULTIPLE TYPES 2	GO:0046872;GO:0005829;GO:0032496;GO:0005737;GO:0016020;GO:0005515;GO:0038095;GO:0005886;GO:0050852;GO:0005654;GO:0007507;GO:0010008;GO:0002223;GO:0070498;GO:0010507;GO:0043123;GO:0002755;GO:0007249;GO:0007254;GO:0051092;GO:0045860;GO:0000187;GO:0070423;GO:0070530	metal ion binding;protein binding;response to lipopolysaccharide;cytoplasm;membrane;cytosol;Fc-epsilon receptor signaling pathway;plasma membrane;T cell receptor signaling pathway;nucleoplasm;heart development;endosome membrane;stimulatory C-type lectin receptor signaling pathway;interleukin-1-mediated signaling pathway;negative regulation of autophagy;positive regulation of I-kappaB kinase/NF-kappaB signaling;MyD88-dependent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;JNK cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of protein kinase activity;activation of MAPK activity;nucleotide-binding oligomerization domain containing signaling pathway;K63-linked polyubiquitin modification-dependent protein binding	3D-structure;Alternative splicing;Chromosomal rearrangement;Coiled coil;Cytoplasm;Disease mutation;Membrane;Metal-binding;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-202403;R-HSA-202424;R-HSA-162582;R-HSA-73887;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-5607764;R-HSA-5621481;R-HSA-9020702;R-HSA-9006934;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-937072;R-HSA-975138;R-HSA-975155;R-HSA-975163;R-HSA-1236394;R-HSA-1251985;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-450321;R-HSA-975871;R-HSA-168643;R-HSA-168638;R-HSA-445989;R-HSA-5357956;R-HSA-75893;R-HSA-9014325;R-HSA-450302;R-HSA-937042	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TCR signaling;Downstream TCR signaling;Signal Transduction;Death Receptor Signalling;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Interleukin-1 signaling;Signaling by Receptor Tyrosine Kinases;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Signaling by ERBB4;Nuclear signaling by ERBB4;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;MyD88 cascade initiated on plasma membrane;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;TNFR1-induced NFkappaB signaling pathway;TNF signaling;TICAM1,TRAF6-dependent induction of TAK1 complex;activated TAK1 mediates p38 MAPK activation;IRAK2 mediated activation of TAK1 complex
COQ6	negative	YBX3	ENSG00000060138	COQ6	1	COQ6	1	0.00318086498077241	WBGene00000472;WBGene00000473;WBGene00000474;WBGene00000475	WBGene00000472(1)			GO:0048471;GO:0005634;GO:0071356;GO:0003730;GO:0003676;GO:0003723;GO:0005737;GO:0005829;GO:0003677;GO:0005515;GO:0000981;GO:0003714;GO:0003700;GO:0000122;GO:0017048;GO:0071474;GO:1902219;GO:0060546;GO:0003690;GO:0009409;GO:0070935;GO:2000767;GO:0005923;GO:0000977;GO:0001227;GO:1905538;GO:0001701;GO:0007283;GO:0008584;GO:0009566;GO:0043066;GO:0046622;GO:0048642	nucleic acid binding;perinuclear region of cytoplasm;nucleus;cellular response to tumor necrosis factor;mRNA 3'-UTR binding;RNA binding;cytoplasm;cytosol;DNA binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;regulation of gene expression;transcription corepressor activity;DNA-binding transcription factor activity;negative regulation of transcription by RNA polymerase II;Rho GTPase binding;cellular hyperosmotic response;negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress;negative regulation of necroptotic process;double-stranded DNA binding;response to cold;3'-UTR-mediated mRNA stabilization;positive regulation of cytoplasmic translation;bicellular tight junction;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;polysome binding;in utero embryonic development;spermatogenesis;male gonad development;fertilization;negative regulation of apoptotic process;positive regulation of organ growth;negative regulation of skeletal muscle tissue development	Acetylation;Alternative splicing;Cytoplasm;DNA-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ6	negative	FAR2	ENSG00000064763	COQ6	1	COQ6	1	0.00318086498077241	WBGene00022200	WBGene00022200(1)			GO:0016491;GO:0055114;GO:0006629;GO:0080019;GO:0102965;GO:0016020;GO:0016021;GO:0005777;GO:0005778;GO:0005782;GO:0005779;GO:0010025;GO:0035336	fatty-acyl-CoA reductase (alcohol-forming) activity;oxidoreductase activity;oxidation-reduction process;lipid metabolic process;alcohol-forming fatty acyl-CoA reductase activity;membrane;integral component of membrane;peroxisome;peroxisomal membrane;intracellular membrane-bounded organelle;peroxisomal matrix;integral component of peroxisomal membrane;wax biosynthetic process;long-chain fatty-acyl-CoA metabolic process	Alternative splicing;Lipid biosynthesis;Lipid metabolism;Membrane;NADP;Oxidoreductase;Peroxisome;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-8848584;R-HSA-9640463	Metabolism;Metabolism of lipids;Wax and plasmalogen biosynthesis;Wax biosynthesis
COQ6	negative	PABPC1	ENSG00000070756	COQ6	1	COQ6	1	0.00318086498077241	WBGene00003902;WBGene00003903				GO:0003723;GO:0003676;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0005925;GO:0031047;GO:0045727;GO:0070062;GO:2000623;GO:0043488;GO:0060213;GO:1900153;GO:1990904;GO:0008022;GO:0010494;GO:0003730;GO:0006413;GO:0008143;GO:0036464;GO:0000184;GO:0045070;GO:0006378;GO:0008266;GO:0008494;GO:0048255	RNA binding;nucleic acid binding;mRNA processing;RNA splicing;nucleus;cytoplasm;membrane;cytosol;focal adhesion;protein binding;spliceosomal complex;mRNA polyadenylation;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;gene silencing by RNA;positive regulation of translation;cell leading edge;extracellular exosome;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of mRNA stability;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;ribonucleoprotein complex;protein C-terminus binding;cytoplasmic stress granule;mRNA 3'-UTR binding;translational initiation;poly(A) binding;cytoplasmic ribonucleoprotein granule;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of viral genome replication;poly(U) RNA binding;translation activator activity;mRNA stabilization	3D-structure;Acetylation;Alternative splicing;Cell projection;Cytoplasm;Direct protein sequencing;Methylation;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;mRNA processing;mRNA splicing	R-HSA-1266738;R-HSA-392499;R-HSA-422475;R-HSA-8953854;R-HSA-376176;R-HSA-450408;R-HSA-450531;R-HSA-9010553;R-HSA-429914;R-HSA-429947;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72737;R-HSA-72766;R-HSA-927802;R-HSA-975957;R-HSA-975956	Developmental Biology;Metabolism of proteins;Axon guidance;Metabolism of RNA;Signaling by ROBO receptors;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Regulation of expression of SLITs and ROBOs;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Cap-dependent Translation Initiation;Translation;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
COQ6	negative	ACTN1	ENSG00000072110	COQ6	1	COQ6	1	0.00318086498077241	WBGene00000228			Autosomal dominant macrothrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 15	GO:0005737;GO:0016020;GO:0046872;GO:0005509;GO:0003779;GO:0051015;GO:1903508;GO:0005615;GO:0042803;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0030054;GO:0051017;GO:0051764;GO:0030374;GO:0005925;GO:0005576;GO:0005829;GO:0070062;GO:0007015;GO:0001725;GO:0044325;GO:0042981;GO:0030018;GO:0001726;GO:0002576;GO:0048041;GO:0005178;GO:0031093;GO:0005911;GO:0005884;GO:0098978;GO:0017166;GO:0003725;GO:0031143;GO:0030220;GO:0051271;GO:0099186;GO:0036344;GO:0051639;GO:0099173;GO:0005903;GO:0005916;GO:0030017	protein binding;calcium ion binding;actin filament binding;actin filament bundle assembly;actin crosslink formation;cytoplasm;membrane;metal ion binding;actin binding;cytoskeleton;focal adhesion;positive regulation of nucleic acid-templated transcription;extracellular space;protein homodimerization activity;plasma membrane;cell projection;cell junction;nuclear receptor transcription coactivator activity;extracellular region;cytosol;extracellular exosome;actin filament organization;stress fiber;ion channel binding;regulation of apoptotic process;Z disc;ruffle;platelet degranulation;focal adhesion assembly;integrin binding;platelet alpha granule lumen;cell-cell junction;actin filament;glutamatergic synapse;vinculin binding;double-stranded RNA binding;pseudopodium;platelet formation;negative regulation of cellular component movement;structural constituent of postsynapse;platelet morphogenesis;actin filament network formation;postsynapse organization;brush border;fascia adherens;sarcomere	3D-structure;Acetylation;Actin-binding;Alternative splicing;Calcium;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-109582;R-HSA-1474244;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-1500931;R-HSA-373753;R-HSA-3000171;R-HSA-446728;R-HSA-3000170;R-HSA-446353;R-HSA-446388	Hemostasis;Extracellular matrix organization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Cell-Cell communication;Nephrin family interactions;Non-integrin membrane-ECM interactions;Cell junction organization;Syndecan interactions;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
COQ6	negative	ITM2A	ENSG00000078596	COQ6	1	COQ6	1	0.00318086498077241	WBGene00016106	WBGene00016106(0)			GO:0016020;GO:0016021;GO:0005515;GO:0005794;GO:0005886;GO:0001540;GO:0002317;GO:0002377;GO:0042985	membrane;integral component of membrane;protein binding;plasma membrane;Golgi apparatus;amyloid-beta binding;plasma cell differentiation;immunoglobulin production;negative regulation of amyloid precursor protein biosynthetic process	Alternative splicing;Disulfide bond;Glycoprotein;Membrane;Polymorphism;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix		
COQ6	negative	TNPO1	ENSG00000083312	COQ6	1	COQ6	1	0.00318086498077241	WBGene00002076				GO:0003723;GO:0005634;GO:0005737;GO:0006886;GO:0015031;GO:0005515;GO:0008536;GO:0006606;GO:0035735;GO:0005929;GO:0005829;GO:0070062;GO:0043488;GO:0016032;GO:0008139;GO:0061608;GO:0005623	intracellular protein transport;Ran GTPase binding;protein import into nucleus;RNA binding;nucleus;cytoplasm;protein transport;protein binding;intraciliary transport involved in cilium assembly;cilium;cytosol;extracellular exosome;regulation of mRNA stability;viral process;nuclear localization sequence binding;nuclear import signal receptor activity	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Host-virus interaction;Nucleus;Protein transport;Reference proteome;Repeat;Transport	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-8953854;R-HSA-450531;R-HSA-450513	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
COQ6	negative	SEL1L3	ENSG00000091490	COQ6	1	COQ6	1	0.00318086498077241	WBGene00004759	WBGene00004759(0)			GO:0016020;GO:0016021;GO:0005634;GO:0005654;GO:0005515	protein binding;membrane;integral component of membrane;nucleoplasm	Alternative splicing;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix		
COQ6	negative	SLC8A3	ENSG00000100678	COQ6	1	COQ6	1	0.00318086498077241	WBGene00003567;WBGene00003566;WBGene00003568				GO:0005737;GO:0016020;GO:0016021;GO:0055085;GO:0046872;GO:0005783;GO:0005789;GO:0005739;GO:0006811;GO:0005886;GO:0042995;GO:0015297;GO:0006814;GO:0006816;GO:0048471;GO:0030054;GO:0005741;GO:0070588;GO:0007154;GO:0030425;GO:0005516;GO:0005887;GO:0043204;GO:0042383;GO:0007613;GO:0043197;GO:0005432;GO:1903779;GO:0035725;GO:0031226;GO:0007612;GO:0031594;GO:0071456;GO:0060291;GO:0042552;GO:0006874;GO:0006851;GO:0051560;GO:0099566;GO:0016528;GO:0048709;GO:0014819;GO:0015368;GO:0099580;GO:1905060;GO:0002244;GO:0021537;GO:0030001;GO:0060402;GO:0071320;GO:0098703;GO:1990034;GO:0005874;GO:0043025;GO:0099055	integral component of membrane;membrane;transmembrane transport;calcium ion transport;cell communication;calcium:sodium antiporter activity;cell;neuronal cell body;cytoplasm;metal ion binding;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;ion transport;plasma membrane;cell projection;antiporter activity;sodium ion transport;perinuclear region of cytoplasm;cell junction;mitochondrial outer membrane;calcium ion transmembrane transport;synapse;dendrite;calmodulin binding;integral component of plasma membrane;perikaryon;sarcolemma;memory;dendritic spine;regulation of cardiac conduction;sodium ion transmembrane transport;intrinsic component of plasma membrane;learning;neuromuscular junction;cellular response to hypoxia;long-term synaptic potentiation;cellular calcium ion homeostasis;myelination;axon;oligodendrocyte differentiation;learning or memory;mitochondrial calcium ion transmembrane transport;mitochondrial calcium ion homeostasis;synapse organization;postsynaptic density;modulation of excitatory postsynaptic potential;regulation of postsynaptic cytosolic calcium ion concentration;sarcoplasm;negative regulation of protein serine/threonine kinase activity;axon terminus;regulation of skeletal muscle contraction;calcium:cation antiporter activity;ion antiporter activity involved in regulation of postsynaptic membrane potential;calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration;hematopoietic progenitor cell differentiation;telencephalon development;metal ion transport;calcium ion transport into cytosol;cellular response to cAMP;calcium ion import across plasma membrane;calcium ion export across plasma membrane;microtubule;integral component of postsynaptic membrane	Alternative splicing;Antiport;Calcium;Calcium transport;Calmodulin-binding;Cell junction;Cell membrane;Cell projection;Cytoplasm;Endoplasmic reticulum;Glycoprotein;Ion transport;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Polymorphism;Reference proteome;Repeat;Signal;Sodium;Sodium transport;Synapse;Transmembrane;Transmembrane helix;Transport	R-HSA-109582;R-HSA-382551;R-HSA-425407;R-HSA-397014;R-HSA-5576891;R-HSA-5578775;R-HSA-425393;R-HSA-418346;R-HSA-418359;R-HSA-418360;R-HSA-425561;R-HSA-8949215	Hemostasis;Transport of small molecules;SLC-mediated transmembrane transport;Muscle contraction;Cardiac conduction;Ion homeostasis;Transport of inorganic cations/anions and amino acids/oligopeptides;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Sodium/Calcium exchangers;Mitochondrial calcium ion transport
COQ6	negative	PLS3	ENSG00000102024	COQ6	1	COQ6	1	0.00318086498077241	WBGene00022425;WBGene00022223	WBGene00022425(1);WBGene00022223(0)		X-linked osteoporosis with fractures;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	GO:0005829;GO:0005886;GO:0005737;GO:0046872;GO:0005509;GO:0003779;GO:0051015;GO:0051017;GO:0060348;GO:0005884;GO:0051639;GO:0032432;GO:0005515	cytosol;plasma membrane;protein binding;calcium ion binding;actin filament binding;actin filament bundle assembly;cytoplasm;metal ion binding;actin binding;bone development;actin filament;actin filament network formation;actin filament bundle	3D-structure;Actin-binding;Alternative splicing;Calcium;Cytoplasm;Direct protein sequencing;Disease mutation;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ6	negative	STK24	ENSG00000102572	COQ6	1	COQ6	1	0.00318086498077241	WBGene00001526;WBGene00015376				GO:0005737;GO:0005634;GO:0016020;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005730;GO:0005829;GO:0005794;GO:0005515;GO:0006915;GO:0005654;GO:0045296;GO:0070062;GO:0009267;GO:0007165;GO:0046777;GO:0097194;GO:0023014;GO:0032147;GO:0042542;GO:0030336;GO:0008631;GO:0048679	ATP binding;protein phosphorylation;protein kinase activity;cytoplasm;nucleus;membrane;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleolus;cytosol;Golgi apparatus;protein binding;apoptotic process;nucleoplasm;cadherin binding;extracellular exosome;cellular response to starvation;signal transduction;protein autophosphorylation;execution phase of apoptosis;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;response to hydrogen peroxide;negative regulation of cell migration;intrinsic apoptotic signaling pathway in response to oxidative stress;regulation of axon regeneration	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-109581;R-HSA-5357801;R-HSA-75153;R-HSA-111465	Apoptosis;Programmed Cell Death;Apoptotic execution phase;Apoptotic cleavage of cellular proteins
COQ6	negative	USP10	ENSG00000103194	COQ6	1	COQ6	1	0.00318086498077241					GO:0003723;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0016579;GO:0016787;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0006281;GO:0006974;GO:0006511;GO:0036459;GO:0006914;GO:0005768;GO:0005769;GO:0004843;GO:0010506;GO:0004197;GO:0044325;GO:0032991;GO:0071347;GO:0043124;GO:0002039;GO:0019985;GO:0030330	ubiquitin-dependent protein catabolic process;thiol-dependent ubiquitinyl hydrolase activity;protein deubiquitination;RNA binding;nucleus;cytoplasm;nucleoplasm;cytosol;hydrolase activity;endosome;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;DNA repair;cellular response to DNA damage stimulus;autophagy;early endosome;thiol-dependent ubiquitin-specific protease activity;regulation of autophagy;cysteine-type endopeptidase activity;ion channel binding;protein-containing complex;cellular response to interleukin-1;negative regulation of I-kappaB kinase/NF-kappaB signaling;p53 binding;translesion synthesis;DNA damage response, signal transduction by p53 class mediator	Acetylation;Alternative splicing;Autophagy;Cytoplasm;DNA damage;DNA repair;Endosome;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Protease;Reference proteome;Thiol protease;Ubl conjugation;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-73894;R-HSA-5688426;R-HSA-5689880;R-HSA-110313;R-HSA-5656169;R-HSA-73893	Metabolism of proteins;Post-translational protein modification;DNA Repair;Deubiquitination;Ub-specific processing proteases;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass
COQ6	negative	CDK2AP1	ENSG00000111328	COQ6	1	COQ6	1	0.00318086498077241	WBGene00012807	WBGene00012807(0)			GO:0005634;GO:0005829;GO:0005654;GO:0005515;GO:0007049;GO:0048471;GO:0001934;GO:0070182;GO:0006261	nucleus;nucleoplasm;cytosol;protein binding;cell cycle;perinuclear region of cytoplasm;positive regulation of protein phosphorylation;DNA polymerase binding;DNA-dependent DNA replication	3D-structure;Alternative splicing;Cell cycle;Disulfide bond;Phosphoprotein;Reference proteome;Tumor suppressor		
COQ6	negative	DSE	ENSG00000111817	COQ6	1	COQ6	1	0.00318086498077241				Musculocontractural Ehlers-Danlos syndrome;Ehlers-Danlos syndrome musculocontractural type 2;EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE 2	GO:0016020;GO:0016021;GO:0016853;GO:0005829;GO:0005654;GO:0000139;GO:0030208;GO:0005783;GO:0005794;GO:0015012;GO:0030206;GO:0047757	membrane;integral component of membrane;isomerase activity;nucleoplasm;cytosol;Golgi membrane;dermatan sulfate biosynthetic process;endoplasmic reticulum;Golgi apparatus;heparan sulfate proteoglycan biosynthetic process;chondroitin sulfate biosynthetic process;chondroitin-glucuronate 5-epimerase activity;chondroitin sulfate metabolic process;dermatan sulfate metabolic process	3D-structure;Disease mutation;Ehlers-Danlos syndrome;Glycoprotein;Isomerase;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71387;R-HSA-1630316;R-HSA-1793185;R-HSA-2022923	Metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis
COQ6	negative	GPD2	ENSG00000115159	COQ6	1	COQ6	1	0.00318086498077241	WBGene00012031;WBGene00013049	WBGene00012031(1)		DIABETES MELLITUS NONINSULIN-DEPENDENT	GO:0016491;GO:0055114;GO:0006072;GO:0009331;GO:0004368;GO:0052590;GO:0052591;GO:0046872;GO:0005509;GO:0005739;GO:0005743;GO:0019563;GO:0006094;GO:0006127;GO:0035264;GO:0043010	oxidation-reduction process;oxidoreductase activity;glycerol-3-phosphate dehydrogenase (quinone) activity;glycerol-3-phosphate metabolic process;glycerol-3-phosphate dehydrogenase complex;sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity;sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity;calcium ion binding;metal ion binding;mitochondrion;mitochondrial inner membrane;glycerol catabolic process;gluconeogenesis;glycerophosphate shuttle;multicellular organism growth;camera-type eye development	Alternative splicing;Calcium;Direct protein sequencing;FAD;Flavoprotein;Metal-binding;Mitochondrion;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-163560;R-HSA-8979227;R-HSA-1483257;R-HSA-1483206;R-HSA-1483166	Metabolism;Metabolism of lipids;Triglyceride catabolism;Triglyceride metabolism;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PA
COQ6	negative	STRN	ENSG00000115808	COQ6	1	COQ6	1	0.00318086498077241	WBGene00010631	WBGene00010631(0)			GO:0005737;GO:0016020;GO:0042995;GO:0005515;GO:0016055;GO:0045211;GO:0005516;GO:0005923;GO:0051721;GO:0008285;GO:0030331;GO:0014069;GO:0043197;GO:0030425;GO:0016358;GO:0044877;GO:0070830;GO:0070016;GO:0007626;GO:0043025;GO:0090443	protein binding;cytoplasm;membrane;cell projection;Wnt signaling pathway;cell junction;synapse;postsynaptic membrane;calmodulin binding;bicellular tight junction;protein phosphatase 2A binding;negative regulation of cell population proliferation;estrogen receptor binding;postsynaptic density;dendritic spine;dendrite;dendrite development;protein-containing complex binding;bicellular tight junction assembly;armadillo repeat domain binding;locomotory behavior;neuronal cell body;FAR/SIN/STRIPAK complex	Alternative splicing;Calmodulin-binding;Cell junction;Cell projection;Coiled coil;Cytoplasm;Membrane;Phosphoprotein;Reference proteome;Repeat;Synapse;WD repeat	R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-9006925;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2219528;R-HSA-199418;R-HSA-2219530;R-HSA-6811558	Signal Transduction;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;Intracellular signaling by second messengers;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;PI3K/AKT Signaling in Cancer;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
COQ6	negative	RAP1A	ENSG00000116473	COQ6	1	COQ6	1	0.00318086498077241	WBGene00004307			Kabuki syndrome	GO:0005737;GO:0016020;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0005886;GO:0005515;GO:0048471;GO:0030054;GO:0032486;GO:0005768;GO:0005769;GO:0007399;GO:0043547;GO:0005829;GO:0070062;GO:0070374;GO:0005770;GO:0043312;GO:0035579;GO:0044877;GO:0061028;GO:0071320;GO:0050796;GO:0098978;GO:0072659;GO:0019003;GO:0045860;GO:0010976;GO:0017034;GO:0098696;GO:0038180;GO:1990090;GO:2001214;GO:1901888;GO:2000301;GO:0017016;GO:0007264;GO:0009743;GO:0032966;GO:0035690;GO:0046326;GO:0071333;GO:0071407;GO:0097327;GO:0097421;GO:1905451;GO:0032045;GO:0043005;GO:0045335	signal transduction;membrane;GTP binding;GTPase activity;Rap protein signal transduction;cytoplasm;nucleotide binding;endosome;plasma membrane;protein binding;perinuclear region of cytoplasm;cell junction;early endosome;nervous system development;positive regulation of GTPase activity;cytosol;extracellular exosome;positive regulation of ERK1 and ERK2 cascade;late endosome;neutrophil degranulation;specific granule membrane;protein-containing complex binding;establishment of endothelial barrier;cellular response to cAMP;regulation of insulin secretion;glutamatergic synapse;protein localization to plasma membrane;GDP binding;positive regulation of protein kinase activity;positive regulation of neuron projection development;Rap guanyl-nucleotide exchange factor activity;regulation of neurotransmitter receptor localization to postsynaptic specialization membrane;nerve growth factor signaling pathway;cellular response to nerve growth factor stimulus;positive regulation of vasculogenesis;regulation of cell junction assembly;negative regulation of synaptic vesicle exocytosis;Ras GTPase binding;small GTPase mediated signal transduction;response to carbohydrate;negative regulation of collagen biosynthetic process;cellular response to drug;positive regulation of glucose import;cellular response to organic cyclic compound;response to antineoplastic agent;liver regeneration;positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;guanyl-nucleotide exchange factor complex;neuron projection;phagocytic vesicle	3D-structure;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Endosome;GTP-binding;Lipoprotein;Membrane;Methylation;Neurogenesis;Nucleotide-binding;Prenylation;Reference proteome;Tumor suppressor	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-9006934;R-HSA-76002;R-HSA-6798695;R-HSA-6802952;R-HSA-6802957;R-HSA-163685;R-HSA-422356;R-HSA-166520;R-HSA-187037;R-HSA-381676;R-HSA-6806834;R-HSA-8875878;R-HSA-187687;R-HSA-354192;R-HSA-76009;R-HSA-9006921;R-HSA-6802949;R-HSA-6802946;R-HSA-6802955;R-HSA-392517;R-HSA-5674135;R-HSA-6802948;R-HSA-169893;R-HSA-170968;R-HSA-170984;R-HSA-354194;R-HSA-372708;R-HSA-8875555	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Metabolism;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;Neutrophil degranulation;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Integration of energy metabolism;Regulation of insulin secretion;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Signaling by MET;MET promotes cell motility;Signalling to ERKs;Integrin signaling;Platelet Aggregation (Plug Formation);;Signaling by RAS mutants;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Rap1 signalling;MAP2K and MAPK activation;Signaling by high-kinase activity BRAF mutants;Prolonged ERK activation events;Frs2-mediated activation;ARMS-mediated activation;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;MET activates RAP1 and RAC1
COQ6	negative	PRDX6	ENSG00000117592	COQ6	1	COQ6	1	0.00318086498077241	WBGene00021401;WBGene00006434;WBGene00011110				GO:0005737;GO:0005623;GO:0005634;GO:0016020;GO:0016491;GO:0055114;GO:0016787;GO:0006629;GO:0016042;GO:0005615;GO:0005829;GO:0045454;GO:0005515;GO:0003824;GO:0008152;GO:0048471;GO:0098869;GO:0004623;GO:0102567;GO:0102568;GO:0005764;GO:0005576;GO:0004601;GO:0051920;GO:0016209;GO:0045296;GO:0070062;GO:0043312;GO:0035578;GO:0034599;GO:0031625;GO:0042803;GO:0004602;GO:0047499;GO:0006979;GO:0042744;GO:0046475;GO:0048026	oxidation-reduction process;oxidoreductase activity;antioxidant activity;cell redox homeostasis;peroxiredoxin activity;cytoplasm;cell;nucleus;membrane;hydrolase activity;lipid metabolic process;lipid catabolic process;extracellular space;cytosol;protein binding;catalytic activity;metabolic process;perinuclear region of cytoplasm;cellular oxidant detoxification;phospholipase A2 activity;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine);phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);lysosome;extracellular region;peroxidase activity;mitochondrion;cadherin binding;extracellular exosome;neutrophil degranulation;azurophil granule lumen;cellular response to oxidative stress;ubiquitin protein ligase binding;identical protein binding;glutathione peroxidase activity;calcium-independent phospholipase A2 activity;response to oxidative stress;hydrogen peroxide catabolic process;glycerophospholipid catabolic process;positive regulation of mRNA splicing, via spliceosome	3D-structure;Acetylation;Antioxidant;Cytoplasm;Direct protein sequencing;Hydrolase;Lipid degradation;Lipid metabolism;Lysosome;Multifunctional enzyme;Oxidoreductase;Peroxidase;Phosphoprotein;Redox-active center;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-2262752;R-HSA-8953897;R-HSA-6798695;R-HSA-3299685	Innate Immune System;Immune System;Cellular responses to stress;Cellular responses to external stimuli;Neutrophil degranulation;Detoxification of Reactive Oxygen Species
COQ6	negative	CCDC18	ENSG00000122483	COQ6	1	COQ6	1	0.00318086498077241							Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome		
COQ6	negative	MTRR	ENSG00000124275	COQ6	1	COQ6	1	0.00318086498077241	WBGene00006510	WBGene00006510(1)		Methylcobalamin deficiency type cblE;Homocystinuria-megaloblastic anemia cbl E type;HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA cblE COMPLEMENTATION TYPE;Neural tube defects folate-sensitive	GO:0010181;GO:0005737;GO:0016491;GO:0055114;GO:0005829;GO:0005515;GO:0008652;GO:0050660;GO:0009235;GO:0006306;GO:0050661;GO:0070402;GO:0046655;GO:0032259;GO:0050667;GO:0009086;GO:0003958;GO:0000096;GO:0043418;GO:0016723;GO:0030586;GO:0050444;GO:0071949;GO:0006555;GO:0033353;GO:1904042	FMN binding;oxidation-reduction process;oxidoreductase activity;cytoplasm;cytosol;protein binding;cellular amino acid biosynthetic process;flavin adenine dinucleotide binding;cobalamin metabolic process;DNA methylation;NADP binding;NADPH binding;folic acid metabolic process;methylation;homocysteine metabolic process;methionine biosynthetic process;NADPH-hemoprotein reductase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;sulfur amino acid metabolic process;homocysteine catabolic process;oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;[methionine synthase] reductase activity;aquacobalamin reductase (NADPH) activity;FAD binding;methionine metabolic process;S-adenosylmethionine cycle;negative regulation of cystathionine beta-synthase activity	3D-structure;Alternative splicing;Amino-acid biosynthesis;Cytoplasm;Disease mutation;FAD;FMN;Flavoprotein;Methionine biosynthesis;NADP;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;S-adenosyl-L-methionine	R-HSA-1430728;R-HSA-71291;R-HSA-1643685;R-HSA-156580;R-HSA-211859;R-HSA-196854;R-HSA-196849;R-HSA-196741;R-HSA-3296469;R-HSA-3296482;R-HSA-5668914;R-HSA-1614635;R-HSA-156581;R-HSA-3359467;R-HSA-3359469	Metabolism;Metabolism of amino acids and derivatives;Disease;Phase II - Conjugation of compounds;Biological oxidations;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Cobalamin (Cbl, vitamin B12) transport and metabolism;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Sulfur amino acid metabolism;Methylation;Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE;Defective MTR causes methylmalonic aciduria and homocystinuria type cblG
COQ6	negative	PSMF1	ENSG00000125818	COQ6	1	COQ6	1	0.00318086498077241					GO:0005829;GO:0005737;GO:0016020;GO:0005783;GO:0010951;GO:0005515;GO:0000502;GO:0006511;GO:0038095;GO:0050852;GO:0005654;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0042803;GO:0046982;GO:0048471;GO:0070628;GO:0005839;GO:0004866;GO:1901799	cytosol;cytoplasm;membrane;endoplasmic reticulum;negative regulation of endopeptidase activity;protein binding;proteasome complex;ubiquitin-dependent protein catabolic process;Fc-epsilon receptor signaling pathway;T cell receptor signaling pathway;nucleoplasm;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;protein homodimerization activity;protein heterodimerization activity;perinuclear region of cytoplasm;proteasome binding;proteasome core complex;endopeptidase inhibitor activity;negative regulation of proteasomal protein catabolic process	3D-structure;Acetylation;Cytoplasm;Endoplasmic reticulum;Methylation;Phosphoprotein;Polymorphism;Proteasome;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
COQ6	negative	FAM110A	ENSG00000125898	COQ6	1	COQ6	1	0.00318086498077241					GO:0005737;GO:0005856;GO:0005515;GO:0000922;GO:0005815	cytoplasm;cytoskeleton;protein binding;spindle pole;microtubule organizing center	Cytoplasm;Cytoskeleton;Polymorphism;Reference proteome		
COQ6	negative	UBE2G1	ENSG00000132388	COQ6	1	COQ6	1	0.00318086498077241	WBGene00006704;WBGene00006709	WBGene00006704(1)			GO:0000166;GO:0005524;GO:0016740;GO:0016567;GO:0004842;GO:0061631;GO:0006511;GO:0070936;GO:0005829;GO:0070062;GO:0031625;GO:0000209;GO:0070534;GO:0044257	nucleotide binding;ATP binding;transferase activity;protein ubiquitination;ubiquitin-protein transferase activity;ubiquitin conjugating enzyme activity;ubiquitin-dependent protein catabolic process;protein K48-linked ubiquitination;cytosol;extracellular exosome;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin protein ligase binding;protein polyubiquitination;protein K63-linked ubiquitination;cellular protein catabolic process	3D-structure;ATP-binding;Acetylation;Direct protein sequencing;Nucleotide-binding;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866652;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ6	negative	POMP	ENSG00000132963	COQ6	1	COQ6	1	0.00318086498077241				Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome;KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA;KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA;PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2	GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0005783;GO:0031090;GO:0043231;GO:0005829;GO:0005515;GO:0043248	proteasome assembly;nucleus;cytoplasm;nuclear speck;membrane;endoplasmic reticulum;organelle membrane;intracellular membrane-bounded organelle;cytosol;protein binding	Chaperone;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Ichthyosis;Isopeptide bond;Membrane;Microsome;Nucleus;Palmoplantar keratoderma;Reference proteome;Ubl conjugation		
COQ6	negative	FAM104A	ENSG00000133193	COQ6	1	COQ6	1	0.00318086498077241					GO:0005515	protein binding	Alternative splicing;Methylation;Reference proteome		
COQ6	negative	KIF20B	ENSG00000138182	COQ6	1	COQ6	1	0.00318086498077241					GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0051301;GO:0042803;GO:0003777;GO:0005856;GO:0042995;GO:0007049;GO:0008017;GO:0048471;GO:0005874;GO:0007018;GO:0005654;GO:0005730;GO:0000922;GO:0005813;GO:0005815;GO:0005819;GO:0030496;GO:0007088;GO:0016887;GO:0005515;GO:0030424;GO:0048812;GO:2000114;GO:2001224;GO:0030426;GO:0007050;GO:0051233;GO:0008284;GO:0005871;GO:0097431;GO:1990023;GO:0032467;GO:0090316;GO:0035372;GO:0070938;GO:1903438;GO:0050699;GO:0008574;GO:0001843;GO:0070201;GO:2001222;GO:0015630;GO:0003774	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;regulation of mitotic nuclear division;nucleus;cytoplasm;nucleotide binding;nucleoplasm;cytosol;intercellular bridge;cytoskeleton;cell division;protein homodimerization activity;cell projection;cell cycle;perinuclear region of cytoplasm;midbody;microtubule;ATPase activity;nucleolus;spindle pole;centrosome;microtubule organizing center;spindle;protein binding;axon;neuron projection morphogenesis;regulation of establishment of cell polarity;positive regulation of neuron migration;growth cone;cell cycle arrest;spindle midzone;positive regulation of cell population proliferation;kinesin complex;mitotic spindle pole;mitotic spindle midzone;positive regulation of cytokinesis;positive regulation of intracellular protein transport;protein localization to microtubule;contractile ring;positive regulation of mitotic cytokinetic process;WW domain binding;ATP-dependent microtubule motor activity, plus-end-directed;neural tube closure;regulation of establishment of protein localization;regulation of neuron migration;microtubule cytoskeleton;motor activity	ATP-binding;Alternative splicing;Cell cycle;Cell division;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Oncogene;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-983189;R-HSA-983231	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ6	negative	CDYL	ENSG00000153046	COQ6	1	COQ6	1	0.00318086498077241		WBGene00007130(0);WBGene00001154(0);WBGene00001152(0)			GO:0005634;GO:0016607;GO:0003824;GO:0016829;GO:0005694;GO:0005515;GO:1903507;GO:0030154;GO:0007283;GO:0003714;GO:0007286;GO:0003682;GO:0030674;GO:0035064;GO:0060816;GO:0120092;GO:0120094;GO:0016020;GO:0016021;GO:0005737	catalytic activity;nucleus;cytoplasm;nuclear speck;lyase activity;chromosome;protein binding;negative regulation of nucleic acid-templated transcription;cell differentiation;spermatogenesis;transcription corepressor activity;spermatid development;chromatin binding;protein binding, bridging;methylated histone binding;random inactivation of X chromosome;crotonyl-CoA hydratase activity;negative regulation of peptidyl-lysine crotonylation;membrane;integral component of membrane	3D-structure;Alternative splicing;Chromosome;Differentiation;Lyase;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Spermatogenesis;Transcription;Transcription regulation		
COQ6	negative	PPBP	ENSG00000163736	COQ6	1	COQ6	1	0.00318086498077241					GO:0008083;GO:0005576;GO:0005615;GO:0005515;GO:0006955;GO:0006935;GO:0005125;GO:0008009;GO:0006952;GO:0071222;GO:0042742;GO:0006954;GO:0030593;GO:0070098;GO:0051781;GO:0007186;GO:0043312;GO:0002576;GO:0031093;GO:1904724;GO:0030595;GO:0061844;GO:0005355;GO:1904659	extracellular region;chemotaxis;immune response;defense response;chemokine activity;growth factor activity;extracellular space;protein binding;cytokine activity;cellular response to lipopolysaccharide;defense response to bacterium;inflammatory response;neutrophil chemotaxis;chemokine-mediated signaling pathway;positive regulation of cell division;G protein-coupled receptor signaling pathway;neutrophil degranulation;platelet degranulation;platelet alpha granule lumen;tertiary granule lumen;CXCR chemokine receptor binding;leukocyte chemotaxis;antimicrobial humoral immune response mediated by antimicrobial peptide;glucose transmembrane transporter activity;glucose transmembrane transport	3D-structure;Antibiotic;Antimicrobial;Chemotaxis;Cleavage on pair of basic residues;Cytokine;Direct protein sequencing;Disulfide bond;Growth factor;Mitogen;Reference proteome;Secreted;Signal	R-HSA-109582;R-HSA-168249;R-HSA-168256;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-76002;R-HSA-6798695;R-HSA-500792;R-HSA-76005;R-HSA-114608;R-HSA-373076;R-HSA-375276;R-HSA-380108	Hemostasis;Innate Immune System;Immune System;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Platelet activation, signaling and aggregation;Neutrophil degranulation;GPCR ligand binding;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines
COQ6	negative	LIMS1	ENSG00000169756	COQ6	1	COQ6	1	0.00318086498077241	WBGene00006826;WBGene00004030	WBGene00006826(1);WBGene00004030(1)			GO:0046872;GO:0016020;GO:0008270;GO:0005886;GO:0005515;GO:0048471;GO:0030054;GO:0005925;GO:0005737;GO:0043547;GO:0005829;GO:0019901;GO:0010628;GO:0005911;GO:0098609;GO:0045892;GO:0071560;GO:0045184;GO:1901224;GO:1900026;GO:0010811;GO:0051894;GO:0034329;GO:0033209;GO:0007569;GO:0045216;GO:2001046	membrane;metal ion binding;zinc ion binding;focal adhesion;plasma membrane;protein binding;perinuclear region of cytoplasm;cell junction;cytoplasm;positive regulation of GTPase activity;cytosol;protein kinase binding;positive regulation of gene expression;cell-cell junction;cell-cell adhesion;negative regulation of transcription, DNA-templated;cellular response to transforming growth factor beta stimulus;establishment of protein localization;positive regulation of NIK/NF-kappaB signaling;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of cell-substrate adhesion;positive regulation of focal adhesion assembly;cell junction assembly;tumor necrosis factor-mediated signaling pathway;cell aging;cell-cell junction organization;positive regulation of integrin-mediated signaling pathway	3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Direct protein sequencing;LIM domain;Membrane;Metal-binding;Reference proteome;Repeat;Zinc	R-HSA-1500931;R-HSA-446728;R-HSA-446353;R-HSA-446388	Cell-Cell communication;Cell junction organization;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
COQ6	negative	CDK1	ENSG00000170312	COQ6	1	COQ6	1	0.00318086498077241	WBGene00000405;WBGene00000407	WBGene00000405(1)			GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0006468;GO:0005634;GO:0005737;GO:0016020;GO:0016301;GO:0016740;GO:0016310;GO:0043066;GO:0005829;GO:0005739;GO:0051301;GO:0005856;GO:0005515;GO:0006281;GO:0007049;GO:0048511;GO:0006915;GO:0006260;GO:0046718;GO:0005813;GO:0005815;GO:0005819;GO:0030496;GO:0005789;GO:0006977;GO:0005654;GO:0070062;GO:0016477;GO:0016579;GO:0031145;GO:1901990;GO:0000784;GO:0000086;GO:0010389;GO:0097711;GO:0007098;GO:0072686;GO:0005876;GO:0006367;GO:0030855;GO:0000226;GO:0042752;GO:0018107;GO:0001618;GO:0030332;GO:0000187;GO:0018105;GO:0004693;GO:0007077;GO:0005759;GO:0003682;GO:0008353;GO:0030544;GO:0035173;GO:0097472;GO:0000278;GO:0007095;GO:0007344;GO:0007569;GO:0008283;GO:0009636;GO:0010243;GO:0010628;GO:0010971;GO:0014038;GO:0014070;GO:0014075;GO:0014823;GO:0016572;GO:0030261;GO:0031100;GO:0034501;GO:0042493;GO:0042542;GO:0044772;GO:0045471;GO:0045740;GO:0045931;GO:0045995;GO:0046686;GO:0046688;GO:0048678;GO:0055015;GO:0060045;GO:0065003;GO:0070301;GO:0090166;GO:1900182;GO:1905448;GO:0000307;GO:0097125	ATP binding;protein phosphorylation;protein kinase activity;nucleotide binding;protein serine/threonine kinase activity;nucleus;cytoplasm;membrane;kinase activity;transferase activity;phosphorylation;negative regulation of apoptotic process;nucleoplasm;cytosol;mitochondrion;cytoskeleton;cell division;protein binding;DNA repair;cell cycle;rhythmic process;apoptotic process;DNA replication;viral entry into host cell;centrosome;microtubule organizing center;spindle;midbody;endoplasmic reticulum membrane;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;extracellular exosome;cell migration;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;nuclear chromosome, telomeric region;viral process;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;centrosome cycle;mitotic spindle;spindle microtubule;transcription initiation from RNA polymerase II promoter;epithelial cell differentiation;microtubule cytoskeleton organization;regulation of circadian rhythm;peptidyl-threonine phosphorylation;virus receptor activity;cyclin binding;activation of MAPK activity;peptidyl-serine phosphorylation;cyclin-dependent protein serine/threonine kinase activity;mitotic nuclear envelope disassembly;mitochondrial matrix;chromatin binding;RNA polymerase II CTD heptapeptide repeat kinase activity;Hsp70 protein binding;histone kinase activity;cyclin-dependent protein kinase activity;mitotic cell cycle;mitotic G2 DNA damage checkpoint;pronuclear fusion;cell aging;cell population proliferation;response to toxic substance;response to organonitrogen compound;positive regulation of gene expression;positive regulation of G2/M transition of mitotic cell cycle;regulation of Schwann cell differentiation;response to organic cyclic compound;response to amine;response to activity;histone phosphorylation;chromosome condensation;animal organ regeneration;protein localization to kinetochore;positive regulation of protein import into nucleus;response to drug;response to hydrogen peroxide;mitotic cell cycle phase transition;response to ethanol;positive regulation of DNA replication;positive regulation of mitotic cell cycle;regulation of embryonic development;response to cadmium ion;response to copper ion;response to axon injury;ventricular cardiac muscle cell development;positive regulation of cardiac muscle cell proliferation;protein-containing complex assembly;cellular response to hydrogen peroxide;Golgi disassembly;positive regulation of protein localization to nucleus;positive regulation of mitochondrial ATP synthesis coupled electron transport;cyclin-dependent protein kinase holoenzyme complex;cyclin B1-CDK1 complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Host cell receptor for virus entry;Host-virus interaction;Isopeptide bond;Kinase;Mitochondrion;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Receptor;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-453274;R-HSA-453276;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69481;R-HSA-69620;R-HSA-8852276;R-HSA-8878166;R-HSA-2500257;R-HSA-380320;R-HSA-68877;R-HSA-2980766;R-HSA-3301854;R-HSA-68875;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-453279;R-HSA-69206;R-HSA-174048;R-HSA-176412;R-HSA-69473;R-HSA-75035;R-HSA-6804114;R-HSA-69273;R-HSA-5689896;R-HSA-2465910;R-HSA-113507;R-HSA-113510;R-HSA-110056;R-HSA-112409;R-HSA-162658;R-HSA-2299718;R-HSA-69205;R-HSA-2514853;R-HSA-2980767;R-HSA-69478;R-HSA-4419969;R-HSA-1538133;R-HSA-1362300;R-HSA-170145;R-HSA-176417	Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2;Resolution of Sister Chromatid Cohesion;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Nuclear Envelope Breakdown;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Mitotic G1 phase and G1/S transition;G1/S Transition;APC/C:Cdc20 mediated degradation of Cyclin B;Phosphorylation of the APC/C;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin A/B1/B2 associated events during G2/M transition;Ovarian tumor domain proteases;MASTL Facilitates Mitotic Progression;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;Golgi Cisternae Pericentriolar Stack Reorganization;Condensation of Prophase Chromosomes;G1/S-Specific Transcription;Condensation of Prometaphase Chromosomes;Activation of NIMA Kinases NEK9, NEK6, NEK7;G2/M DNA replication checkpoint;Depolymerisation of the Nuclear Lamina;G0 and Early G1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes;Phosphorylation of Emi1
COQ6	negative	AKIRIN1	ENSG00000174574	COQ6	1	COQ6	1	0.00318086498077241	WBGene00017088	WBGene00017088(0)			GO:0005634;GO:0005654;GO:0031965;GO:0005515;GO:0010592;GO:0010759;GO:0014839;GO:0045663;GO:1902723;GO:1902725	nucleus;nucleoplasm;nuclear membrane;protein binding;positive regulation of lamellipodium assembly;positive regulation of macrophage chemotaxis;myoblast migration involved in skeletal muscle regeneration;positive regulation of myoblast differentiation;negative regulation of skeletal muscle satellite cell proliferation;negative regulation of satellite cell differentiation	Alternative splicing;Nucleus;Phosphoprotein;Reference proteome		
COQ6	negative	TMEM50A	ENSG00000183726	COQ6	1	COQ6	1	0.00318086498077241	WBGene00022280	WBGene00022280(0)			GO:0016020;GO:0016021;GO:0005783;GO:0032511;GO:0005737;GO:0043025;GO:0097386	membrane;integral component of membrane;endoplasmic reticulum;late endosome to vacuole transport via multivesicular body sorting pathway;cytoplasm;neuronal cell body;glial cell projection	Acetylation;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ6	negative	NAP1L1	ENSG00000187109	COQ6	1	COQ6	1	0.00318086498077241	WBGene00017075				GO:0005634;GO:0006334;GO:0003723;GO:0005737;GO:0016020;GO:0005515;GO:0042470;GO:0007399;GO:0050769;GO:2000179;GO:0008284;GO:0006260	nucleus;nucleosome assembly;RNA binding;cytoplasm;membrane;protein binding;melanosome;positive regulation of neurogenesis;positive regulation of neural precursor cell proliferation;nervous system development;positive regulation of cell population proliferation;DNA replication	Acetylation;Alternative splicing;Cytoplasm;Lipoprotein;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Prenylation;Reference proteome		
COQ6	negative	BLOC1S5	ENSG00000188428	COQ6	1	COQ6	1	0.00318086498077241					GO:1904115;GO:0005515;GO:0031083;GO:0030133;GO:0008089;GO:0032438;GO:0048490;GO:0031175;GO:0035646;GO:0032402;GO:0050942	BLOC-1 complex;transport vesicle;cell;axon cytoplasm;protein binding;anterograde axonal transport;melanosome organization;anterograde synaptic vesicle transport;neuron projection development;endosome to melanosome transport;melanosome transport;positive regulation of pigment cell differentiation	Acetylation;Alternative splicing;Coiled coil;Reference proteome		
COQ6	negative	HLA-A	ENSG00000206503	COQ6	1	COQ6	1	0.00318086498077241				Birdshot chorioretinopathy;Phenytoin or carbamazepine toxicity;SEVERE CUTANEOUS ADVERSE REACTION SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS SUSCEPTIBILITY TO INCLUDED	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005794;GO:0005886;GO:0006955;GO:0009986;GO:0002376;GO:0050776;GO:0005887;GO:0042605;GO:0019882;GO:0002474;GO:0042612;GO:0016567;GO:0070062;GO:0002479;GO:0030670;GO:0000139;GO:0060333;GO:0012507;GO:0060337;GO:0071556;GO:0031901;GO:0002480;GO:0042270;GO:0055038;GO:0030881;GO:0046977;GO:0036037;GO:0042590;GO:0001913	immune response;antigen processing and presentation;RNA binding;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;cell surface;immune system process;innate immune response;adaptive immune response;regulation of immune response;protein binding;defense response to Gram-positive bacterium;integral component of plasma membrane;peptide antigen binding;protein ubiquitination;extracellular exosome;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral process;antibacterial humoral response;antigen processing and presentation of peptide antigen via MHC class I;MHC class I protein complex;phagocytic vesicle membrane;T cell receptor signaling pathway;Golgi membrane;interferon-gamma-mediated signaling pathway;signaling receptor binding;endoplasmic reticulum exit site;ER to Golgi transport vesicle membrane;type I interferon signaling pathway;positive regulation of T cell mediated cytotoxicity;TAP complex binding;MHC class I peptide loading complex;integral component of lumenal side of endoplasmic reticulum membrane;early endosome membrane;detection of bacterium;positive regulation of interferon-gamma production;TAP binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent;protection from natural killer cell mediated cytotoxicity;recycling endosome membrane;beta-2-microglobulin binding;T cell receptor binding;CD8 receptor binding;T cell mediated cytotoxicity;T cell mediated cytotoxicity directed against tumor cell target;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent;positive regulation of T cell cytokine production;antigen processing and presentation of endogenous peptide antigen via MHC class I;CD8-positive, alpha-beta T cell activation;antigen processing and presentation of exogenous peptide antigen via MHC class I;positive regulation of CD8-positive, alpha-beta T cell proliferation;positive regulation of memory T cell activation;positive regulation of CD8-positive, alpha-beta T cell activation;Golgi medial cisterna	3D-structure;Adaptive immunity;Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Host-virus interaction;Immunity;Immunoglobulin domain;Innate immunity;MHC I;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal;Sulfation;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-1280218;R-HSA-168256;R-HSA-198933;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-983169;R-HSA-1236974;R-HSA-1236975;R-HSA-1280215;R-HSA-913531;R-HSA-877300;R-HSA-909733;R-HSA-983170;R-HSA-1236977	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Class I MHC mediated antigen processing & presentation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Endosomal/Vacuolar pathway
COQ6	negative	PPM1N	ENSG00000213889	COQ6	1	COQ6	1	0.00318086498077241	WBGene00006460	WBGene00018362(0);WBGene00006460(0);WBGene00016580(0);WBGene00022832(0)			GO:0046872;GO:0000287;GO:0016787;GO:0003824;GO:0004721;GO:0006470;GO:0030145;GO:0004722;GO:0005634;GO:0005829;GO:0004724;GO:0043124;GO:0090263	magnesium ion binding;manganese ion binding;phosphoprotein phosphatase activity;metal ion binding;hydrolase activity;catalytic activity;protein dephosphorylation;protein serine/threonine phosphatase activity;nucleus;cytosol;magnesium-dependent protein serine/threonine phosphatase activity;negative regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of canonical Wnt signaling pathway	Alternative splicing;Hydrolase;Magnesium;Manganese;Metal-binding;Protein phosphatase;Reference proteome		
COQ6	negative	MYCBP	ENSG00000214114	COQ6	1	COQ6	1	0.00318086498077241					GO:0005634;GO:0005737;GO:0003713;GO:0006355;GO:0005739;GO:1903508;GO:0005515;GO:0007283	regulation of transcription, DNA-templated;transcription coactivator activity;nucleus;cytoplasm;nucleoplasm;mitochondrion;positive regulation of nucleic acid-templated transcription;protein binding;spermatogenesis	3D-structure;Cytoplasm;Direct protein sequencing;Mitochondrion;Nucleus;Reference proteome;Transcription;Transcription regulation		
COQ6	negative	STRAP	ENSG00000023734	COQ6	1	COQ6	1	0.00599052570587644					GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005515;GO:0000387;GO:0032797;GO:0034719;GO:0050680;GO:0030512;GO:0010719;GO:0060394;GO:0030277;GO:0010633;GO:0005102;GO:0000122	protein binding;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;cytosol;spliceosomal snRNP assembly;SMN complex;SMN-Sm protein complex;negative regulation of epithelial cell proliferation;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of epithelial to mesenchymal transition;negative regulation of pathway-restricted SMAD protein phosphorylation;maintenance of gastrointestinal epithelium;negative regulation of epithelial cell migration;signaling receptor binding;negative regulation of transcription by RNA polymerase II	Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat;mRNA processing;mRNA splicing	R-HSA-162582;R-HSA-9006936;R-HSA-170834;R-HSA-2173788;R-HSA-2173789	Signal Transduction;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
COQ6	negative	CNTLN	ENSG00000044459	COQ6	1	COQ6	1	0.00599052570587644					GO:0005737;GO:0005813;GO:0005829;GO:0005654;GO:0005856;GO:0070062;GO:0019901;GO:0005814;GO:0019904;GO:0030674;GO:0033365;GO:0010457	cytoplasm;nucleoplasm;cytosol;cytoskeleton;centrosome;extracellular exosome;protein kinase binding;centriole;protein domain specific binding;protein binding, bridging;protein localization to organelle;centriole-centriole cohesion	Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome		
COQ6	negative	GNA15	ENSG00000060558	COQ6	1	COQ6	1	0.00599052570587644		WBGene00001664(0);WBGene00001675(0);WBGene00001665(0);WBGene00001678(0);WBGene00001666(0);WBGene00001745(0);WBGene00001670(0);WBGene00001671(0);WBGene00001674(0);WBGene00001673(0);WBGene00001668(0);WBGene00001676(0);WBGene00001667(0)			GO:0046872;GO:0000166;GO:0007186;GO:0007165;GO:0003924;GO:0005525;GO:0001664;GO:0005834;GO:0019001;GO:0031683;GO:0005886;GO:0007188;GO:0030168;GO:0060158;GO:0007202;GO:0051482;GO:0007207;GO:0007200	G protein-coupled receptor signaling pathway;signal transduction;GTPase activity;G-protein beta/gamma-subunit complex binding;G protein-coupled receptor binding;guanyl nucleotide binding;cell;metal ion binding;nucleotide binding;GTP binding;heterotrimeric G-protein complex;synapse;plasma membrane;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;platelet activation;phospholipase C-activating dopamine receptor signaling pathway;activation of phospholipase C activity;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway	ADP-ribosylation;GTP-binding;Magnesium;Metal-binding;Nucleotide-binding;Polymorphism;Reference proteome;Transducer	R-HSA-109582;R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-392518;R-HSA-76002;R-HSA-456926;R-HSA-163685;R-HSA-422356;R-HSA-418592;R-HSA-428930;R-HSA-400451;R-HSA-434316;R-HSA-399997	Hemostasis;Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Signal amplification;Platelet activation, signaling and aggregation;Thrombin signalling through proteinase activated receptors (PARs);Integration of energy metabolism;Regulation of insulin secretion;ADP signalling through P2Y purinoceptor 1;Thromboxane signalling through TP receptor;Free fatty acids regulate insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Acetylcholine regulates insulin secretion
COQ6	negative	CNN2	ENSG00000064666	COQ6	1	COQ6	1	0.00599052570587644	WBGene00000777;WBGene00000778;WBGene00000779;WBGene00000780	WBGene00000778(0);WBGene00000777(0);WBGene00000780(0);WBGene00000779(0)			GO:0016020;GO:0003779;GO:0005925;GO:0005576;GO:0005516;GO:0031032;GO:0045296;GO:0043312;GO:0035722;GO:0005856;GO:0035580;GO:1904724;GO:0005911;GO:0001725;GO:0007010;GO:0032970;GO:0071260;GO:0005515;GO:0010628;GO:0030097;GO:0030336;GO:0042060;GO:0042127;GO:0050765	protein binding;actin binding;actomyosin structure organization;membrane;focal adhesion;extracellular region;calmodulin binding;cadherin binding;neutrophil degranulation;interleukin-12-mediated signaling pathway;cytoskeleton;specific granule lumen;tertiary granule lumen;cell-cell junction;stress fiber;cytoskeleton organization;regulation of actin filament-based process;cellular response to mechanical stimulus;positive regulation of gene expression;hemopoiesis;negative regulation of cell migration;wound healing;regulation of cell population proliferation;negative regulation of phagocytosis	3D-structure;Acetylation;Actin-binding;Alternative splicing;Calmodulin-binding;Direct protein sequencing;Phosphoprotein;Reference proteome;Repeat	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-6798695;R-HSA-447115;R-HSA-8950505;R-HSA-9020591	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Neutrophil degranulation;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
COQ6	negative	MSANTD3	ENSG00000066697	COQ6	1	COQ6	1	0.00599052570587644					GO:0042802	identical protein binding	Alternative splicing;Coiled coil;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation		
COQ6	negative	KIF2A	ENSG00000068796	COQ6	1	COQ6	1	0.00599052570587644	WBGene00002219			Malformations of cortical development and microcephaly.;CORTICAL DYSPLASIA COMPLEX WITH OTHER BRAIN MALFORMATIONS 3	GO:0005737;GO:0016020;GO:0005634;GO:0005813;GO:0000166;GO:0005524;GO:0005730;GO:0051301;GO:0003777;GO:0005856;GO:0005515;GO:0007049;GO:0016604;GO:0008017;GO:0007275;GO:0005874;GO:0007018;GO:0030154;GO:0000922;GO:0005815;GO:0005819;GO:0007399;GO:0016887;GO:0005829;GO:0006890;GO:0005814;GO:0005876;GO:0003774;GO:0000226;GO:0007019;GO:0007052;GO:0019886;GO:0030334;GO:0090307;GO:0005871;GO:0120103;GO:0097228	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cytoplasm;membrane;nucleotide binding;nucleoplasm;nucleolus;cytoskeleton;cell division;centrosome;protein binding;cell cycle;nuclear body;multicellular organism development;microtubule;cell differentiation;spindle pole;microtubule organizing center;spindle;nervous system development;ATPase activity;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;centriole;spindle microtubule;motor activity;microtubule cytoskeleton organization;microtubule depolymerization;mitotic spindle organization;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of cell migration;mitotic spindle assembly;kinesin complex;centriolar subdistal appendage;sperm principal piece	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Developmental protein;Differentiation;Disease mutation;Lissencephaly;Microtubule;Mitosis;Motor protein;Neurogenesis;Nucleotide-binding;Phosphoprotein;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2132295;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-983189;R-HSA-983231;R-HSA-141424;R-HSA-141444;R-HSA-69618	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Kinesins;Factors involved in megakaryocyte development and platelet production;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ6	negative	MCM2	ENSG00000073111	COQ6	1	COQ6	1	0.00599052570587644	WBGene00003154	WBGene00003154(1)		Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 70	GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0005654;GO:0016787;GO:0003677;GO:0015630;GO:0005515;GO:0006270;GO:0007049;GO:0006915;GO:0006260;GO:0003678;GO:0004386;GO:0042555;GO:0000784;GO:0003697;GO:1905775;GO:0000785;GO:0000082;GO:0000727;GO:0003688;GO:0043138;GO:0006268;GO:1902975;GO:0006267;GO:0017116;GO:0019899;GO:0042393;GO:0006334;GO:0071353;GO:0090102;GO:0005664;GO:0032508	DNA binding;nucleus;ATP binding;DNA replication;DNA replication initiation;negative regulation of DNA helicase activity;MCM complex;cytoplasm;metal ion binding;nucleotide binding;nucleoplasm;hydrolase activity;microtubule cytoskeleton;protein binding;cell cycle;apoptotic process;DNA helicase activity;helicase activity;nuclear chromosome, telomeric region;chromatin;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;single-stranded DNA binding;DNA replication origin binding;3'-5' DNA helicase activity;DNA unwinding involved in DNA replication;mitotic DNA replication initiation;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;enzyme binding;histone binding;nucleosome assembly;cellular response to interleukin-4;cochlea development;nuclear origin of replication recognition complex;DNA duplex unwinding	3D-structure;ATP-binding;Acetylation;Cell cycle;DNA replication;DNA-binding;Deafness;Disease mutation;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Non-syndromic deafness;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1640170;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-176974;R-HSA-69190	Cell Cycle;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Unwinding of DNA;DNA strand elongation
COQ6	negative	UBE2A	ENSG00000077721	COQ6	1	COQ6	1	0.00599052570587644	WBGene00006701			X-linked intellectual disability Nascimento type;UBE2A-Related X-Linked Syndromic Mental Retardation;MENTAL RETARDATION X-LINKED SYNDROMIC NASCIMENTO TYPE	GO:0000166;GO:0005524;GO:0016740;GO:0016567;GO:0006325;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0051865;GO:0006511;GO:0000790;GO:0061631;GO:0070936;GO:0005654;GO:0005829;GO:0000209;GO:0043161;GO:0031625;GO:0008284;GO:0009411;GO:0000785;GO:0070979;GO:0033503;GO:0033522;GO:0006301;GO:0001701;GO:0001835;GO:0060135;GO:0001741	nucleotide binding;ATP binding;transferase activity;protein ubiquitination;chromatin organization;protein binding;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;protein autoubiquitination;ubiquitin-dependent protein catabolic process;nuclear chromatin;ubiquitin conjugating enzyme activity;protein K48-linked ubiquitination;nucleoplasm;cytosol;protein polyubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin protein ligase binding;positive regulation of cell population proliferation;response to UV;chromatin;protein K11-linked ubiquitination;HULC complex;histone H2A ubiquitination;postreplication repair;in utero embryonic development;blastocyst hatching;histone ubiquitination;maternal process involved in female pregnancy;XY body	3D-structure;ATP-binding;Alternative splicing;Chromatin regulator;DNA damage;DNA repair;Disease mutation;Mental retardation;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-8866652;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ6	negative	NLK	ENSG00000087095	COQ6	1	COQ6	1	0.00599052570587644	WBGene00003048	WBGene00003048(0);WBGene00002187(0);WBGene00002188(0);WBGene00008200(0);WBGene00013091(0);WBGene00007977(0);WBGene00013705(0);WBGene00004055(0);WBGene00004056(0)			GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0000287;GO:0004707;GO:0042169;GO:0000165;GO:0006355;GO:0018107;GO:0030178;GO:0035556;GO:0042501;GO:0046777;GO:0005515;GO:0016055;GO:0005654;GO:0005829;GO:0050821;GO:0010468;GO:0031625;GO:0008134;GO:0007179;GO:0007223	ATP binding;protein phosphorylation;protein kinase activity;MAP kinase activity;nucleus;cytoplasm;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;magnesium ion binding;SH2 domain binding;MAPK cascade;regulation of transcription, DNA-templated;peptidyl-threonine phosphorylation;negative regulation of Wnt signaling pathway;intracellular signal transduction;serine phosphorylation of STAT protein;protein autophosphorylation;protein binding;Wnt signaling pathway;nucleoplasm;cytosol;protein stabilization;regulation of gene expression;ubiquitin protein ligase binding;transcription factor binding;transforming growth factor beta receptor signaling pathway;Wnt signaling pathway, calcium modulating pathway	ATP-binding;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Wnt signaling pathway	R-HSA-162582;R-HSA-195721;R-HSA-3858494;R-HSA-4086398	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;Ca2+ pathway
COQ6	negative	STRN4	ENSG00000090372	COQ6	1	COQ6	1	0.00599052570587644	WBGene00010631	WBGene00010631(0)			GO:0005737;GO:0016020;GO:0042995;GO:0005515;GO:0005516;GO:0051721;GO:0008150;GO:0043197;GO:0030425;GO:0044877;GO:0070016;GO:0090443;GO:0019904;GO:0032991	protein binding;cytoplasm;membrane;cell projection;cell junction;synapse;calmodulin binding;protein phosphatase 2A binding;biological_process;dendritic spine;dendrite;protein-containing complex binding;armadillo repeat domain binding;FAR/SIN/STRIPAK complex;protein domain specific binding;protein-containing complex	Alternative splicing;Calmodulin-binding;Cell junction;Cell projection;Coiled coil;Cytoplasm;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Synapse;WD repeat		
COQ6	negative	CMTM6	ENSG00000091317	COQ6	1	COQ6	1	0.00599052570587644		WBGene00017909(0);WBGene00018527(0)			GO:0016020;GO:0016021;GO:0015031;GO:0005886;GO:0005515;GO:0005768;GO:0031901;GO:0055038;GO:0043312;GO:0035579;GO:0031647;GO:0035577;GO:0032456	membrane;integral component of membrane;protein transport;intracellular membrane-bounded organelle;endosome;plasma membrane;protein binding;early endosome membrane;recycling endosome membrane;neutrophil degranulation;specific granule membrane;regulation of protein stability;azurophil granule membrane;endocytic recycling	Acetylation;Cell membrane;Direct protein sequencing;Endosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ6	negative	CRKL	ENSG00000099942	COQ6	1	COQ6	1	0.00599052570587644	WBGene00000416	WBGene00000416(1)		Distal 22q11.2 microdeletion syndrome;Bladder exstrophy plus	GO:0010629;GO:0071560;GO:0001933;GO:0001934;GO:0003723;GO:0005829;GO:0005654;GO:0005515;GO:0042802;GO:0045296;GO:0019221;GO:0001784;GO:0005070;GO:0035556;GO:0007265;GO:0046579;GO:0070374;GO:1900026;GO:0000186;GO:0008284;GO:0007254;GO:0000187;GO:0001558;GO:0001568;GO:0001655;GO:0001764;GO:0001783;GO:0002685;GO:0003151;GO:0006629;GO:0007283;GO:0007338;GO:0007389;GO:0007416;GO:0007507;GO:0008543;GO:0008584;GO:0009887;GO:0009952;GO:0010468;GO:0016358;GO:0021766;GO:0021987;GO:0030010;GO:0033628;GO:0035685;GO:0035690;GO:0038026;GO:0048384;GO:0048538;GO:0050773;GO:0050852;GO:0060017;GO:0060326;GO:0060465;GO:0071774;GO:0086100;GO:0090630;GO:0095500;GO:0098749;GO:0098761;GO:1903977;GO:1904393;GO:1904888;GO:2000404;GO:0031594;GO:0032991;GO:0045202;GO:0098890	protein binding;negative regulation of gene expression;cellular response to transforming growth factor beta stimulus;negative regulation of protein phosphorylation;positive regulation of protein phosphorylation;RNA binding;nucleoplasm;cytosol;identical protein binding;cadherin binding;cytokine-mediated signaling pathway;phosphotyrosine residue binding;SH3/SH2 adaptor activity;intracellular signal transduction;Ras protein signal transduction;positive regulation of Ras protein signal transduction;positive regulation of ERK1 and ERK2 cascade;positive regulation of substrate adhesion-dependent cell spreading;activation of MAPKK activity;positive regulation of cell population proliferation;JNK cascade;activation of MAPK activity;regulation of cell growth;blood vessel development;urogenital system development;neuron migration;B cell apoptotic process;regulation of leukocyte migration;outflow tract morphogenesis;lipid metabolic process;spermatogenesis;single fertilization;pattern specification process;synapse assembly;heart development;fibroblast growth factor receptor signaling pathway;male gonad development;animal organ morphogenesis;anterior/posterior pattern specification;regulation of gene expression;dendrite development;hippocampus development;cerebral cortex development;establishment of cell polarity;regulation of cell adhesion mediated by integrin;helper T cell diapedesis;cellular response to drug;reelin-mediated signaling pathway;retinoic acid receptor signaling pathway;thymus development;regulation of dendrite development;T cell receptor signaling pathway;parathyroid gland development;cell chemotaxis;pharynx development;response to fibroblast growth factor;endothelin receptor signaling pathway;activation of GTPase activity;acetylcholine receptor signaling pathway;cerebellar neuron development;cellular response to interleukin-7;positive regulation of glial cell migration;regulation of skeletal muscle acetylcholine-gated channel clustering;cranial skeletal system development;regulation of T cell migration;neuromuscular junction;protein-containing complex;synapse;extrinsic component of postsynaptic membrane	3D-structure;Phosphoprotein;Reference proteome;Repeat;SH2 domain;SH3 domain	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-186797;R-HSA-9006934;R-HSA-512988;R-HSA-9006335;R-HSA-912631;R-HSA-166520;R-HSA-186763;R-HSA-187037;R-HSA-6806834;R-HSA-8875878;R-HSA-187687;R-HSA-9027284;R-HSA-169893;R-HSA-170968;R-HSA-8875555;R-HSA-8875656	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by Erythropoietin;Regulation of signaling by CBL;Signaling by NTRKs;Downstream signal transduction;Signaling by NTRK1 (TRKA);Signaling by MET;MET promotes cell motility;Signalling to ERKs;Erythropoietin activates RAS;Prolonged ERK activation events;Frs2-mediated activation;MET activates RAP1 and RAC1;MET receptor recycling
COQ6	negative	MYL12A	ENSG00000101608	COQ6	1	COQ6	1	0.00599052570587644	WBGene00003372	WBGene00003370(0);WBGene00003369(0)			GO:0046872;GO:0005509;GO:0016459;GO:0005515;GO:0005829;GO:0070062;GO:0070527;GO:0006936;GO:0035254;GO:0008360;GO:0072659;GO:0001725;GO:0016460;GO:0030018	calcium ion binding;metal ion binding;myosin complex;protein binding;cytosol;extracellular exosome;platelet aggregation;muscle contraction;glutamate receptor binding;regulation of cell shape;protein localization to plasma membrane;stress fiber;myosin II complex;Z disc	Calcium;Metal-binding;Motor protein;Muscle protein;Myosin;Phosphoprotein;Reference proteome;Repeat	R-HSA-1266738;R-HSA-422475;R-HSA-397014;R-HSA-2682334;R-HSA-3928664;R-HSA-445355	Developmental Biology;Axon guidance;Muscle contraction;EPH-Ephrin signaling;Ephrin signaling;Smooth Muscle Contraction
COQ6	negative	NXT2	ENSG00000101888	COQ6	1	COQ6	1	0.00599052570587644	WBGene00003836	WBGene00003836(0)			GO:0051028;GO:0005634;GO:0005737;GO:0015031;GO:0005829;GO:0005654;GO:0005515;GO:0048471;GO:0006606;GO:0044613;GO:0006913	mRNA transport;nucleus;cytoplasm;protein transport;nucleoplasm;cytosol;protein binding;perinuclear region of cytoplasm;protein import into nucleus;nuclear pore central transport channel;nucleocytoplasmic transport	Alternative splicing;Cytoplasm;Nucleus;Protein transport;Reference proteome;Transport;mRNA transport		
COQ6	negative	SF3A2	ENSG00000104897	COQ6	1	COQ6	1	0.00599052570587644	WBGene00008683	WBGene00008683(0)			GO:0005634;GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0008270;GO:0046872;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0005654;GO:0005686;GO:0071005;GO:0071004;GO:0000245;GO:0000389;GO:1903241;GO:0010976;GO:0016607	zinc ion binding;nucleus;nucleic acid binding;RNA binding;mRNA processing;RNA splicing;metal ion binding;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;nucleoplasm;U2 snRNP;U2-type precatalytic spliceosome;U2-type prespliceosome;spliceosomal complex assembly;mRNA 3'-splice site recognition;U2-type prespliceosome assembly;positive regulation of neuron projection development;nuclear speck	3D-structure;Acetylation;Direct protein sequencing;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ6	negative	ALOX12	ENSG00000108839	COQ6	1	COQ6	1	0.00599052570587644					GO:0005737;GO:0016020;GO:0046872;GO:0016491;GO:0055114;GO:0016787;GO:0006629;GO:0005829;GO:0006631;GO:0005506;GO:0005515;GO:0051213;GO:0016702;GO:0070062;GO:0042383;GO:0061436;GO:0016165;GO:0050473;GO:0019369;GO:0019372;GO:0051122;GO:0004052;GO:0043651;GO:0042759;GO:2001301;GO:0090331;GO:0042554;GO:2001303;GO:0047977;GO:0007568;GO:0010628;GO:0010656;GO:0010942;GO:0019395;GO:0033559;GO:0043065;GO:0043066;GO:0043280;GO:0043536;GO:0048661;GO:0051121;GO:0051901;GO:0071396;GO:0097755;GO:1901751;GO:1905956;GO:2001306	metal ion binding;protein binding;oxidation-reduction process;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;iron ion binding;cytoplasm;membrane;oxidoreductase activity;hydrolase activity;lipid metabolic process;cytosol;fatty acid metabolic process;dioxygenase activity;plasma membrane;arachidonic acid metabolic process;extracellular exosome;sarcolemma;establishment of skin barrier;linoleate 13S-lipoxygenase activity;arachidonate 15-lipoxygenase activity;lipoxygenase pathway;lipid oxidation;hepoxilin biosynthetic process;arachidonate 12(S)-lipoxygenase activity;linoleic acid metabolic process;long-chain fatty acid biosynthetic process;lipoxin biosynthetic process;negative regulation of platelet aggregation;superoxide anion generation;fatty acid oxidation;lipoxin A4 biosynthetic process;hepoxilin-epoxide hydrolase activity;aging;positive regulation of gene expression;negative regulation of muscle cell apoptotic process;positive regulation of cell death;unsaturated fatty acid metabolic process;positive regulation of apoptotic process;negative regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of blood vessel endothelial cell migration;positive regulation of smooth muscle cell proliferation;hepoxilin metabolic process;positive regulation of mitochondrial depolarization;cellular response to lipid;positive regulation of blood vessel diameter;leukotriene A4 metabolic process;positive regulation of endothelial tube morphogenesis;lipoxin B4 biosynthetic process	3D-structure;Cytoplasm;Dioxygenase;Fatty acid metabolism;Hydrolase;Iron;Lipid metabolism;Membrane;Metal-binding;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-2142753;R-HSA-2142712;R-HSA-9018677;R-HSA-9018678;R-HSA-2142700;R-HSA-9018683;R-HSA-9025094;R-HSA-9026290;R-HSA-9025106;R-HSA-2142696	Metabolism;Metabolism of lipids;Fatty acid metabolism;Arachidonic acid metabolism;Synthesis of 12-eicosatetraenoic acid derivatives;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Synthesis of Lipoxins (LX);Biosynthesis of DPA-derived SPMs;Biosynthesis of DPAn-3 SPMs;Biosynthesis of DPAn-3-derived maresins;Biosynthesis of DPAn-6 SPMs;Synthesis of Hepoxilins (HX) and Trioxilins (TrX)
COQ6	negative	PANX1	ENSG00000110218	COQ6	1	COQ6	1	0.00599052570587644					GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005886;GO:0006811;GO:0006812;GO:0006816;GO:0002020;GO:0003779;GO:0005243;GO:0015267;GO:0044325;GO:0046982;GO:0051015;GO:0097110;GO:0002931;GO:0007267;GO:0033198;GO:0050715;GO:0050716;GO:0050717;GO:0050718;GO:0055085;GO:0005921;GO:0030054;GO:0032991;GO:0005262;GO:0070588;GO:0034214;GO:0005102;GO:0032059;GO:0055077;GO:0022840;GO:0022829	channel activity;cation transport;positive regulation of interleukin-1 secretion;membrane;integral component of membrane;plasma membrane;endoplasmic reticulum;endoplasmic reticulum membrane;ion transport;calcium ion transport;protease binding;actin binding;structural molecule activity;gap junction channel activity;ion channel binding;protein-containing complex binding;actin filament binding;scaffold protein binding;response to ischemia;cell-cell signaling;response to ATP;positive regulation of cytokine secretion;positive regulation of interleukin-1 alpha secretion;positive regulation of interleukin-1 beta secretion;transmembrane transport;gap junction;cell junction;protein-containing complex;calcium channel activity;calcium ion transmembrane transport;signaling receptor binding;bleb;leak channel activity;wide pore channel activity	Alternative splicing;Calcium;Calcium channel;Calcium transport;Cell junction;Cell membrane;Differentiation;Disease mutation;Endoplasmic reticulum;Gap junction;Glycoprotein;Ion channel;Ion transport;Membrane;Oogenesis;Polymorphism;Reference proteome;S-nitrosylation;Transmembrane;Transmembrane helix;Transport	R-HSA-168249;R-HSA-168256;R-HSA-112316;R-HSA-168643;R-HSA-622312;R-HSA-844456;R-HSA-112303;R-HSA-112307	Innate Immune System;Immune System;Neuronal System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The NLRP3 inflammasome;Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses 
COQ6	negative	MAGOHB	ENSG00000111196	COQ6	1	COQ6	1	0.00599052570587644	WBGene00003123	WBGene00003123(1)			GO:0008380;GO:0005634;GO:0035145;GO:0043025;GO:0003723;GO:0006397;GO:0051028;GO:0005515;GO:0005681;GO:0000398;GO:0005654;GO:0006406;GO:0006405;GO:0031124;GO:0000184;GO:0071006;GO:0071005;GO:0071013	nucleus;RNA splicing;exon-exon junction complex;neuronal cell body;RNA binding;mRNA processing;mRNA transport;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;nucleoplasm;mRNA export from nucleus;RNA export from nucleus;mRNA 3'-end processing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;U2-type catalytic step 1 spliceosome;U2-type precatalytic spliceosome;catalytic step 2 spliceosome	3D-structure;Acetylation;Direct protein sequencing;Nucleus;Polymorphism;RNA-binding;Reference proteome;Spliceosome;Transport;mRNA processing;mRNA splicing;mRNA transport	R-HSA-1266738;R-HSA-73857;R-HSA-74160;R-HSA-422475;R-HSA-8953854;R-HSA-376176;R-HSA-9010553;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-927802;R-HSA-975957	Developmental Biology;RNA Polymerase II Transcription;Gene expression (Transcription);Axon guidance;Metabolism of RNA;Signaling by ROBO receptors;Regulation of expression of SLITs and ROBOs;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
COQ6	negative	IVNS1ABP	ENSG00000116679	COQ6	1	COQ6	1	0.00599052570587644	WBGene00006493				GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005856;GO:0005654;GO:0005515;GO:0009615;GO:0016032;GO:0031397;GO:0006383;GO:0005681;GO:0005667;GO:2001243	protein binding;RNA splicing;nucleus;cytoplasm;cytosol;cytoskeleton;nucleoplasm;response to virus;viral process;negative regulation of protein ubiquitination;transcription by RNA polymerase III;spliceosomal complex;transcription factor complex;negative regulation of intrinsic apoptotic signaling pathway	3D-structure;Cytoplasm;Cytoskeleton;Host-virus interaction;Kelch repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat		
COQ6	negative	PLA2G4A	ENSG00000116711	COQ6	1	COQ6	1	0.00599052570587644				Cryptogenic multifocal ulcerous stenosing enteritis;Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder;GASTROINTESTINAL ULCERATION RECURRENT WITH DYSFUNCTIONAL PLATELETS	GO:0005737;GO:0046872;GO:0005829;GO:0016787;GO:0005509;GO:0004620;GO:0006629;GO:0009395;GO:0016042;GO:0005811;GO:0031410;GO:0005544;GO:0004623;GO:0102567;GO:0102568;GO:0005634;GO:0005783;GO:0005794;GO:0005789;GO:0047498;GO:0005743;GO:0019369;GO:0006654;GO:0036148;GO:0036149;GO:0036150;GO:0036151;GO:0036152;GO:0004622;GO:0006644;GO:0046475;GO:0035965;GO:0006663;GO:0006690;GO:0042127;GO:0046456;GO:0050482;GO:0071236	calcium ion binding;phospholipase activity;phospholipid catabolic process;cytoplasm;metal ion binding;cytosol;hydrolase activity;lipid metabolic process;lipid catabolic process;lipid droplet;cytoplasmic vesicle;calcium-dependent phospholipid binding;Golgi membrane;phospholipase A2 activity;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine);phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);nucleus;endoplasmic reticulum;Golgi apparatus;leukotriene biosynthetic process;endoplasmic reticulum membrane;phosphatidylinositol-5-phosphate binding;phosphatidylinositol-3-phosphate binding;calcium-dependent phospholipase A2 activity;mitochondrial inner membrane;arachidonic acid metabolic process;nuclear envelope;prostaglandin biosynthetic process;phosphatidic acid biosynthetic process;phosphatidylglycerol acyl-chain remodeling;phosphatidylinositol acyl-chain remodeling;phosphatidylserine acyl-chain remodeling;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;phosphatidylinositol-4-phosphate binding;lysophospholipase activity;phospholipid metabolic process;glycerophospholipid catabolic process;icosanoid metabolic process;phosphatidylcholine catabolic process;cardiolipin acyl-chain remodeling;O-acyltransferase activity;calcium-independent phospholipase A2 activity;ceramide 1-phosphate binding;positive regulation of T-helper 1 type immune response;monoacylglycerol biosynthetic process;platelet activating factor biosynthetic process;positive regulation of platelet activation;phosphatidylglycerol catabolic process;regulation of cell population proliferation;positive regulation of macrophage activation;icosanoid biosynthetic process;arachidonic acid secretion;cellular response to antibiotic	3D-structure;Calcium;Cytoplasm;Direct protein sequencing;Disease mutation;Fatty acid biosynthesis;Fatty acid metabolism;Glycerol metabolism;Golgi apparatus;Hydrolase;Isopeptide bond;Leukotriene biosynthesis;Lipid biosynthesis;Lipid degradation;Lipid metabolism;Lipid-binding;Membrane;Metal-binding;Nucleus;Phospholipid degradation;Phospholipid metabolism;Phosphoprotein;Polymorphism;Prostaglandin biosynthesis;Prostaglandin metabolism;Ubl conjugation	R-HSA-109582;R-HSA-5653656;R-HSA-1430728;R-HSA-556833;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-8978868;R-HSA-199991;R-HSA-6811442;R-HSA-8856688;R-HSA-418594;R-HSA-6811436;R-HSA-111885;R-HSA-112040;R-HSA-112043;R-HSA-392518;R-HSA-76002;R-HSA-1483257;R-HSA-418346;R-HSA-2142753;R-HSA-1483206;R-HSA-418592;R-HSA-1483166;R-HSA-1482788;R-HSA-1482801;R-HSA-1482839;R-HSA-1482922;R-HSA-1482925;R-HSA-111996;R-HSA-1482798;R-HSA-432142;R-HSA-1483115;R-HSA-111995	Hemostasis;Vesicle-mediated transport;Metabolism;Metabolism of lipids;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Fatty acid metabolism;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;G alpha (i) signalling events;COPI-independent Golgi-to-ER retrograde traffic;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Signal amplification;Platelet activation, signaling and aggregation;Phospholipid metabolism;Platelet homeostasis;Arachidonic acid metabolism;Glycerophospholipid biosynthesis;ADP signalling through P2Y purinoceptor 1;Synthesis of PA;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Ca-dependent events;Acyl chain remodeling of CL;Platelet sensitization by LDL;Hydrolysis of LPC;phospho-PLA2 pathway
COQ6	negative	PPP6C	ENSG00000119414	COQ6	1	COQ6	1	0.00599052570587644	WBGene00007922	WBGene00007922(0)			GO:0005737;GO:0046872;GO:0016787;GO:0005739;GO:0004721;GO:0005515;GO:0007049;GO:0002376;GO:0045087;GO:0000139;GO:0005829;GO:0000082;GO:0004722;GO:0006470;GO:0048208	hydrolase activity;cytoplasm;metal ion binding;mitochondrion;phosphoprotein phosphatase activity;protein binding;cell cycle;protein dephosphorylation;immune system process;innate immune response;Golgi membrane;cytosol;G1/S transition of mitotic cell cycle;protein serine/threonine phosphatase activity;COPII vesicle coating	Acetylation;Alternative splicing;Cell cycle;Cytoplasm;Direct protein sequencing;Hydrolase;Immunity;Innate immunity;Manganese;Metal-binding;Mitochondrion;Protein phosphatase;Reference proteome	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport
COQ6	negative	AFTPH	ENSG00000119844	COQ6	1	COQ6	1	0.00599052570587644	WBGene00021561	WBGene00021561(0)			GO:0005737;GO:0015031;GO:0005794;GO:0043231;GO:0005634;GO:0005829;GO:0046907;GO:0030276;GO:0032588;GO:0030121	cytoplasm;protein transport;Golgi apparatus;intracellular membrane-bounded organelle;nucleoplasm;cytosol;intracellular transport;clathrin binding;trans-Golgi network membrane;AP-1 adaptor complex	Alternative splicing;Cytoplasm;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Transport		
COQ6	negative	NAA50	ENSG00000121579	COQ6	1	COQ6	1	0.00599052570587644	WBGene00018238;WBGene00018831	WBGene00018238(0)			GO:0005634;GO:0005737;GO:0016740;GO:0016746;GO:0005829;GO:0005515;GO:0008080;GO:0043967;GO:0070062;GO:0010485;GO:0004596;GO:0006474;GO:0031415;GO:0016573;GO:0007064;GO:0071962;GO:0052858;GO:0034087	N-acetyltransferase activity;nucleus;cytoplasm;transferase activity;transferase activity, transferring acyl groups;cytosol;protein binding;histone H4 acetylation;extracellular exosome;H4 histone acetyltransferase activity;peptide alpha-N-acetyltransferase activity;N-terminal protein amino acid acetylation;NatA complex;histone acetylation;mitotic sister chromatid cohesion;mitotic sister chromatid cohesion, centromeric;peptidyl-lysine acetyltransferase activity;establishment of mitotic sister chromatid cohesion	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Transferase		
COQ6	negative	NMI	ENSG00000123609	COQ6	1	COQ6	1	0.00599052570587644					GO:0005737;GO:0005829;GO:0005654;GO:0003712;GO:0006366;GO:0005515;GO:1903506;GO:0042802;GO:0006954;GO:0007259;GO:0032480;GO:0045355;GO:0045358;GO:0045824;GO:0060333;GO:1902524	transcription coregulator activity;transcription by RNA polymerase II;interferon-gamma-mediated signaling pathway;cytoplasm;nucleoplasm;cytosol;protein binding;regulation of nucleic acid-templated transcription;identical protein binding;inflammatory response;receptor signaling pathway via JAK-STAT;negative regulation of type I interferon production;negative regulation of interferon-alpha biosynthetic process;negative regulation of interferon-beta biosynthetic process;negative regulation of innate immune response;positive regulation of protein K48-linked ubiquitination	Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome		
COQ6	negative	TPST2	ENSG00000128294	COQ6	1	COQ6	1	0.00599052570587644	WBGene00013737;WBGene00018365	WBGene00018365(1);WBGene00013737(1)			GO:0016020;GO:0016021;GO:0016740;GO:0005794;GO:0042803;GO:0008476;GO:0006478;GO:0000139;GO:0005783;GO:0050427	protein-tyrosine sulfotransferase activity;peptidyl-tyrosine sulfation;membrane;integral component of membrane;transferase activity;Golgi apparatus;protein homodimerization activity;Golgi membrane;endoplasmic reticulum;3'-phosphoadenosine 5'-phosphosulfate metabolic process;sulfotransferase activity	3D-structure;Disulfide bond;Glycoprotein;Golgi apparatus;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-156580;R-HSA-211859;R-HSA-156584	Metabolism;Phase II - Conjugation of compounds;Biological oxidations;Cytosolic sulfonation of small molecules
COQ6	negative	SPCS3	ENSG00000129128	COQ6	1	COQ6	1	0.00599052570587644	WBGene00019679	WBGene00019679(0)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0031090;GO:0043231;GO:0016787;GO:0008233;GO:0006508;GO:0006465;GO:0005787;GO:0045047;GO:0019082	integral component of membrane;peptidase activity;signal peptide processing;signal peptidase complex;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle;hydrolase activity;proteolysis;protein targeting to ER;viral protein processing	Endoplasmic reticulum;Glycoprotein;Hydrolase;Membrane;Microsome;Protease;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-2980736;R-HSA-381771;R-HSA-400508;R-HSA-72766;R-HSA-400511;R-HSA-422085;R-HSA-1799339	Metabolism of proteins;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Incretin synthesis, secretion, and inactivation;Translation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;SRP-dependent cotranslational protein targeting to membrane
COQ6	negative	SAT1	ENSG00000130066	COQ6	1	COQ6	1	0.00599052570587644	WBGene00008408	WBGene00008408(1)		Keratosis follicularis spinulosa decalvans	GO:0004145;GO:0005515;GO:0008080;GO:0005737;GO:0016740;GO:0016746;GO:0042802;GO:0005829;GO:0019809;GO:0006595;GO:0006598;GO:0032918;GO:0042127;GO:0001525;GO:0005622;GO:0006596;GO:0009447	protein binding;diamine N-acetyltransferase activity;N-acetyltransferase activity;cytoplasm;transferase activity;transferase activity, transferring acyl groups;cytosol;identical protein binding;spermidine binding;polyamine metabolic process;polyamine catabolic process;spermidine acetylation;regulation of cell population proliferation;angiogenesis;intracellular;polyamine biosynthetic process;putrescine catabolic process	3D-structure;Acyltransferase;Cytoplasm;Direct protein sequencing;Reference proteome;Transferase	R-HSA-1430728;R-HSA-71291;R-HSA-351202;R-HSA-351200	Metabolism;Metabolism of amino acids and derivatives;Metabolism of polyamines;Interconversion of polyamines
COQ6	negative	SLC6A6	ENSG00000131389	COQ6	1	COQ6	1	0.00599052570587644	WBGene00004902;WBGene00004910				GO:0016020;GO:0016021;GO:0005887;GO:0015293;GO:0005328;GO:0006836;GO:0055085;GO:0005368;GO:0005369;GO:0015734;GO:0050804;GO:0098982;GO:0099055;GO:0005886;GO:0003333;GO:0043005;GO:0015812;GO:0015171;GO:0006865;GO:0005332;GO:0042165	integral component of membrane;membrane;integral component of plasma membrane;taurine:sodium symporter activity;neurotransmitter transport;neurotransmitter:sodium symporter activity;symporter activity;transmembrane transport;taurine transmembrane transporter activity;taurine transport;modulation of chemical synaptic transmission;GABA-ergic synapse;integral component of postsynaptic membrane;plasma membrane;amino acid transmembrane transport;neuron projection;gamma-aminobutyric acid transmembrane transporter activity;gamma-aminobutyric acid import;import across plasma membrane;plasma membrane protein complex;amino acid transmembrane transporter activity;amino acid transport;gamma-aminobutyric acid:sodium symporter activity;neurotransmitter binding	Alternative splicing;Cell membrane;Glycoprotein;Membrane;Neurotransmitter transport;Phosphoprotein;Polymorphism;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-425407;R-HSA-425393;R-HSA-425366;R-HSA-442660;R-HSA-352230	Transport of small molecules;SLC-mediated transmembrane transport;Transport of inorganic cations/anions and amino acids/oligopeptides;Transport of bile salts and organic acids, metal ions and amine compounds;Na+/Cl- dependent neurotransmitter transporters;Amino acid transport across the plasma membrane
COQ6	negative	TMEM258	ENSG00000134825	COQ6	1	COQ6	1	0.00599052570587644	WBGene00021960	WBGene00021960(1)			GO:0016020;GO:0016021;GO:0005783;GO:0006487;GO:0006486;GO:0034998	protein N-linked glycosylation;oligosaccharyltransferase I complex;membrane;integral component of membrane;endoplasmic reticulum;protein glycosylation;protein-containing complex;membrane-bounded organelle	3D-structure;Acetylation;Direct protein sequencing;Endoplasmic reticulum;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ6	negative	GLUL	ENSG00000135821	COQ6	1	COQ6	1	0.00599052570587644	WBGene00001604;WBGene00001602;WBGene00001603;WBGene00001606;WBGene00001607	WBGene00001604(0);WBGene00001602(0);WBGene00001606(0);WBGene00001607(0)		Congenital brain dysgenesis due to glutamine synthetase deficiency;CONGENITAL SYSTEMIC GLUTAMINE DEFICIENCY;GLUTAMINE DEFICIENCY CONGENITAL	GO:0000166;GO:0005524;GO:0003824;GO:0016874;GO:0006807;GO:0004356;GO:0006542;GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0005829;GO:0005783;GO:0043231;GO:0005739;GO:0019706;GO:0005886;GO:0005515;GO:0042254;GO:0042802;GO:0070062;GO:0008283;GO:0001525;GO:1904749;GO:0008652;GO:0006538;GO:0010594;GO:1903670;GO:0001504;GO:0018345;GO:0000287;GO:0016595;GO:0030145;GO:0045503;GO:0006536;GO:0009267;GO:0009749;GO:0019676;GO:0032024;GO:0050679;GO:0051260;GO:0051968;GO:0005791;GO:0032991;GO:0042995;GO:0043005;GO:0043204;GO:0043209;GO:0043679;GO:0044297;GO:0097386	catalytic activity;nitrogen compound metabolic process;glutamate-ammonia ligase activity;glutamine biosynthetic process;nucleotide binding;ATP binding;ligase activity;nucleus;cytoplasm;membrane;metal ion binding;transferase activity;cytosol;endoplasmic reticulum;intracellular membrane-bounded organelle;mitochondrion;protein-cysteine S-palmitoyltransferase activity;plasma membrane;protein binding;ribosome biogenesis;identical protein binding;extracellular exosome;angiogenesis;regulation of protein localization to nucleolus;cell population proliferation;cellular amino acid biosynthetic process;glutamate catabolic process;regulation of endothelial cell migration;regulation of sprouting angiogenesis;neurotransmitter uptake;protein palmitoylation;magnesium ion binding;glutamate binding;manganese ion binding;dynein light chain binding;glutamate metabolic process;cellular response to starvation;response to glucose;ammonia assimilation cycle;positive regulation of insulin secretion;positive regulation of epithelial cell proliferation;positive regulation of synaptic transmission, glutamatergic;rough endoplasmic reticulum;protein-containing complex;cell projection;neuron projection;perikaryon;myelin sheath;axon terminus;cell body;glial cell projection	3D-structure;ATP-binding;Acetylation;Angiogenesis;Cell membrane;Cytoplasm;Disease mutation;Endoplasmic reticulum;Ligase;Lipoprotein;Magnesium;Manganese;Membrane;Metal-binding;Microsome;Mitochondrion;Nucleotide-binding;Palmitate;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation	R-HSA-1430728;R-HSA-71291;R-HSA-112315;R-HSA-112316;R-HSA-8964539;R-HSA-112313;R-HSA-210455	Metabolism;Metabolism of amino acids and derivatives;Transmission across Chemical Synapses;Neuronal System;Glutamate and glutamine metabolism;Neurotransmitter uptake and metabolism In glial cells;Astrocytic Glutamate-Glutamine Uptake And Metabolism
COQ6	negative	RAB5A	ENSG00000144566	COQ6	1	COQ6	1	0.00599052570587644	WBGene00004268				GO:0003924;GO:0005525;GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0005829;GO:0005886;GO:0042995;GO:0005515;GO:0042470;GO:0031410;GO:0006886;GO:0005768;GO:0005769;GO:0006897;GO:0070062;GO:0030670;GO:0045022;GO:0031901;GO:0032482;GO:0010008;GO:0043687;GO:0030424;GO:0008021;GO:0030425;GO:0001726;GO:0019003;GO:0045921;GO:0006909;GO:0061024;GO:0006661;GO:0036465;GO:0043195;GO:0030665;GO:0039694;GO:0007596;GO:0032009;GO:0045335;GO:0043025;GO:0051489;GO:0036477;GO:2000300;GO:0098993;GO:0048169;GO:0051036;GO:0150093;GO:2000286;GO:2000785;GO:0043679;GO:0098559;GO:0098842;GO:0019001;GO:0015629;GO:0030139;GO:0045121	GTP binding;GTPase activity;protein binding;cytoplasm;membrane;protein transport;nucleotide binding;hydrolase activity;endosome;cytosol;plasma membrane;cell projection;melanosome;guanyl nucleotide binding;endocytosis;ruffle;early endosome;actin cytoskeleton;endocytic vesicle;early phagosome;membrane raft;phagocytic vesicle;cytoplasmic vesicle;intracellular protein transport;extracellular exosome;phagocytic vesicle membrane;early endosome to late endosome transport;early endosome membrane;Rab protein signal transduction;endomembrane system;endosome membrane;post-translational protein modification;axon;synaptic vesicle;dendrite;GDP binding;positive regulation of exocytosis;phagocytosis;membrane organization;phosphatidylinositol biosynthetic process;synaptic vesicle recycling;terminal bouton;clathrin-coated vesicle membrane;viral RNA genome replication;blood coagulation;neuronal cell body;regulation of filopodium assembly;somatodendritic compartment;regulation of synaptic vesicle exocytosis;anchored component of synaptic vesicle membrane;regulation of long-term neuronal synaptic plasticity;regulation of endosome size;amyloid-beta clearance by transcytosis;receptor internalization involved in canonical Wnt signaling pathway;regulation of autophagosome assembly;axon terminus;cytoplasmic side of early endosome membrane;postsynaptic early endosome	3D-structure;Alternative splicing;Cell membrane;Cell projection;Cytoplasm;Cytoplasmic vesicle;Endocytosis;Endosome;GTP-binding;Hydrolase;Lipoprotein;Membrane;Nucleotide-binding;Phagocytosis;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-109582;R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-556833;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719;R-HSA-983231;R-HSA-8856828;R-HSA-1483255;R-HSA-1483257;R-HSA-1660499;R-HSA-8854214	Hemostasis;Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Metabolism;Metabolism of lipids;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation;Factors involved in megakaryocyte development and platelet production;Clathrin-mediated endocytosis;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;TBC/RABGAPs
COQ6	negative	CISD2	ENSG00000145354	COQ6	1	COQ6	1	0.00599052570587644	WBGene00044026	WBGene00044026(0)		Wolfram syndrome;Wolfram syndrome type 2;WOLFRAM SYNDROME 2	GO:0051537;GO:0043231;GO:0003723;GO:0016020;GO:0016021;GO:0046872;GO:0005783;GO:0005789;GO:0005739;GO:0042803;GO:0005515;GO:0005741;GO:0006914;GO:0051536;GO:0010506;GO:0097038;GO:0032991;GO:0010259;GO:0000422	2 iron, 2 sulfur cluster binding;intracellular membrane-bounded organelle;RNA binding;membrane;integral component of membrane;metal ion binding;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;protein homodimerization activity;protein binding;mitochondrial outer membrane;autophagy;iron-sulfur cluster binding;regulation of autophagy;perinuclear endoplasmic reticulum;protein-containing complex;multicellular organism aging;autophagy of mitochondrion	2Fe-2S;3D-structure;Autophagy;Deafness;Diabetes mellitus;Direct protein sequencing;Endoplasmic reticulum;Iron;Iron-sulfur;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ6	negative	SCLT1	ENSG00000151466	COQ6	1	COQ6	1	0.00599052570587644					GO:0045162;GO:0005737;GO:0005856;GO:0005813;GO:0060271;GO:0005829;GO:0005814;GO:0097711;GO:0097539;GO:0008022;GO:0017080;GO:0030276;GO:0071439	clustering of voltage-gated sodium channels;cytoplasm;cytoskeleton;centrosome;cilium assembly;cytosol;centriole;ciliary basal body-plasma membrane docking;ciliary transition fiber;protein C-terminus binding;sodium channel regulator activity;clathrin binding;clathrin complex	Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
COQ6	negative	CENPU	ENSG00000151725	COQ6	1	COQ6	1	0.00599052570587644					GO:0005634;GO:0005737;GO:0005694;GO:0005515;GO:0005815;GO:0000775;GO:0000776;GO:0000777;GO:0005654;GO:0005829;GO:0016032;GO:0034080;GO:0043009	nucleus;cytoplasm;nucleoplasm;chromosome;protein binding;centriolar satellite;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;viral process;CENP-A containing nucleosome assembly;chordate embryonic development	Alternative splicing;Centromere;Chromosome;Coiled coil;Cytoplasm;Host-virus interaction;Isopeptide bond;Kinetochore;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ6	negative	AZIN1	ENSG00000155096	COQ6	1	COQ6	1	0.00599052570587644	WBGene00003844;WBGene00018764	WBGene00018764(0)			GO:0005634;GO:0003824;GO:0043085;GO:0005515;GO:0042978;GO:0006596;GO:1902269;GO:0005737;GO:0005829;GO:0006521;GO:0042177;GO:0004586;GO:0033387	catalytic activity;polyamine biosynthetic process;ornithine decarboxylase activator activity;nucleus;positive regulation of catalytic activity;protein binding;positive regulation of polyamine transmembrane transport;cytoplasm;cytosol;regulation of cellular amino acid metabolic process;negative regulation of protein catabolic process;ornithine decarboxylase activity;putrescine biosynthetic process from ornithine	3D-structure;Nucleus;Polyamine biosynthesis;Reference proteome;Ubl conjugation	R-HSA-1430728;R-HSA-71291;R-HSA-350562;R-HSA-351202	Metabolism;Metabolism of amino acids and derivatives;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines
COQ6	negative	UBE2L6	ENSG00000156587	COQ6	1	COQ6	1	0.00599052570587644	WBGene00006713;WBGene00006719	WBGene00006720(0);WBGene00006713(0)			GO:0016740;GO:0016567;GO:0005515;GO:0031625;GO:0061631;GO:0006511;GO:0000151;GO:0005654;GO:0005829;GO:0044267;GO:0004842;GO:0006464;GO:0042296;GO:0043130;GO:0019985;GO:0032020;GO:0032480;GO:0019787;GO:0019941;GO:0000166;GO:0005524	transferase activity;protein ubiquitination;protein binding;ubiquitin protein ligase binding;ubiquitin conjugating enzyme activity;ubiquitin-dependent protein catabolic process;ubiquitin ligase complex;nucleoplasm;cytosol;cellular protein metabolic process;ubiquitin-protein transferase activity;cellular protein modification process;ISG15 transferase activity;ubiquitin binding;translesion synthesis;ISG15-protein conjugation;negative regulation of type I interferon production;ubiquitin-like protein transferase activity;modification-dependent protein catabolic process;nucleotide binding;ATP binding	3D-structure;Alternative splicing;Direct protein sequencing;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-983168;R-HSA-983169;R-HSA-977225;R-HSA-73894;R-HSA-1280215;R-HSA-1169408;R-HSA-1169410;R-HSA-913531;R-HSA-168928;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-936440	Adaptive Immune System;Innate Immune System;Immune System;Metabolism of proteins;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Amyloid fiber formation;DNA Repair;Cytokine Signaling in Immune system;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Negative regulators of DDX58/IFIH1 signaling
COQ6	negative	TCHH	ENSG00000159450	COQ6	1	COQ6	1	0.00599052570587644	WBGene00000100;WBGene00009888;WBGene00044201			UNCOMBABLE HAIR SYNDROME 3	GO:0046872;GO:0005509;GO:0005856;GO:0046914;GO:0031424;GO:0005829;GO:0008150;GO:0070268;GO:0001533;GO:0045109	calcium ion binding;transition metal ion binding;metal ion binding;cytoskeleton;keratinization;cytosol;biological_process;cornification;cornified envelope;intermediate filament organization	Calcium;Citrullination;Keratinization;Metal-binding;Polymorphism;Reference proteome;Repeat	R-HSA-1266738;R-HSA-6805567;R-HSA-6809371	Developmental Biology;Keratinization;Formation of the cornified envelope
COQ6	negative	SLC37A1	ENSG00000160190	COQ6	1	COQ6	1	0.00599052570587644	WBGene00011688;WBGene00011717;WBGene00011718;WBGene00011719	WBGene00010931(0);WBGene00011185(0);WBGene00012443(0);WBGene00019187(0);WBGene00021157(0);WBGene00021158(0);WBGene00019655(0);WBGene00020700(0);WBGene00011556(0);WBGene00010755(0);WBGene00018920(0);WBGene00021226(0);WBGene00018918(0);WBGene00021223(0);WBGene00018429(0);WBGene00001135(0);WBGene00015272(0);WBGene00021220(0);WBGene00008000(0);WBGene00015271(0);WBGene00021219(0);WBGene00020584(0);WBGene00016003(0);WBGene00020583(0);WBGene00008677(0);WBGene00007669(0);WBGene00020697(0);WBGene00020698(0);WBGene00020699(0);WBGene00302978(0)			GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005887;GO:0005783;GO:0005789;GO:0015297;GO:0008643;GO:0030176;GO:0015760;GO:0061513;GO:0035435	integral component of membrane;transmembrane transporter activity;transmembrane transport;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;antiporter activity;carbohydrate transport;integral component of endoplasmic reticulum membrane;glucose-6-phosphate transport;glucose 6-phosphate:inorganic phosphate antiporter activity;phosphate ion transmembrane transport	Antiport;Endoplasmic reticulum;Glycoprotein;Membrane;Polymorphism;Reference proteome;Sugar transport;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-70326;R-HSA-71387;R-HSA-70263	Metabolism;Glucose metabolism;Metabolism of carbohydrates;Gluconeogenesis
COQ6	negative	CXCL16	ENSG00000161921	COQ6	1	COQ6	1	0.00599052570587644					GO:0005615;GO:0030335;GO:0016020;GO:0016021;GO:0005886;GO:0005576;GO:0006935;GO:0005044;GO:0005125;GO:0008009;GO:0006898;GO:0007186;GO:0005041;GO:0030307;GO:0034097;GO:0034341;GO:0034612;GO:0048247;GO:0010818	chemotaxis;chemokine activity;scavenger receptor activity;receptor-mediated endocytosis;low-density lipoprotein particle receptor activity;positive regulation of cell growth;positive regulation of cell migration;response to cytokine;response to interferon-gamma;response to tumor necrosis factor;lymphocyte chemotaxis;extracellular space;membrane;integral component of membrane;plasma membrane;extracellular region;cytokine activity;G protein-coupled receptor signaling pathway;T cell chemotaxis	Cell membrane;Chemotaxis;Cytokine;Disulfide bond;Glycoprotein;Membrane;Polymorphism;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-500792;R-HSA-373076;R-HSA-375276;R-HSA-380108	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines
COQ6	negative	SYK	ENSG00000165025	COQ6	1	COQ6	1	0.00599052570587644					GO:0005737;GO:0016020;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0035556;GO:0004713;GO:0005829;GO:0005886;GO:0005515;GO:0004715;GO:0007229;GO:0002376;GO:0045087;GO:0002250;GO:0038095;GO:0038096;GO:0050853;GO:0042742;GO:0030593;GO:0002223;GO:0016032;GO:0032991;GO:0001525;GO:0032753;GO:0005178;GO:0030168;GO:0005634;GO:0001784;GO:0120162;GO:0009887;GO:0045780;GO:0002366;GO:0004674;GO:0001945;GO:0048514;GO:0050764;GO:0032009;GO:0032930;GO:0042535;GO:0045410;GO:0031623;GO:0006606;GO:0070372;GO:0043280;GO:0038110;GO:0010543;GO:0045416;GO:0042101;GO:0007159;GO:0071404;GO:0090330;GO:0033630;GO:0031334;GO:0002281;GO:0002283;GO:0038156;GO:0016170;GO:0002554;GO:0010803;GO:0032928;GO:0043306;GO:0043313;GO:0045082;GO:0045084;GO:0045579;GO:0046641;GO:0051090;GO:0051712;GO:0071226;GO:0071639;GO:0090237;GO:0018108;GO:0019901;GO:0019902;GO:0035325;GO:0042169;GO:0000187;GO:0001820;GO:0002092;GO:0007166;GO:0007167;GO:0007257;GO:0018105;GO:0019370;GO:0032481;GO:0038063;GO:0043366;GO:0045401;GO:0045425;GO:0045588;GO:0046638;GO:0046777;GO:0050715;GO:0050731;GO:0050850;GO:0019815	ATP binding;cytoplasm;protein phosphorylation;intracellular signal transduction;protein kinase activity;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;membrane;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;plasma membrane;protein binding;integrin-mediated signaling pathway;immune system process;innate immune response;adaptive immune response;Fc-epsilon receptor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;B cell receptor signaling pathway;defense response to bacterium;neutrophil chemotaxis;phosphotyrosine residue binding;stimulatory C-type lectin receptor signaling pathway;viral process;protein-containing complex;angiogenesis;positive regulation of interleukin-4 production;integrin binding;platelet activation;nucleus;positive regulation of cold-induced thermogenesis;animal organ morphogenesis;positive regulation of bone resorption;leukocyte activation involved in immune response;protein serine/threonine kinase activity;lymph vessel development;blood vessel morphogenesis;positive regulation of interleukin-8 biosynthetic process;regulation of phagocytosis;early phagosome;positive regulation of superoxide anion generation;positive regulation of tumor necrosis factor biosynthetic process;positive regulation of interleukin-6 biosynthetic process;receptor internalization;macrophage activation involved in immune response;protein import into nucleus;regulation of ERK1 and ERK2 cascade;interleukin-2-mediated signaling pathway;positive regulation of protein-containing complex assembly;regulation of platelet activation;T cell receptor complex;leukocyte cell-cell adhesion;cellular response to low-density lipoprotein particle stimulus;regulation of platelet aggregation;positive regulation of cell adhesion mediated by integrin;neutrophil activation involved in immune response;interleukin-3-mediated signaling pathway;interleukin-15 receptor binding;serotonin secretion by platelet;regulation of tumor necrosis factor-mediated signaling pathway;regulation of superoxide anion generation;positive regulation of mast cell degranulation;regulation of neutrophil degranulation;positive regulation of interleukin-10 biosynthetic process;positive regulation of interleukin-12 biosynthetic process;positive regulation of B cell differentiation;positive regulation of alpha-beta T cell proliferation;regulation of DNA-binding transcription factor activity;positive regulation of killing of cells of other organism;cellular response to molecule of fungal origin;positive regulation of monocyte chemotactic protein-1 production;regulation of arachidonic acid secretion;peptidyl-tyrosine phosphorylation;protein kinase binding;phosphatase binding;Toll-like receptor binding;SH2 domain binding;activation of MAPK activity;serotonin secretion;positive regulation of receptor internalization;cell surface receptor signaling pathway;enzyme linked receptor protein signaling pathway;activation of JUN kinase activity;peptidyl-serine phosphorylation;leukotriene biosynthetic process;positive regulation of type I interferon production;collagen-activated tyrosine kinase receptor signaling pathway;beta selection;positive regulation of interleukin-3 biosynthetic process;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;positive regulation of gamma-delta T cell differentiation;positive regulation of alpha-beta T cell differentiation;protein autophosphorylation;positive regulation of cytokine secretion;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of calcium-mediated signaling;B cell receptor complex	3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Angiogenesis;Cell membrane;Cytoplasm;Host-virus interaction;Immunity;Innate immunity;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH2 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-983695;R-HSA-983705;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-5607764;R-HSA-5621481;R-HSA-2172127;R-HSA-76002;R-HSA-451927;R-HSA-512988;R-HSA-912631;R-HSA-114604;R-HSA-2424491;R-HSA-354192;R-HSA-76009;R-HSA-9006921;R-HSA-9020558;R-HSA-5621480	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);DAP12 interactions;Platelet activation, signaling and aggregation;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Regulation of signaling by CBL;GPVI-mediated activation cascade;DAP12 signaling;Integrin signaling;Platelet Aggregation (Plug Formation);;Interleukin-2 signaling;Dectin-2 family
COQ6	negative	C18orf54	ENSG00000166845	COQ6	1	COQ6	1	0.00599052570587644					GO:0005515;GO:0005576;GO:0008285	protein binding;extracellular region;negative regulation of cell population proliferation	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal		
COQ6	negative	NUDT21	ENSG00000167005	COQ6	1	COQ6	1	0.00599052570587644	WBGene00009668	WBGene00009668(1)			GO:0003723;GO:0003729;GO:0006397;GO:0005634;GO:0005737;GO:0042803;GO:0016787;GO:0005515;GO:0016604;GO:0005815;GO:0006378;GO:0003682;GO:0010608;GO:2000738;GO:2000975;GO:0005849;GO:0030154;GO:0042802;GO:0005654;GO:0031124;GO:0000398;GO:0042826;GO:0035925;GO:0006369;GO:0031439;GO:0051262;GO:0051290;GO:0098789;GO:0110104;GO:1900365;GO:1990120;GO:0005813;GO:0005847;GO:0042382	hydrolase activity;mRNA binding;mRNA polyadenylation;mRNA cleavage factor complex;RNA binding;mRNA processing;nucleus;cytoplasm;protein homodimerization activity;protein binding;nuclear body;centriolar satellite;identical protein binding;chromatin binding;posttranscriptional regulation of gene expression;positive regulation of stem cell differentiation;positive regulation of pro-B cell differentiation;cell differentiation;nucleoplasm;mRNA 3'-end processing;mRNA splicing, via spliceosome;histone deacetylase binding;AU-rich element binding;mRNA 3'-UTR AU-rich region binding;termination of RNA polymerase II transcription;positive regulation of mRNA cleavage;protein tetramerization;protein heterotetramerization;pre-mRNA cleavage required for polyadenylation;mRNA alternative polyadenylation;positive regulation of mRNA polyadenylation;messenger ribonucleoprotein complex assembly;centrosome;mRNA cleavage and polyadenylation specificity factor complex;paraspeckles	3D-structure;Acetylation;Cytoplasm;Differentiation;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-75067;R-HSA-77595	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs
COQ6	negative	ING2	ENSG00000168556	COQ6	1	COQ6	1	0.00599052570587644	WBGene00013095;WBGene00021545;WBGene00020287	WBGene00020287(0)	MMP13		GO:0005634;GO:0005794;GO:0046872;GO:0005829;GO:0005654;GO:0042981;GO:0003677;GO:0006325;GO:0005515;GO:0003682;GO:0008285;GO:0045893;GO:0035091;GO:0040008;GO:2000772;GO:0007165;GO:0006355;GO:0030511;GO:0044877;GO:0035064;GO:0005886;GO:1902166;GO:0007283;GO:0016602;GO:0031065;GO:0030317;GO:0007286;GO:0016580;GO:0007141;GO:0048133;GO:0072520;GO:2001020;GO:2001234	nucleus;regulation of apoptotic process;chromatin binding;chromatin organization;negative regulation of cell population proliferation;regulation of cellular senescence;Golgi apparatus;metal ion binding;nucleoplasm;cytosol;DNA binding;protein binding;positive regulation of transcription, DNA-templated;phosphatidylinositol binding;regulation of growth;regulation of transcription, DNA-templated;signal transduction;positive regulation of transforming growth factor beta receptor signaling pathway;protein-containing complex binding;methylated histone binding;plasma membrane;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;spermatogenesis;CCAAT-binding factor complex;positive regulation of histone deacetylation;flagellated sperm motility;spermatid development;Sin3 complex;male meiosis I;male germ-line stem cell asymmetric division;seminiferous tubule development;regulation of response to DNA damage stimulus;negative regulation of apoptotic signaling pathway	Alternative splicing;Chromatin regulator;Coiled coil;Direct protein sequencing;Growth regulation;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-2990846;R-HSA-3108232;R-HSA-5633007;R-HSA-3899300;R-HSA-6804758;R-HSA-6811555	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);SUMOylation;SUMO E3 ligases SUMOylate target proteins;Regulation of TP53 Activity;SUMOylation of transcription cofactors;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation
COQ6	negative	MFF	ENSG00000168958	COQ6	1	COQ6	1	0.00599052570587644		WBGene00018894(0)		MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect;ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION2	GO:0016020;GO:0016021;GO:0005739;GO:0042803;GO:0030054;GO:0031410;GO:0045202;GO:0005741;GO:0005777;GO:0005515;GO:0090314;GO:0051260;GO:0001836;GO:0000266;GO:0010821;GO:0016559;GO:0043653;GO:0070584;GO:0090200;GO:1900063;GO:0008021;GO:0008053;GO:0006626;GO:0032592;GO:0090141	membrane;integral component of membrane;mitochondrion;protein homodimerization activity;protein binding;cell junction;cytoplasmic vesicle;identical protein binding;mitochondrial outer membrane;synapse;peroxisome;positive regulation of protein targeting to membrane;protein-containing complex;release of cytochrome c from mitochondria;mitochondrial fission;regulation of mitochondrion organization;peroxisome fission;mitochondrial fragmentation involved in apoptotic process;mitochondrion morphogenesis;positive regulation of release of cytochrome c from mitochondria;regulation of peroxisome organization;synaptic vesicle;mitochondrial fusion;protein targeting to mitochondrion;integral component of mitochondrial membrane;positive regulation of mitochondrial fission	Alternative splicing;Cell junction;Coiled coil;Cytoplasmic vesicle;Membrane;Mitochondrion;Mitochondrion outer membrane;Peroxisome;Phosphoprotein;Polymorphism;Reference proteome;Synapse;Transmembrane;Transmembrane helix		
COQ6	negative	CAMTA1	ENSG00000171735	COQ6	1	COQ6	1	0.00599052570587644	WBGene00020251			Epithelioid hemangioendothelioma;Non-progressive cerebellar ataxia with intellectual disability;CEREBELLAR ATAXIA NONPROGRESSIVE WITH MENTAL RETARDATION;CEREBELLAR ATAXIA NONPROGRESSIVE WITH MENTAL RETARDATION	GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0003677;GO:0000981;GO:0043565;GO:0045944;GO:0035307;GO:0070886;GO:0050885;GO:0005515;GO:0006357	DNA binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nucleus;cytoplasm;nucleolus;cytosol;sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;positive regulation of protein dephosphorylation;positive regulation of calcineurin-NFAT signaling cascade;neuromuscular process controlling balance;regulation of transcription by RNA polymerase II	3D-structure;ANK repeat;Activator;Alternative splicing;Cytoplasm;Mental retardation;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation		
COQ6	negative	KCMF1	ENSG00000176407	COQ6	1	COQ6	1	0.00599052570587644	WBGene00022785	WBGene00022785(0)			GO:0003676;GO:0008270;GO:0046872;GO:0016740;GO:0005829;GO:0016567;GO:0061630;GO:0005576;GO:0043312;GO:1904813	zinc ion binding;nucleic acid binding;ubiquitin protein ligase activity;metal ion binding;transferase activity;cytosol;protein ubiquitination;extracellular region;neutrophil degranulation;ficolin-1-rich granule lumen	Acetylation;Coiled coil;Metal-binding;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ6	negative	UBE2L3	ENSG00000185651	COQ6	1	COQ6	1	0.00599052570587644	WBGene00006713			Systemic lupus erythematosus	GO:0005737;GO:0003723;GO:0005634;GO:0000166;GO:0005524;GO:0016740;GO:0016567;GO:1903508;GO:0005515;GO:0004842;GO:0006511;GO:0003713;GO:0031625;GO:0061631;GO:0070979;GO:0000151;GO:0005654;GO:0005829;GO:0008283;GO:0019899;GO:0006355;GO:0006464;GO:1903955;GO:0000209;GO:0031398;GO:0071383;GO:0071385;GO:0044770;GO:0097027;GO:0051443	cytoplasm;RNA binding;nucleus;nucleotide binding;ATP binding;transferase activity;protein ubiquitination;positive regulation of nucleic acid-templated transcription;protein binding;ubiquitin-protein transferase activity;ubiquitin-dependent protein catabolic process;transcription coactivator activity;ubiquitin protein ligase binding;ubiquitin conjugating enzyme activity;protein K11-linked ubiquitination;ubiquitin ligase complex;nucleoplasm;cytosol;regulation of transcription, DNA-templated;enzyme binding;cellular protein modification process;positive regulation of protein targeting to mitochondrion;cell population proliferation;protein polyubiquitination;positive regulation of protein ubiquitination;cellular response to steroid hormone stimulus;cellular response to glucocorticoid stimulus;cell cycle phase transition;ubiquitin-protein transferase activator activity;positive regulation of ubiquitin-protein transferase activity	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleotide-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-8866652;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ6	negative	ILRUN	ENSG00000196821	COQ6	1	COQ6	1	0.00599052570587644	WBGene00016490				GO:0005634;GO:0005737;GO:0002376;GO:0045087;GO:0005515;GO:0016236;GO:0005776;GO:0032480;GO:0000407;GO:0043130;GO:0032720;GO:0050687;GO:0043392;GO:1900181	protein binding;nucleus;cytoplasm;immune system process;innate immune response;macroautophagy;negative regulation of type I interferon production;phagophore assembly site;ubiquitin binding;negative regulation of tumor necrosis factor production;negative regulation of defense response to virus;negative regulation of DNA binding;negative regulation of protein localization to nucleus	Alternative splicing;Cytoplasm;Immunity;Innate immunity;Nucleus;Phosphoprotein;Reference proteome		
COQ6	negative	NRAS	ENSG00000213281	COQ6	1	COQ6	1	0.00599052570587644	WBGene00002335;WBGene00004310			Differentiated thyroid carcinoma;Juvenile myelomonocytic leukemia;Large congenital melanocytic nevus;Linear nevus sebaceus syndrome;Noonan Syndrome;RAS-associated autoimmune leukoproliferative disease;Selection of therapeutic option in colorectal cancer;Noonan syndrome type 6;Colorectal Cancer;Melanocytic nevus syndrome congenital;Melanosis neurocutaneous;NEVUS EPIDERMAL;NOONAN SYNDROME 6;RAS-associated autoimmune leukoproliferative disorder;SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME;THYROID CANCER NONMEDULLARY 2	GO:0016020;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0005794;GO:0005886;GO:0005515;GO:0000139;GO:0007265;GO:0070062;GO:0000165;GO:0002223;GO:0043312;GO:0070821;GO:0001938;GO:0044877;GO:0019003	signal transduction;membrane;GTP binding;GTPase activity;nucleotide binding;Golgi apparatus;plasma membrane;protein binding;Golgi membrane;Ras protein signal transduction;extracellular exosome;MAPK cascade;stimulatory C-type lectin receptor signaling pathway;neutrophil degranulation;tertiary granule membrane;positive regulation of endothelial cell proliferation;protein-containing complex binding;GDP binding	3D-structure;Acetylation;Cell membrane;Disease mutation;GTP-binding;Golgi apparatus;Isopeptide bond;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Palmitate;Phosphoprotein;Prenylation;Proto-oncogene;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-2454202;R-HSA-2871796;R-HSA-983705;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-1168372;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5621481;R-HSA-5658442;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-416476;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-2172127;R-HSA-186797;R-HSA-375165;R-HSA-9006934;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-6798695;R-HSA-6802952;R-HSA-6802957;R-HSA-9006335;R-HSA-112399;R-HSA-1433557;R-HSA-166520;R-HSA-186763;R-HSA-187037;R-HSA-194138;R-HSA-210993;R-HSA-2404192;R-HSA-2424491;R-HSA-2428924;R-HSA-2428928;R-HSA-4420097;R-HSA-74751;R-HSA-74752;R-HSA-1227986;R-HSA-1236394;R-HSA-1250196;R-HSA-1250347;R-HSA-1963640;R-HSA-8848021;R-HSA-9006927;R-HSA-177929;R-HSA-442742;R-HSA-442982;R-HSA-1643713;R-HSA-179812;R-HSA-180336;R-HSA-6806834;R-HSA-1226099;R-HSA-5655302;R-HSA-167044;R-HSA-171007;R-HSA-187687;R-HSA-190236;R-HSA-5654738;R-HSA-5655253;R-HSA-5654687;R-HSA-5654688;R-HSA-5654693;R-HSA-5654696;R-HSA-5654699;R-HSA-5654700;R-HSA-5654736;R-HSA-5218921;R-HSA-9634635;R-HSA-5654704;R-HSA-5654706;R-HSA-5654708;R-HSA-5654712;R-HSA-5654716;R-HSA-5654719;R-HSA-5654741;R-HSA-5654743;R-HSA-5655332;R-HSA-8853338;R-HSA-6802949;R-HSA-9006115;R-HSA-9028731;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-9027284;R-HSA-5621575;R-HSA-1169092;R-HSA-1236382;R-HSA-2179392;R-HSA-5637810;R-HSA-5637812;R-HSA-5637815;R-HSA-881907;R-HSA-112412;R-HSA-2428933;R-HSA-5655291;R-HSA-5674135;R-HSA-5675221;R-HSA-6802948;R-HSA-6802953;R-HSA-8849471;R-HSA-8851805;R-HSA-8853334;R-HSA-9026519;R-HSA-9034015;R-HSA-9034864	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Signaling by the B Cell Receptor (BCR);Developmental Biology;Axon guidance;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Disease;Downstream signaling events of B Cell Receptor (BCR);Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;C-type lectin receptors (CLRs);Regulation of RAS by GAPs;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;G alpha (q) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;DAP12 interactions;Signaling by PDGF;NCAM signaling for neurite out-growth;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Neutrophil degranulation;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Signaling by Erythropoietin;IRS-mediated signalling;Signaling by SCF-KIT;Signaling by NTRKs;Downstream signal transduction;Signaling by NTRK1 (TRKA);Signaling by VEGF;Tie2 Signaling;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;VEGFA-VEGFR2 Pathway;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by ERBB2;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;GRB2 events in ERBB2 signaling;Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;Signaling by EGFR;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Ras activation upon Ca2+ influx through NMDA receptor;Signaling by EGFR in Cancer;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Signaling by MET;Signaling by FGFR in disease;Signaling by FGFR1 in disease;Signalling to RAS;p38MAPK events;Signalling to ERKs;Signaling by FGFR;Signaling by FGFR2;Signaling by FGFR2 in disease;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Signaling by FGFR1;VEGFR2 mediated cell proliferation;Estrogen-stimulated signaling through PRKCZ;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR3 in disease;Signaling by FGFR3 point mutants in cancer;Signaling by RAS mutants;Signaling by NTRK2 (TRKB);Activated NTRK2 signals through FRS2 and FRS3;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Erythropoietin activates RAS;CD209 (DC-SIGN) signaling;Activation of RAS in B cells;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;EGFR Transactivation by Gastrin;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Gastrin-CREB signalling pathway via PKC and MAPK;SOS-mediated signalling;SHC-related events triggered by IGF1R;Signaling by FGFR4 in disease;MAP2K and MAPK activation;Negative regulation of MAPK pathway;Signaling by high-kinase activity BRAF mutants;RAS signaling downstream of NF1 loss-of-function variants;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Activated NTRK2 signals through RAS;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS
